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Type 2 diabetes mellitus has been diagnosed in ~21 million people in the 
United States and is closely correlated with obesity, prompting the need for a 
detailed understanding of adipocyte metabolism in the development of diabetes. 
The intake of excess nutrients surpasses the energy requirements of the cell and 
leads to increased mitochondrial stress in the adipocyte. We have shown that 
this is associated with increased levels of the mitochondrial metabolite fumarate. 
Fumarate can react with cysteine thiol groups to form the chemical modification 
S-(2-succino)cysteine (2SC), also termed protein succination. Succination is 
significantly increased in the adipose tissue of type 2 diabetic mouse models 
(ob/ob and db/db) and in adipocytes matured in high glucose medium, resulting 
in impaired protein function. The endoplasmic reticulum (ER) oxidoreductase 
protein disulfide isomerase (PDI) is succinated in adipocytes matured in high 
glucose, and we investigated if succination would alter PDI oxidoreductase 
activity, directly linking mitochondrial stress and ER stress. PDI is succinated by 
fumarate on both CXXC containing active sites, contributing to reduced 
enzymatic activity. In the presence of prolonged ER stress the unfolded protein 
response (UPR) triggers the production of the pro-apoptotic protein C/EBP 
homologous protein (CHOP). Succinated PDI has decreased reductase activity in 
adipocytes matured in high glucose, and in db/db epididymal adipose tissue, in 
association with increased levels of the ER stress marker CHOP. PDI succination 
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and ER stress were decreased, and PDI reductase activity was restored when 
exposure to chronic high glucose was limited, highlighting the importance of 
calorie restriction in the improvement of adipocyte metabolic function. The 
experiments completed in chapter 2 confirm succination of PDI as a novel 
biochemical mechanism linking altered mitochondrial metabolism to perturbed 
ER proteostasis in the adipocyte during diabetes. 
Our observations in chapter 2 consistently demonstrated that CHOP 
levels are elevated in all cases where fumarate and protein succination are 
increased. Here we show that CHOP levels are significantly increased in 
adipocytes matured in high glucose in the absence of UPR signaling and with no 
sign of apoptosis. We propose that the post-translational modification S-2-
succinocysteine may be an alternative physiological regulator of CHOP stability 
under diabetic conditions. Kelch-like ECH-associated protein 1 
(Keap1) negatively regulates CHOP degradation in the adipocyte, and Keap1 is 
succinated in cancers where fumarate levels are elevated. We discovered that 
while Keap1 is directly succinated in the presence of excess fumarate derived 
from genetic knockdown methods, it is the oxidative modification of Keap1 that 
predominates in adipocytes matured in high glucose. Notably, we also 
determined that succination indirectly regulates CHOP stability through the 
induction of oxidative stress. The results shown in chapter 3 demonstrate that 
increased fumarate induces increased oxidative stress and that the oxidation of 
Keap1 contributes to sustained CHOP stability and adipocyte dysfunction during 
diabetes. The studies conducted in chapters 2 and 3 demonstrate that early 
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biochemical changes in mitochondrial metabolism have important implications for 
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1.1 Epidemiology of Obesity and Type 2 Diabetes 
A total of 29.1 million people or 9.3% of the United States population 
were documented to have diabetes in the Center for Disease Control 2014 
National Diabetes Statistics Report. Within this group 21 million people have 
been clinically diagnosed with diabetes, and estimated 8.1 million people suffer 
from undiagnosed/uncontrolled diabetes (CDC 2014). Prediabetes, a condition 
that often precedes the development of Type 2 diabetes, is estimated to occur in 
86 million people based on an irregular hemoglobin A1C (>6.5%) and elevated 
fasting blood glucose levels (>126 mg/dL or 7 mM). Type 2 diabetes is primarily 
diagnosed in adults aged 45 to 64 and is also called “adult onset” diabetes. 
Unfortunately, childhood obesity and type 2 diabetes are also on the rise with a 
shocking 5,089 individuals under the age of 20 reported to be newly diagnosed 
with type 2 diabetes from 2008-2009. In 2012 the estimated cost of treating 
clinically determined cases of type 2 diabetes was $245 billion, with direct medial 
costs totaling $176 billion. Comorbidities of diabetes such as cardiovascular 
disease, stroke, blindness, kidney disease and amputations worsen medical 
expenses and account for ~10% of the medical costs associated with treatment 
(CDC 2014). 
 Obesity is a major contributing factor to the development of type 2 
diabetes with roughly 85.2% of diabetes patients described as overweight or 
obese. Obesity is characterized by the body mass index (BMI) scale used to 
categorize body mass based on a person’s weight to height ratio (BMI = 
kilograms/meters2). A normal healthy person has a BMI range of 18.5 to 24.9 
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kg/m2. A BMI between 25 to 29.9 kg/m2 is classified as overweight and a BMI 
greater than 29.9 kg/m2 defines the obese category. In 2011-2014 over one-third 
(36.5%) of adults and 17% of children in the U.S. were considered clinically 
obese. In addition, the annual medical expenditures of obese individuals are 
$1,429 higher than individuals of normal healthy weight due to obesity-related 
conditions including heart disease, stroke and type 2 diabetes (CDC 2014). With 
the prevalence of obesity and type 2 diabetes near epidemic proportions it is 
critical to understand the economic, environmental and biological factors that 
induce type 2 diabetes, and to establish more effective preventative and 
therapeutic strategies. 
1.2 Insulin Signaling 
 In metabolically healthy people the pancreatic beta cell secretes insulin 
in response to carbohydrate intake after a meal, prompting the uptake of glucose 
into insulin sensitive tissues. The insulin tyrosine kinase receptor is a dimer 
comprised of an α subunit that binds insulin at the extracellular face of the 
plasma membrane and a transmembrane β subunit that facilitates intracellular 
signaling. Insulin binding instigates auto-phosphorylation of the β subunit and 
subsequent phosphorylation of the insulin receptor substrate (IRS) 1 and 2. 
Activated IRS-1 and -2 will bind phosphoinositide 3-kinase (PI3K) to generate the 
second messenger phosphatidylinositol (3,4,5)-triphosphate, leading to 
phosphorylation of Akt, also called protein kinase B. Insulin signaling via pAkt 
regulates the translocation of glucose transporter 4 (GLUT4) to the plasma 
membrane of skeletal muscle myocytes and adipose tissue adipocytes to 
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augment glucose uptake. Nutrients are then catabolized to produce energy, 
predominantly generating adenosine triphosphate (ATP). If there is a fuel 
surplus, insulin will facilitate increased glycogen synthesis in the liver and 
muscle, as well as lipogenesis in the adipose tissue to store glucose and fatty 
acids for use during fasting and exercise. In addition, insulin acts to suppress 
glucose production in the liver to restore homeostatic blood glucose levels after 
consuming a meal. 
 The development of Type 2 diabetes is characterized by initial 
hyperinsulinemia in response to insulin resistance when the muscle, liver and 
adipose tissues no longer respond properly to insulin signaling, discussed below. 
Impaired insulin sensitivity prompts pancreatic beta cells to produce and secrete 
increasing amounts of insulin in an attempt to boost insulin signaling and lower 
blood glucose levels. Over time, the beta cells fail to meet the insulin demand to 
invoke a normal response in the peripheral insulin sensitive tissues. This results 
in the accumulation of glucose in the blood stream due to the lack of glucose 
uptake by the muscle and adipose tissue, and sustained glucose output by the 
liver. 
1.3 Symptoms and Treatments for Type 2 Diabetes 
Impaired tissue glucose uptake increases fasting blood glucose levels in 
type 2 diabetic patients, causing a variety of symptoms including recurrent 
urination, increased thirst and fatigue. Further systemic complications are 
common with chronic hyperglycemia and disease progression including diabetic 
retinopathy, peripheral nerve damage and diabetic nephropathy. This is due to 
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exacerbated GLUT-1 mediated glucose uptake into the non-insulin dependent 
capillary beds of the retina and kidneys, as well as the GLUT-3 mediated uptake 
of glucose in nerve cells. Glucose oxidation and the generation of reactive 
metabolic intermediates are proposed to induce mitochondrial dysfunction, 
oxidative stress and intracellular damage in these tissues (Brownlee, 2005). 
Living with type 2 diabetes requires inconvenient and consistent monitoring of 
blood glucose levels that fluctuate with meal to meal caloric intake and daily 
physical activity. The primary treatment for these patients is to closely monitor 
blood glucose levels throughout the day, and micromanage food consumption 
and physical activity coupled to a variety of pharmacological approaches. 
Pharmacological agents such as metformin, which reduces hepatic 
gluconeogenesis (Miller et al. 2013) and lipid metabolism (Fullerton et al. 2013), 
are prescribed if lifestyle interventions do not result in sufficient glycemic control. 
Sulfonylureas that stimulate the pancreas to release insulin (Thulé and 
Umpierrez, 2014), and the peroxisome proliferator-activated receptor (PPAR) 
agonist group thiazolidinediones (Hauner, 2002) are supplementary clinical 
therapeutic agents employed to aid metformin in the reduction of blood glucose 
levels. Exenatide and liraglutide are glucagon-like peptide 1 (GLP-1) analogs, 
also called ‘incretin mimics’, and bind the glucagon-like 1 receptor on the islets of 
Langerhans cells to stimulate insulin and inhibit glucagon release. These result in 
moderately lower blood glucose levels in prolonged diabetes (Campbell et al. 
2013, Fehse et al. 2005). Dipeptidyl peptidase-4 (DPP-4) is the incretin 
inactivating enzyme, and DPP-4 inhibitors or gliptins have also been considered, 
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but with limited evidence of efficacy, as a treatment for type 2 diabetes. In 
addition, both GLP-1 agonists and DPP-4 inhibitors are under investigation as 
perpetuators of pancreatitis, pancreatic cancer and heart failure (Rehman et al. 
2017). Although these drugs can help to improve fasting blood glucose levels 
there is still no cure for type 2 diabetes.  
1.4 Adipocyte Metabolism 
Preadipocytes are dispersed throughout the adipose tissue of 
metabolically healthy individuals, and can differentiate into mature adipocytes 
allowing flexibility in the adipose tissue storage capacity.. Insulin signaling 
promotes adipogenesis through suppression of forkhead transcription factor O1 
leading to upregulation of peroxisome proliferator-activated receptor gamma 
(PPARƴ), a key regulator of the mature adipocyte phenotype. In a state of caloric 
excess white adipose tissue expands to accommodate the surplus energy in the 
form of triglycerides. De novo triglyceride synthesis, also known as lipogenesis, 
is mediated by insulin signaling in the adipose tissue; relieving phosphorylation 
mediated inhibition of acetyl-CoA carboxylase to promote fatty acid synthesis and 
triglyceride production. Insulin signaling also prevents phosphorylation and 
activation of hormone sensitive lipase to inhibit lipolysis when blood glucose 
levels are high. During fasting or in response to a pronounced increase in energy 
expenditure, the stored triglycerides in white adipose tissue are hydrolyzed to 
release free fatty acids to be used as fuel in metabolically active tissues. 
Adipocyte hypertrophy and obesity occurs when the balance between energy 
intake and energy expenditure is disproportionate due to excessive fuel intake. 
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Adipose tissue is the healthiest site for the deposition of additional caloric energy 
in the form of triglycerides (Unger et al. 2013). However, when adipose tissue 
expansion reaches its threshold, triglycerides will begin to accumulate in other 
organs such as the liver, resulting in non-alcoholic fatty liver disease (Schwenger 
and Allard, 2014, Rosen and Spiegelman, 2014). 
In addition to its role as an energy storage depot, adipose tissue is an 
important endocrine organ that secretes a variety of hormones known as 
adipokines. Perturbation in the levels of several adipokines is closely associated 
with obesity and type 2 diabetes. Adiponectin is produced and secreted from the 
adipocyte in an insulin sensitizing manner and acts to increase fatty acid 
oxidation in the skeletal muscle and suppress gluconeogenesis in the liver. 
Decreased circulating levels of adiponectin are an established hallmark in obese 
type 2 diabetic patients (Cao et al. 2014). Leptin is another key adipokine that 
functions in caloric regulation by binding to the leptin receptor on 
proopiomelanocortin-cocaine amphetamine regulated transcript (POMC-CART) 
neurons in the arcuate nucleus of the hypothalamus. This stimulates the release 
of melanocortins that mediate appetite suppression. Leptin also regulates satiety 
by binding its receptor on the agouti related peptide (AgRP) neurons in the 
arcuate nucleus, inhibiting the release of neuropeptide Y and orexins (Abizaid 
and Horvath, 2008, Hakansson et al. 1999, Stephens et al. 1995). Leptin 
secretion is directly proportional to adipose tissue mass; yet despite the 
hyperleptinemina in obese individuals, the hormonal response in the 
hypothalamus is attenuated due to leptin resistance (Cao et al. 2014).  
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Diabetes is a complex multi-organ disease involving hormonal and 
metabolic mediators, and it is clear that compromised adipose tissue functionality 
is a significant component of Type 2 diabetes (Cusi, 2010, Lee et al. 2016, Smith 
and Kahn, 2016). The following sections highlight the recognized and proposed 
contributors to adipocyte stress and dysfunction in the development of Type 2 
diabetes. 
1.5 Adipocyte Stress in Type 2 Diabetes 
1.5a Inflammation and Insulin Resistance 
Type 2 diabetes is closely correlated with increased obesity and a state 
of chronic low grade inflammation in the adipose tissue, in association with 
lifestyle factors such as a poor diet and lack of exercise. Adipose tissue was 
typically regarded as a unassuming reservoir for triglyceride storage within 
adipocytes, but is now valued as a complex organ encompassing a variety of 
interacting cell types including adipocytes, macrophages, eosinophils, 
neutrophils, endothelial cells, fibroblasts, stem cells and neuronal projections 
(Cohen and Spiegelman, 2016). While some adipose tissue is necessary for lipid 
storage and hormone production, the accumulation of excess adipose tissue is 
associated with the secretion of pro-inflammatory cytokines. Several intracellular 
inflammatory signaling responses are activated in the adipocyte including Toll-
like receptor (TLR)-4 and -2, inflammasome activation, c-Jun N-terminal kinase 
(JNK) and inhibitor of nuclear factor kappa-B kinase-β (IKKβ) signaling, and the 
production of inflammatory cytokines due to metabolic stress (Gregor and 
Hotamisligil, 2011, Solinas et al. 2010). The increased production and secretion 
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of potent cytokines including tumor necrosis factor α (TNFα), interferon (IFN)-γ, 
interleukin (IL)-6, IL-β and monocyte chemoattractant protein 1 (MCP1) occurs in 
parallel with adipocyte hypertrophy (Berg et al. 2005). MCP1 acts to recruit 
monocytes and macrophages to the site of cellular distress (Kanda et al. 2006), 
resulting in the accumulation of macrophages in the subcutaneous adipose 
tissue of obese type 2 diabetic patients, and in the visceral adipose tissue of 
ob/ob and db/db type 2 diabetic mice (Amano et al. 2014, Haase et al. 2013, 
Weisberg et al. 2003). Macrophages tend to congregate at sites of adipocyte cell 
death forming crown-like structures surrounding the cellular debris and lipid 
droplets for removal (Cinti et al. 2005). Importantly, obese adipose tissue 
resident macrophages significantly contribute to the production of pro-
inflammatory cytokines, e.g., TNFα and IL1β, in the adipose tissue 
microenvironment of diabetic ob/ob and db/db mice (Xu et al. 2003). This is due 
to the M1 or “classically activated” pro-inflammatory phenotype of macrophages 
localized in obese adipose tissue compared to the anti-inflammatory M2 or 
“alternatively activated” polarized macrophages found in lean adipose tissue 
(Lumeg et al. 2007). Suzuki et al. recently described that the loss of T-helper (Th) 
2 cytokine signaling from adipocytes regulates macrophage polarity and this 
promotes the M1 phenotype in insulin resistant mice fed a high fat diet (Suzuki et 
al. 2017). The reduced quantity of anti-inflammatory cytokines in the adipose 
tissue microenvironment is also attributed to decreased resident Th2 and T 
regulatory cells and a buildup of CD8+ T cells and Th1 cells that contribute to 
macrophage recruitment and prolonged inflammation (Solinas et al. 2010). 
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Importantly, adipose tissue inflammation is recognized as being present when 
there is decreased systemic insulin sensitivity, prior to the development of Type 2 
diabetes (Samuel and Shulman, 2012, Solinas et al. 2010, Suzuki et al. 2017, 
Tanti et al. 1994).  
Pro-inflammatory cytokines impair insulin sensitivity in tissues through 
activation of JNK and IKKβ pathways (Solinas et al. 2010, Solinas and Becattini, 
2016). JNK activation leads to increased phosphorylation of IRS-1 at the Ser307 
residue and IRS-2 at Thr348, inhibiting the interaction and activation of IRS by 
the insulin receptor via tyrosine phosphorylation in response to insulin (Aguirre et 
al. 2000, Aguirre et al. 2002, Solinas et al. 2006). Under normal conditions, IRS-1 
activity is diminished by mammalian target of rapamycin (mTOR) and its 
downstream effector ribosomal S6 kinase 1 (S6K1) via direct phosphorylation at 
residues Ser636, Ser639 and Ser307 that results in desensitization of insulin 
signaling (Ozes et al. 2001). Lee et al. described that TNFα stimulation of IKKβ 
induces hyperactivation of mTOR signaling and consequent insulin resistance in 
hepatocytes of mice fed a high fat diet and ob/ob mice (Lee et al. 2008). Pro-
inflammatory cytokines also increase adipose lipolysis (Kawakami et al. 1987) by 
suppressing the lipolysis inhibitor fat specific protein 27 (Ranjit et al. 2011), 
contributing to high levels of circulating free fatty acids. Saturated fatty acids are 
able to bind TLR4 culminating in heightened IKKβ/NFkB signaling to produce 
additional pro-inflammatory cytokines (Shi et al. 2006), perpetuating a positive 
feedback loop to sustain systemic insulin resistance (Jauhiainen et al. 2011). 
Interestingly, adipose tissue specific deletion of the phosphatase PTEN 
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(phosphatase and tensin homolog), a known negative regulator of insulin 
signaling, is sufficient to improve serum adiponectin levels, systemic insulin 
sensitivity, hepatic p-Akt and reduce TNFα production in subcutaneous adipose 
tissue (Morley et al. 2015). Therefore, reducing adipose tissue inflammation is 
imperative to re-establish insulin sensitivity and normal hormonal control over 
glucose homeostasis. 
1.5b Endoplasmic Reticulum Stress 
The endoplasmic reticulum (ER) is the intracellular organelle where 
proteins designated for secretion or incorporation into the plasma membrane are 
translated, folded and processed. Several chaperone and oxidoreductase 
proteins reside in the ER lumen to assist with protein folding. Protein disulfide 
isomerase (PDI) is an ER chaperone protein that aids in the formation of 
correctly configured substrate disulfide bonds via a series of redox reactions. PDI 
contains two CGHC sequence active site motifs and each cysteine plays a 
crucial role in the reduction and oxidation of substrate disulfide bonds 
(Appenzeller-Herzog et al. 2008). The N-terminal cysteines (Cys55 and Cys399) 
in both active sites have a lower pKa (~4.5) compared to the high pKa of the C-
terminal cysteines (Cys58 and Cys402) (pKa ~9.5) (Hawkins and Freedman, 
1991, Karala et al. 2010, Lappi et al. 2004). This promotes the increased 
nucleophilicity of the N-terminal cysteines and the reduction of PDI active site 
cysteines, accompanied by the oxidation and formation of a substrate disulfide 
bond (Hawkins and Freedman, 1991, Karala et al. 2010, Lappi et al. 2004). ER 
oxidoreductin 1 (Ero1) acts in conjunction with FAD+ to re-oxidize PDI through 
 
12 
the shuffling of electrons via similar CXXC regulatory sites. This facilitates the 
recycling of PDI active site cysteines to continue protein folding (Tu et al. 2002). 
Excess reactive peroxides are produced in the ER via Ero1 re-oxidation and 
these are quenched by peroxiredoxin-4 (Prx4) (Tavender et al. 2008, Tavender 
et al. 2010). PDI reduces the oxidized form of Prx-4, salvaging its active site 
cysteines and facilitating continued regulation of potentially harmful reactive 
peroxide levels in the ER (Tavender et al. 2010, Zito et al. 2010). 
A disturbance to ER homeostasis, alterations in the oxidative 
environment or the accumulation of misfolded proteins, is taxing to the ER 
organelle and denotes a state of ER stress. The unfolded protein response 
(UPR) is activated in adipocytes during diabetes in an effort to prevent the 
development of ER stress (Özcan et al. 2004). The UPR is comprised of three 
separate pathways; protein kinase-like endoplasmic reticulum kinase (PERK), 
inositol-requiring enzyme 1 (IRE1), and activating transcription factor 6 (ATF6). 
The accumulation of misfolded proteins is first sensed by glucose related protein 
78 (GRP78) causing it to dissociate from IRE1, PERK and/or ATF6. This allows 
for the homodimerization and phosphorylation of the IRE1 and PERK protein 
complexes. pIRE1 possesses spliceosome activity and cleaves X-box binding 
protein 1 (XBP1) in the cytosol to generate the truncated isoform spliced-XBP1 
(sXBP1) a transcription factor that forms homodimers or heterodimers with other 
UPR proteins. Dissociation of GRP78 from ATF6 results in translocation of ATF6 
from the ER membrane to the golgi apparatus where ATF6 is also cleaved. The 
spliced form of ATF6 translocates into the nucleus and forms transcription factor 
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complexes with sXBP1 to promote the production of additional ER chaperone 
proteins to aid in protein folding (Figure 1.1). The PERK pathway serves to 
temporarily inhibit protein translation via phosphorylation of eukaryotic initiation 
factor α (eIF2α), this arm of the UPR is prominently activated in the 3T3-L1 
adipocyte cultured in diabetic conditions (Han et al. 2013a). If the UPR is 
persistent and ER stress develops, the UPR signaling will result in the production 
of the pro-apoptotic protein C/EBP homologous protein (CHOP). Acute CHOP 
expression induces growth arrest and DNA damage-inducible protein (GADD34) 
and results in dephosphorylated eIF2α and reinstatement of protein synthesis 
(Han et al. 2013b), contributing further to the already defective proteostatic 
environment. The activation of the UPR and presence of ER stress in diabetes 
has been well documented (Boden et al. 2008, Özcan et al. 2006) however, there 
is limited mechanistic insight on the direct initiator of ER stress in the adipocyte. 
In chapter 2 we investigate a novel biochemical mechanism contributing to the 
development of sustained ER stress in the adipocyte during diabetes. 
1.5c Oxidative Stress 
 Hydroxyl radicals, superoxide, hydrogen peroxide, ketoaldehydes, and 
hydroxynonenal are chemically reactive molecules characterized as reactive 
oxygen species (ROS). ROS are endogenously generated during cellular 
metabolism and may be beneficial or detrimental, dependent upon the 
concentration produced in the tissue. ROS such as hydrogen peroxide have a 
physiological role in redox signaling, however, excessive production of ROS 
leads to the damaging oxidative modification of cellular macromolecules (Circu et 
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al. 2010). Similar to extracellular inflammatory cytokine signaling, intracellular 
ROS accumulation can activate JNK and IKKβ to impair insulin signaling 
(Tiganis, 2011), aiding the development of type 2 diabetes. 
 Mitochondria are a premier site of ROS production with the electron 
transport chain, pyruvate dehydrogenase and α-ketoglutarate dehydrogenase 
complexes able to generate superoxide anion (Fisher-Wellman et al. 2013, 
Starkov et al. 2004). Superoxide produced via the transfer of electrons through 
complexes I and III of the electron transport chain to molecular oxygen is 
metabolized by manganese superoxide dismutase to hydrogen peroxide. 
Hydrogen peroxide can be oxidized to form a hydroxyl radical in the presence of 
ferrous iron, leading to lipid peroxidation to generate reactive unsaturated lipid 
aldehydes such as 4-hydroxy-trans-2,3-nonenal (4-HNE) (Grimsrud et al. 2008). 
These highly reactive aldehydes irreversibly modify protein side chains of 
cysteine, lysine and histidine residues, termed protein carbonylation (Curtis et al. 
2012). Total protein carbonylation positively correlates with growing adiposity and 
increasing serum free fatty acid levels in obese adults (Frohnert et al. 2011), 
highlighting oxidative protein damage as a severe consequence of glucotoxicity. 
Importantly, a significant increase in protein carbonylation underlies the 
development of insulin resistance in human adipose tissue after just 6 days of 
excess caloric intake (Boden et al. 2015). Specifically, the identification of GLUT4 
carbonylation in response to acute gluco-lipotoxicity (Boden et al. 2015) implied 
that oxidative stress is a major contributor to the observed deficiency in glucose 
uptake and decreased adipose tissue insulin sensitivity.  
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 Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) 4 
is an abundant adipose tissue protein and has been attributed to initiate ROS 
production during early stages of obesity (Han et al. 2012). Excess nutrients 
increase pentose phosphate pathway (PPP) activity and NADPH levels in 3T3-L1 
adipocytes (Han et al. 2012). Located in the mitochondria, NOX4 transfers 
electrons from NADPH to oxygen, thus generating the radical superoxide (Block 
et al. 2009). Intracellular superoxide signaling has been shown to activate the 
pro-inflammatory NF-κB pathway promoting adipose tissue insulin resistance 
(Kaul and Forman, 1996). Interestingly, adipose tissue specific NOX4 deficiency 
lowered ROS production and inflammation, and delayed the onset of insulin 
resistance in mice fed a high fat and high sucrose diet (Den Hartigh et al. 2017). 
However, reduced NADPH levels due to slower PPP flux are observed when the 
adipocyte has reached its maximum triglyceride storage capacity, which may limit 
NOX4 driven ROS generation in later stages of obesity (Han, 2016). Overall, 
sustained ROS production in the adipose tissue appears to be a significant factor 
in obesity associated inflammation and insulin resistance (Houstis et al. 2006) 
contributing to the onset of type 2 diabetes. Thus, it is important to understand 
the mechanisms that mediate prolonged ROS production and oxidative stress in 
the adipose tissue. 
The cell is equipped with several redox systems including the glutathione 
and thioredoxin systems in order to combat chronic oxidative stress. The 
antioxidant response element (ARE) is located within the promoter region of 
several antioxidant genes and regulates the facilitation of the antioxidant 
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response (Rushmore et al. 1991). Nuclear factor (erythroid-derived 2)-like 2 
(Nrf2) is a transcription factor that translocates to the nucleus and binds to the 
ARE. Nrf2 up-regulates the transcription of several detoxification enzymes and 
antioxidant genes including heme oxygenase-1, NAD(P)H: quinone 
oxidoreductase 1, glutathione peroxidase and glutathione S-transferase. Under 
normal conditions the negative regulator Kelch-like ECH-associated protein 1 
(Keap1) binds the Cullin3-based E3 ligase complex and sequesters Nrf2 in the 
cytosol to be tagged with ubiquitin and degraded by the proteasome (Akira et al. 
2004, Kobayashi et al. 2004). Keap1 contains at least 3 cysteine residues 
confirmed to be sensitive to oxidative stress (Levonen et al. 2004, McMahon et 
al. 2010). The covalent modification of these cysteine residues is crucial for Nrf2 
activation, disturbing Keap1/Nrf2 binding and stimulating Nrf2 stabilization and 
transcriptional activity during cellular stress (Kobayashi et al. 2006). Activation of 
Nrf2 is generally considered beneficial for a variety of cells as it invokes the 
protective antioxidant response. Nrf2 activation upon sulforaphane modification, 
that targets Keap1 redox sensitive cysteines, reduces the concentration of ROS 
in endothelial cells exposed to hyperglycemic conditions (Xue et al. 2008). Nrf2 
also stimulates the transcription of glyoxalase 1 leading to reductions in 
methyglyoxal induced protein damage in endothelial (HMEC-1) and hepatic 
(HepG2) cell lines (Xue et al. 2012).  
Although Nrf2 activation is considered protective in the defense against 
glycemic stress during diabetes, the enhancement of Nrf2 activity in the adipose 
tissue of diabetic mice is controversial and is associated with negative metabolic 
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effects. Constitutive Nrf2 activation via Keap1 knockdown decreases glucose 
tolerance, lipogenic gene expression and lipid accumulation while simultaneously 
increasing insulin resistance in the adipose tissue of ob/ob type 2 diabetic mice 
(Xu et al. 2012). The pharmacological enrichment of Nrf2 with sulforaphane 
inhibits adipogenesis in mouse embryonic fibroblasts (MEFs) in vitro (Xu et al. 
2012) which is often proposed as a beneficial means to combat obesity. 
However, impaired adipogenesis and lipid storage in the adipose tissue 
contributes to hepatic steatosis during type 2 diabetes and after high fat diet 
feeding (More et al. 2013, Xu et al. 2012). Therefore enhanced Nrf2 activity due 
to defects in the Keap1 degradation pathway may actually induce harmful effects 
as decreased adipogenesis does not offer any benefit when the lipid is instead 
stored in other tissues such as liver and muscle. 
 In addition, Keap1 has also been described as a negative regulator of 
the ER stress protein CHOP in adipocytes (Huang et al. 2012), as CHOP is also 
degraded by the ubiquitin proteasome system (Diaz et al. 2015, Li et al. 2006). 
Keap1 binding to CHOP results in polyubiquitination of CHOP due to the 
recruitment of ubiquitin by the COP9 signalosome/cullin3-based E3 ligase 
complex (Figure 1.2), while knockdown of Keap1 expression results in 
upregulation of CHOP in adipocytes (Huang et al. 2012). In addition to oxidative 
modification, Keap1 cysteines are susceptible to modification by other 
electrophiles including a range of xenobiotic compounds. In chapter 3 we 
propose an alternative mechanism regulating CHOP degradation and stability in 
the adipocyte in response to glucotoxicity. 
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1.6 C/EBP Homologous Protein 
Although adipogenesis is regulated by several transcription factor 
families (White et al. 2010), this section will discuss the CCAT/enhancer binding 
protein (C/EBP) transcription factors as this family is highly regulated by CHOP 
signaling. The C/EBP family has a firmly established regulatory role in the 
development of adipocyte differentiation. In response to hormonal stimuli in 
adipocyte culture conditions (insulin, dexamethasone and 
isobutylmethylxanthine), the C/EBP isoforms δ and β dimerize and upregulate 
transcription of C/EBPα (Cao, 1991, Yeh, 1995) by attaching to the C/EBP 
binding site in the gene promoter region (Christy et al. 1991). In turn, C/EBPα 
stimulates transcription of the master adipogenic regulator peroxisome 
proliferator-activated receptor gamma (PPAR-ƴ) (Rosen et al. 2002) that 
promotes lipogenesis (Tontonoz et al. 1994). Deletion of the C/EBP δ, β or α 
genes can be fatal and effectively stunts white adipose tissue development in 
surviving mice (Tanaka et al. 1997, Wang et al. 1995). Recent evidence suggests 
a significant role for the direct interaction of transcriptional cofactor cyclin C with 
C/EBPα to activate adipogenesis of brown adipose tissue (Song et al. 2017). In 
addition, knocking down the expression of cyclin C in 3T3-L1 fibroblasts inhibits 
adipogenesis, detectable as reduced lipid accumulation and expression of the 
adipogenic genes PPARƴ, C/EBPα, adiponectin and fatty acid binding protein 4 
(Song et al. 2017). Overall this demonstrates the importance of C/EBP signaling 
for proper adipose tissue function, as enhanced adipogenesis is essential to 
accommodate the lipid overload due to excessive nutrient consumption.  
 
19 
C/EBP homologous protein (CHOP) is a basic leucine zipper 
transcription factor known to form heterodimers with C/EBPα and C/EBPβ family 
members. Unlike C/EBPα and C/EBPβ, CHOP contains glycine and proline 
substitutions in the conserved C/EBP-DNA binding region. Therefore, CHOP 
binding of C/EBP isoforms suppresses gene transcription due to the inability of 
the complex to interact with normal C/EBP binding sequences on the target gene 
(Ubeda et al. 1996). The production of CHOP is known to be upregulated in 
response to cellular stress, e.g., ER stress, DNA damage, glucose starvation, 
hypoxia and oxidative stress (Carriére et al. 2004, Han et al. 2013a, Luethy and 
Holbrook, 1992, Mihai et al. 2015). Importantly, ectopic expression of CHOP 
following retrovirus transfection, glucose starvation, hypoxia or the induction of 
ER stress reduces C/EBPα and PPARƴ production and downstream signaling to 
prevent adipogenesis (Batchvarova et al. 1995, Han et al. 2013a). Consistent 
with these findings, CHOP knockout mice display larger adipocytes and fat pads 
compared to wild mice fed a high fat diet (Maris et al. 2012). The inhibition of 
adipogenesis due to elevated CHOP expression may be detrimental in obesity, 
forcing the accumulation of lipids in peripheral tissues due to the inability to 
differentiate new adipocytes for energy storage. 
It is increasingly recognized that CHOP has additional physiological roles 
beyond its ability to regulate adipogenesis. CHOP controls the induction of cell 
cycle arrest between the G1/S phase in fibroblasts (Barone et al. 1994), and the 
regulation of Bcl-2 family members to promote apoptosis in cardiomyocytes, 
hepatocytes, podocytes and pancreatic beta cells (Kim et al. 2008, Li et al. 2014, 
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Malhi et al. 2013). Jauhiainen et al. reported that tunicamycin induced CHOP 
accumulates in the cytoplasm, in addition to the nucleus, of human fibroblasts 
and GOT3 sarcoma cells (Jauhiainen et al. 2012). Further gene expression 
profiling by microarray and ontology analysis revealed that cytoplasmic CHOP 
indirectly controls the expression of 94 different genes related to cellular 
movement, development, proliferation and growth, cell cycle, cell death and gene 
expression (Jauhiainen et al. 2012).  
In addition, CHOP has been shown to directly bind the DNA 
promoter/enhancer region of Ppara, Srebf1 and Cebpα in hepatocytes 
culminating in the suppression of metabolic gene expression during stress (Chika 
et al. 2013). Prasad et al. have described a novel role for CHOP as an important 
mediator of phosphate movement into the mitochondria in adrenal cells. This 
results in increased steroid synthesis by stabilizing 3β-hydroxysteroid 
dehydrogenase type-2 protein conformation and its association with Translocase 
Outer Membrane-22 during periods of stress due to cold temperatures (Prasad et 
al. 2016). CHOP mRNA and protein levels are also increased in the tumors of a 
genetic mouse model of hepatocellular carcinoma generated by mobilized 
T2/Onc3 transposon and human hepatocellular carcinoma (DeZwaan-McCabe et 
al. 2013). Here CHOP promotes hepatocyte cell death that provokes a pro-
inflammatory response and fibrotic deposition. Additionally, tumorigenesis is 
reduced by 50% in CHOP knockout mice treated with diethylnitrosamine 
compared to wild type animals (DeZwaan-McCabe et al. 2013, Scaiewicz et al. 
2013) suggesting a prominent role for CHOP to stimulate oncogenesis. 
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 In considering alternative roles for CHOP function beyond the 
suppression of adipogenesis, we have noted an increase in CHOP as adipocytes 
progress through maturation in high glucose (similar to Han et al. 2013a). In 
contrast, this increase in CHOP is not sustained in adipocytes in normal glucose 
despite the fact that they also progress normally through adipogenesis, nor is it 
present in the adipose tissue of healthy mice versus diabetic mice. Since our in 
vitro studies specifically compared adipocytes simultaneously undergoing 
adipogenesis and maturation in either normal or high glucose, it suggests that 
sustained CHOP unique to high glucose conditions may have an alternative role 
during diabetes. Two studies examining CHOP knockout mice distinguish CHOP 
as an important component of inflammation mediated insulin resistance in mice 
fed a high fat diet (Maris et al. 2012, Suzuki et al. 2017).  
CHOP knockout mice show a significant improvement in fasting blood 
glucose levels and insulin sensitivity compared to wild type mice after high fat 
diet feeding (Suzuki et al. 2017). Interestingly, while the degree of macrophage 
infiltration does not change between wild type and CHOP knockout mice (Maris 
et al. 2012, Suzuki et al. 2017), CHOP deficiency specifically in the adipose 
tissue induces anti-inflammatory M2 macrophage polarization (Suzuki et al. 
2017). In addition, the absence of CHOP in adipose tissue promotes eotaxin 
production and eosinophil recruitment in the adipose tissue microenvironment of 
mice fed a high fat diet (Suzuki et al. 2017). Overall, increased or sustained 
CHOP levels in the absence of increased apoptosis in the adipose tissue 
appears to be detrimental during diabetes. The exact mechanism by which 
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CHOP regulates inflammation and insulin resistance in the adipose tissue 
remains to be explored. 
1.7 Protein Succination 
Cysteine is one of the least common amino acids incorporated into the 
primary sequence of a protein, however, it is most often included as an important 
structural or active site residue governing protein function or regulation. The thiol 
group of cysteine has a pKa ~8.5, while the pKa of an active site cysteine may 
range from 3-6. The lower pKa value of the active site thiolate indicates the 
increased reactivity of the nucleophilic cysteine residue. Our laboratory was first 
to describe the Michael addition reaction between the Krebs cycle intermediate 
fumarate and the thiolate group of cysteine to form a thioether bond and the 
chemical modification S-(2-succino)cysteine (2SC). This enzymatically 
irreversible reaction is termed succination (Figure 1.3) (Alderson et al. 2006). 
2SC was first identified in vivo in human plasma proteins where fumarate 
modifies ~3.5% of total albumin from healthy individuals (Alderson et al. 2006). 
We assessed the kinetics of succination in vitro after incubating fumarate with N-
acetylcysteine (pKa ~9.5) and commercial glyceraldehyde-3 phosphate 
dehydrogenase (GAPDH) (pKa ~6) (Alderson et al. 2006, Blatnik et al. 2008). As 
predicted the succination of GAPDH was ~250 times faster than N-acetylcysteine 
due to the lower pKa and increased reactivity of GAPDH cysteine residues 
(Alderson et al. 2006). The degree of protein succination directly correlates with 
the concentration of fumarate, and since succination is a slow chemical reaction, 
the cysteines must be exposed to reasonably high levels of fumarate for a 
 
23 
prolonged period (Alderson et al. 2006, Blatnik et al. 2008, Frizzell et al. 2009, 
Nagai et al. 2007). Consistent with this data, decreasing intracellular fumarate 
levels directly reduces protein succination (Frizzell et al. 2012, Tanis et al. 2015). 
Protein succination increases ~3.5 fold in the skeletal muscle of 
streptozotocin-induced type 1 diabetic rats (Blatnik et al. 2008). Matrix assisted 
laser desorption/ionization – time of flight (MALDI-TOF) and ultra-performance 
liquid chromatography electrospray ionization tandem mass spectrometry (UPLC 
ESI-MS/MS) analysis of GAPDH isolated from the gastrocnemius muscle 
confirmed a pronounced increase in the relative amount of succinated peptides 
to control peptides containing active site Cys149 and peripheral Cys244 in 
diabetic versus control rats (Blatnik et al. 2008). Interestingly, modification of 
GAPDH by fumarate correlates indirectly with GAPDH enzymatic activity in a 
dose dependent manner in vitro, and in the muscle of diabetic rats (Blatnik et al. 
2008). This study was the first to describe the targeted effect of succination to 
inhibit enzyme activity via direct cysteine modification by fumarate. A number of 
additional functional studies on specific succinated proteins have since been 
conducted in adipocytes (Frizzell et al. 2009), neurons (Linker et al. 2011), 
fibroblasts (Adam et al. 2011, Ternette et al. 2013), T cells (Blewett et al. 2016), 
as well as purified protein in vitro (Piroli et al. 2014). Beyond the original 
identification of endogenous succination of plasma albumin, increased protein 
succination has been documented in the context of several diverse disease 
settings including; type 2 diabetes (Merkley et al. 2014), Leigh syndrome (Piroli 
et al. 2016), renal cell carcinoma (Yang et al. 2014), tuberculosis management 
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(Ruecker et al. 2017) and the pharmacological modulation of autoimmune 
disorders (Blewett et al. 2016, Piroli et al. 2017 in preparation). 
1.7a Type 2 Diabetes 
As discussed in Section 1.4, the hyperglycemic/hyperinsulinemic state 
observed during type 2 diabetes exceeds the energy needs of adipocytes. This 
creates a build-up of ATP, relative to ADP, in adipocytes matured in high glucose 
(Frizzell et al. 2012). Respiratory control prevents further ATP production, 
reducing ATP synthase activity and the translocation of hydrogen ions back into 
the mitochondrial matrix. The accumulation of hydrogen ions in the inner 
membrane space increases the mitochondrial membrane potential and 
contributes to reductive stress, i.e. the accumulation of increased NADH relative 
to NAD+. A consequence of this ’pseudohypoxic’ state is the temporary inhibition 
of the NAD+-dependent Krebs cycle enzymes and the accumulation of Krebs 
cycle intermediates (Frizzell et al. 2012). Lai and Goldman reported that 3T3-L1 
adipocytes matured in high glucose will release elevated concentrations of 
several Krebs cycle intermediates, including fumarate, into the cell culture 
medium (Lai and Goldman, 1992). We have established that intracellular 
fumarate levels increase ~2.5-4 fold in adipocytes matured in high (30 mM) 
versus normal (5 mM) glucose concentrations as a direct result of this 
glucotoxicity driven mitochondrial stress (Nagai et al. 2007, Frizzell et al. 
2012)(Figure 1.4). The presence of excess fumarate results in a pronounced 
increase in protein succination in both adipocytes matured in 30 mM glucose, 
and in the adipose tissue from diabetic ob/ob and db/db mice (Nagai et al. 2007, 
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Frizzell et al. 2009, Thomas et al. 2012). Notably, when compared with other 
tissues in the db/db model (kidney medulla and cortex, lungs, skeletal muscle, 
cardiac muscle, liver and spleen) this increase in 2SC seems to be selective for 
the adipose tissue (Thomas et al. 2012). This may be due to elevated fumarate in 
the relatively compressed cytoplasmic volume of the adipocyte in comparison 
with the total cell size, or that total tissue protein analyses cannot detect subtle 
cell-type specific changes. Protein succination was not detected in the catabolic 
adipose tissue of type 1 diabetic rats, and only subtle succination is observed in 
the adipose tissue from mice fed a high fat diet for 12 weeks (Thomas et al. 
2012). This suggests that succination is distinctly associated with the presence of 
type 2 diabetes, rather than insulin resistance alone, in adipose tissue. A list of 
38 total protein targets of elevated fumarate in adipocytes matured in high 
glucose have been identified by strong cation exchange or high pH fractionation 
followed by capillary LC-MS/MS mass spectrometry (Merkley et al. 2014). 
However, the stoichiometry, structural and function significance of 2SC remains 
to be determined for many of these adipocyte target proteins.  
To date, we have characterized the effect of protein succination on the 
function of two proteins in the adipocyte; adiponectin (Frizzell et al. 2009) and 
tubulin (Piroli et al. 2014). Adiponectin is a homopolymeric protein assembled in 
the endoplasmic reticulum (Liu et al. 2008, Liu and Liu, 2010) and secreted into 
circulation where it regulates fatty acid beta oxidation in the skeletal muscle and 
glucose homeostasis in the liver. Type 2 diabetic patients consistently exhibit 
decreased plasma levels of both total and high molecular weight (HMW) 
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adiponectin, and this has been linked to the development of insulin resistance 
(Chang et al. 2009). Cys39 of the monomeric adiponectin isoform has been 
confirmed as the site of succination, preventing the formation of adiponectin 
multimers. Consistent with this, the succinated adiponectin is not secreted into 
the medium of adipocytes matured in high glucose (Frizzell et al. 2009). Similar 
to the in vitro profile, the succination of intracellular adiponectin was also 
increased in the epididymal adipose tissue from db/db mice and was not 
detected in the plasma (Frizzell et al. 2009). This study confirms that the site 
specific succination of adiponectin inhibits the formation and secretion of HMW 
species from adipocytes, consistent with the reduced levels of plasma 
adiponectin observed in type 2 diabetes (Frizzell et al. 2009).  
α and β tubulin form heterodimers that generate the basic subunits of 
cytoskeletal microtubule polymers. The tubulin heterodimer is comprised of 20 
cysteine residues and is consistently the most prominent succinated protein 
detected by our unique anti-2SC antibody in the brain, adipose tissue, cardiac 
and skeletal muscle and lung tissue from db/db mice, as well as 3T3-L1 
adipocytes and C2C12 myocytes (Thomas et al. 2012 and Piroli et al. 2014). 
Consistent with our previous study (Thomas et al. 2012) the degree of tubulin 
succination increases only in the adipocyte under diabetic conditions and 
succination of tubulin remains unaltered between control and diabetic conditions 
in all other tissues examined to date (Thomas et al. 2012, Piroli et al. 2014). 
Assessment of the effect of succination on tubulin polymerization in vitro showed 
that physiological levels of fumarate do not influence polymerization. Using 
 
27 
MS/MS mass spectrometry I identified Cys347 and Cys376 on α tubulin and 
Cys12 and Cys303 on β tubulin from purified porcine brain tubulin as the precise 
sites of succination. Interestingly, succination of these cysteine residues impairs 
the detection ability of antibodies targeting tubulin epitopes that contain Cys347, 
Cys376 or Cys303 (Piroli et al. 2014). The observed decrease in antigen-
antibody binding with increasing succination suggests that succination may alter 
the interaction of tubulin with microtubule associated proteins (MAPs) within 
these regions. In addition, these results underscore the importance of validating 
antibodies with cysteine containing epitopes to ensure succination does not 
affect antibody recognition.  
The progressive increase in protein succination over 8 days of adipocyte 
maturation occurs in parallel with increased CHOP levels and enhanced 
inflammatory cytokine secretion (Tanis et al. 2015). Intriguingly, we have 
observed that the ER proteins glucose related protein 78 (GRP78) and protein 
disulfide isomerase (PDI) are targets of succination in 3T3-L1 adipocytes 
matured in high glucose (Nagai et al. 2007). In chapter 2 we investigate the 
functional significance of succination on the oxidoreductase PDI and how this 
contributes to adipocyte dysfunction during diabetes. Sodium phenylbutyrate 
(PBA) is a small chemical chaperone known to reduce ER stress and inhibit 
adipogenesis (Basseri et al. 2009, Özcan et al. 2006). We discovered that PBA 
acts to lower protein succination by reducing glucose uptake and the 
mitochondrial membrane potential in adipocytes cultured in 30 mM glucose 
(Tanis et al. 2015), independent of any effect on ER stress. Despite claims that 
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PBA acts to reduce ER stress in diabetic animals (Özcan et al. 2006), we 
detected no change in protein succination, UPR markers and greater CHOP 
levels in the adipose tissue of db/db mice treated with PBA (unpublished 
observations). In chapter 3 we further pursue the relationship between protein 
succination and CHOP stability, independent of the UPR and ER stress, in the 
adipocyte matured in high glucose. 
Elimination of the fumarase gene in mouse embryonic fibroblasts 
significantly increases protein succination (Adam et al. 2011) due to the inability 
of fumarase to convert fumarate to malate. Our collaborators Yang et al. recently 
developed and characterized the phenotype of a unique adipose tissue specific 
fumarase knockout mouse (AFHKO) (Yang et al. 2016). This novel mouse model 
permits the investigation of the systemic implications of increased fumarate alone 
in the adipose tissue. Deletion of the fumarase gene under control of 
adiponectin-Cre specifically in the adipose tissue resulted in severe mitochondrial 
dysfunction in the perigonadal white adipose tissue, as evidenced by swollen 
mitochondria with reduced or absent cristae and insufficient ATP production 
(Yang et al. 2016). Cell death, cytoplasmic degeneration, lipid extrusion into the 
interstitial space and adipose tissue macrophage accumulation was also 
documented to occur in the white adipose tissue of these AFHKO mice (Yang et 
al. 2016). Unexpectedly, the AFHKO mice exhibited lower fat mass compared to 
controls, remained insulin sensitive and glucose tolerant and showed no change 
in liver mass or liver triglyceride levels after consuming a high fat diet over 9-11 
weeks (Yang et al. 2016). Surprisingly, the absence of fumarase in the adipocyte 
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appeared to be protective against high fat diet induced obesity, insulin resistance 
and hepatic steatosis. 
The aP2(adipocyte protein 2)-Cre and adipo(adiponectin)-Cre models 
are the most effective tools available to target adipose tissue specific deletions in 
vivo. An unfortunate limitation of both the aP2-Cre and adipo-Cre models is the 
inability to distinguish between white adipose tissue and brown adipose tissue as 
both aP2 and adiponectin are expressed in each adipose subtype. Therefore, the 
consequences of defective brown adipose tissue also have to be considered 
when explaining the overall phenotype of the AFHKO mouse. Brown adipose 
tissue demonstrated irregular and elongated mitochondria, decreased uncoupling 
protein 1 and β3 adrenergic receptor mRNA expression and impaired adaptive 
thermogenesis were present in the AFHKO mouse (Yang et al. 2016). The failure 
of brown adipose tissue to contribute to heat production in AFHKO mice housed 
at ~22ºC resulted in active skeletal muscle-mediated shivering thermogenesis 
(Yang et al. 2016). Shivering thermogenesis increases skeletal muscle energy 
expenditure in AFHKO mice housed at 22ºC and results in minimal lipid 
accumulation and improved insulin sensitivity, even during high fat diet feeding. 
Significantly, equilibration of AFHKO mice thermoneutral conditions (30ºC) 
reversed the unexpected protective effect of adipose tissue fumarase deficiency. 
Further experiments in this model at thermoneutral temperatures will provide 
more meaningful information on the homeostatic significance of adipose tissue 
fumarase deficiency, and validates the importance of thermoneutral housing for 
metabolic studies (Stemmer et al. 2015, Tian et al. 2016, Yang et al. 2016). 
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1.7b Leigh Syndrome 
Leigh Syndrome is distinguished by progressive neurodegeneration and 
the production of lesions in the brainstem and basal ganglia (Finsterer, 2008, 
Rahman et al. 1996). This fatal mitochondrial disease develops due to mutations 
in the genes encoding protein subunits of complex I and VI of the electron 
transport chain (Ruhoy and Saneto, 2014). Ndufs4 is an 18 kDa protein that aids 
in the final assembly of complex I and was one of the first mutated genes 
identified to cause Leigh Syndrome. The loss of Ndufs4 leads to a form of 
complex I that lacks the NADH dehydrogenase unit, and is associated with the 
accumulation of NADH and impaired movement of electrons through the electron 
transport chain. Similar to glucotoxicity driven mitochondrial stress and 
succination in the adipocyte, pseudohypoxia drives the accumulation of fumarate 
in Ndufs4 deficient neurons. We have recently described elevated protein 
succination in the brainstem and cerebellar nuclei of Ndufs4 knockout mice (Piroli 
et al. 2015), particularly in the vestibular nucleus where most of the pathology is 
observed. The Ndufs4 knockout mouse displays many of the clinical and 
neurological symptoms detected in human Leigh syndrome (Quintana et al. 
2010). We propose the fumarate accumulation and subsequent protein 
modification may provide a novel biochemical link to the underlying pathology.  
Voltage dependent anion channel (VDAC) 1 and 2 are transmembrane 
proteins in the outer mitochondrial membrane and function as the primary 
channels for the movement of ADP, ATP and other ions and metabolites 
between the mitochondria and the cytosol. We confirmed that both VDAC 1 and 
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2 are novel targets of succination in the brainstem of Ndufs4 knockout mice by 
mass spectrometry and western blotting (Piroli et al. 2015). Further analysis by 
LC-MS/MS mass spectrometry identified Cys77 and Cys48 as the endogenous 
targets of succinated VDAC2 in the brainstem (Piroli et al. 2015). Current 
investigations aim to understand if succination of VDAC impairs channel activity 
as this may contribute further to the mitochondrial bioenergetic deficit observed in 
Leigh Syndrome, potentially by reducing mitochondrial ATP export. 
1.7c Cancer 
Fumarase is responsible for the hydration of fumarate to malate in the 
mitochondria. Genetic loss-of-function mutations in a fumarase allele 
predisposes patients to hereditary leiomyomatosis and renal cell carcinoma 
(HLRCC) (Tomlinson et al. 2002), further loss of heterozygosity specifically 
precedes the development of the aggressive renal carcinoma and results in a 
significant increase in fumarate levels (Pollard et al. 2005). Fumarate has since 
gained recognition as an oncometabolite, a small molecule component of normal 
metabolism whose accumulation signifies metabolic dysregulation and 
subsequently leads cells to oncogenesis (Yang et al. 2012). As expected, the 
substantial increase in fumarate leads to a pronounced increase in the amount of 
succinated proteins in kidney cells of a renal specific fumarase knockout mouse 
model (Pollard et al. 2007). MS/MS analysis has identified 94 succinated proteins 
in fumarase knockout mouse embryonic fibroblasts (MEF) and renal cysts 
(Ternette et al. 2013), and 60 confirmed protein targets of 2SC in human 
UOK262 and NCC-FH-1 cells and tumors (Yang et al. 2014). Selective 
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evaluation of the role of 2SC in fumarase deficient cancers identified the redox 
sensitive Cys151 and Cys288 of Keap1 as prominent targets of succination 
(Adam et al. 2011, Ooi et al. 2011). Modification of these precise cysteine 
residues impairs Keap1/Nrf2 binding and activates the Nrf2 anti-oxidant 
response. Continuous with the inhibitory effects of 2SC on protein functionality, 
succination of the mitochondrial enzyme aconitase at Cys385, Cys448 and 
Cys451, which are crucial for iron-sulfur cluster binding, significantly reduces 
enzyme activity in vitro and in fumarase knockout MEFs (Ternette et al. 2013). 
Kerins et al. have determined iron regulatory protein 2 is a target protein of 
succination in UOK262 cells, and that this allows for ferritin activation to promote 
the production of the pro-mitotic transcription factor Forkhead box protein M1 
(Kerins et al. 2017). Additionally, fumarate inhibits demethylation of miR-
200ba429, an anti-metastatic miRNA cluster, promoting the expression of 
epithelial-to-mesenchymal related transcription factors in fumarase deficient 
MEFs (Sciacovelli et al. 2016). These studies demonstrate protein succination is 
a critical link between fumarase deficiency and cell malignancy in HLRCC (Kerins 
et al. 2017). Unlike non-malignant cells, protein succination is advantageous to 
the cancer cell by boosting its antioxidant response and promoting metastasis, as 
well promoting metabolic plasticity in fuel utilization, e.g. decreased aconitase 
activity may force alternate anaplerotic fuel usage. Future investigations will 
continue to focus on the contribution of 2SC in HLRCC pathology progression. 
Interestingly, as fumarate is increasingly accepted as a novel oncometabolite 
(Yang et al. 2012), protein succination is also actively being pioneered as a 
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reliable early disease stage diagnostic marker (Chen et al. 2014, Llamas-Velasco 
et al. 2016). 
1.7d Fumaric Acid Esters 
Fumarate esters dimethyl fumarate (DMF) and monomethyl fumarate 
(MMF) (Figure 1.5) have been used to treat symptoms of autoimmune diseases, 
such as psoriasis, for more than fifty years (Ghoreschi et al. 2011, Gold et al. 
2012, Papadopoulou et al. 2010). In 2013 the U.S. Food and Drug Administration 
approved DMF for multiple sclerosis treatment as an oral pharmaceutical drug 
marketed as Tecfidera® (Linker et al. 2013). Elucidation of the complete 
biochemical mechanism underlying the therapeutic benefits and side effects of 
DMF and MMF has received heightened attention (Ghoreschi et al. 2011, Blewett 
et al. 2016, Wu et al. 2017, Schloder et al. 2017). Fumarate esters enter the cell 
where they react rapidly with available thiols, including intracellular glutathione 
(Ghoreschi et al. 2011, Schmidt et al. 2010, Thiessen et al. 2010, Manuel and 
Frizzell, 2013). The depletion of glutathione levels by fumarate esters increases 
heme-oxygenase 1 expression and STAT1 activation that amplifies IL-10 and 
impairs IL-12 and IL-23 production promoting the type II dendritic cell phenotype 
(Ghoreschi et al. 2011). This induces a switch from the pro-inflammatory Th1 
profile towards a favorable Th2 profile in the experimental autoimmune 
encephalomyelitis (EAE) mouse model (Ghoreschi et al. 2011). Linker et al. 
showed that DMF stimulates the Keap1/Nrf2 antioxidant pathway by direct 
modification of Keap1 redox sensitive cysteines (Linker et al. 2011). The 
induction of the antioxidant response by Nrf2 preserved neuronal health and 
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axonal myelination in the myelin oligodendrocyte glycoprotein induced EAE 
mouse model of multiple sclerosis (Linker et al. 2011). While Nrf2 activation 
remains the dominant accepted mechanism of action of DMF, recent studies 
demonstrate that DMF can act independent of Nrf2 and is therapeutically 
beneficial for the treatment of multiple sclerosis models in Nrf2 knockout mice 
(Peng et al. 2016). A thorough proteomic approach has uncovered 40 DMF 
modified cysteines in primary human T cells, elucidating the reactivity of this 
potent electrophile with immunomodulatory proteins including IKKβ, tumor 
necrosis factor-α-induced protein 3 (TNFAIP3) and IL-16 (Blewett et al. 2016). 
Blewett et al. further established that DMF prevents T cell activation and IL-2 
production via succination of a CXXC motif on protein kinase Cθ that disrupts its 
interaction with CD28 at the immunological synapse (Blewett et al. 2016). 
Our laboratory has conducted a new extensive proteomics study to 
investigate new neuronal targets of fumarate esters that may be affected by 
treatment with Tecfidera®. I utilized bottom-up shotgun proteomics with the 
Orbitrap Velos Pro to identify an additional mass of 144.1270 Da or 130.0262 Da 
indicating the DMF or MMF cysteine modification on the fragment ion, 
respectively (Figure 1.5). In total, we identified 4 cysteine containing peptides in 
primary mouse neurons, 11 cysteines in primary rat astrocytes and 13 novel 
cysteine containing peptides in differentiated N1E-115 neuroblastoma cells that 
were succinated by DMF or MMF. Cofilin-1 was identified in primary astrocytes to 
be succinated by MMF at Cys139. Cofilin-1 modulates the actin cytoskeleton by 
depolymerizing filamentous actin and producing monomeric actin that can be 
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used to reorganize the actin cytoskeleton in response to cellular dynamics. 
Analysis of Colifin-1 depolymerization activity in vitro suggests that the chemical 
modification of Cys139 by fumarate esters reduces its capacity to regulate actin 
dynamics (data not published). We are continuing to examine the effect of 
fumarate esters on additional protein targets, both in vitro and in vivo,to better 
understand the positive therapeutic mechanism of DMF during multiple sclerosis.  
While these diverse scenarios for fumarate accumulation provide new 
information on the role of succination, the studies in this dissertation will focus on 
the early mechanism of adipocyte dysfunction in diabetes. I propose that 
succination of the important ER oxidoreductase protein PDI inhibits PDI 
reductase activity, contributing to an accumulation of misfolded proteins and ER 
stress. I also investigate succination of Ero1 that contains a similar active site 
motif to PDI and may also be a prominent target for succination. In addition, I 
hypothesize that decreasing protein succination with mild mitochondrial 
uncouplers will relieve ER stress, identifying a new mechanism of glucotoxicity 
induced adipocyte dysfunction. In chapter 3 I propose that Keap1 is succinated in 
adipocytes matured in high glucose and that modification of Keap1 promotes 
CHOP stability. I confirmed that CHOP accumulates in the nuclear fraction of 
adipocytes matured in high glucose corresponding to decreased secretion of IL-







Figure 1.1: The unfolded protein response (UPR) pathway. Homeostatic 
imbalance initiated by the accumulation of misfolded proteins in the endoplasmic 
reticulum (ER) activates the UPR. The UPR is comprised of three separate 
pathways (1) IRE1 will splice XBP1 and (2) cleaved ATF6 in the golgi act as 
transcription factors to up-regulate ER chaperone proteins. The PERK pathway 
acts to attenuate translation via phosphorylation of eIF2a and continued 
activation of the PERK arm results in transcriptional up-regulation of C/EBP 







Figure 1.2: C/EBP homologous protein (CHOP) degradation pathway.  
The COP9 signalosome (CSN) removes the ubiquitin-like protein Nedd8 from 
cullin-3 to inhibit cullin-3 activity. The CSN associated protein ubiquitin specific 
protease 15 (USP15) protects Keap1 from auto-ubiquitination and degradation. 
The degradation supercomplex will bind CHOP and CSN associated kinases, 
casein kinase 2 (CK2) and protein kinase D (PKD), phosphorylate CHOP to 






Figure 1.3: Formation of 2-(S-succino)cysteine (2SC). The Michael addition 






Figure 1.4: Schematic of how glucotoxicity derived mitochondrial stress 
drives the increase in protein succination and potentially endoplasmic 
reticulum (ER) stress in the adipocyte during diabetes. Elevated 
carbohydrate fuel supply exceeds the metabolic needs of the adipocyte leading 
to an increase in the basal oxygen consumption rate and ATP: ADP ratio. The 
decrease in mitochondrial ADP concentrations inhibits ATP synthase and results 
in a high mitochondrial membrane potential. Electron transport is inhibited with 
the accumulation of H+ in the inner membrane space of the mitochondria and the 
cellular redox status shifts towards an increase in NADH concentration. The 
increase in NADH: NAD+ causes an increase in fumarate and malate, consistent 
with feedback inhibition of the NAD+ -dependent dehydrogenases of the 
tricarboxylic acid cycle. Excess fumarate is available to react with cysteine 
residues, including the succination of the ER oxidoreductase PDI. Sustained 





Figure 1.5: Fumarate and fumaric acid esters structures. Chemical structures 
of fumarate (116.07 Da), monomethyl fumarate (130.0262 Da) and dimethyl 
fumarate (144.1270 Da). 
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Succination of Protein Disulfide Isomerase Links Mitochondrial Stress and 




Proper protein folding and disulfide bond arrangement requires the 
concerted activities of endoplasmic reticulum (ER) chaperones and isomerases, 
particularly during the correction of non-native disulfide bond configurations. 
Consequently, if the ER accessory protein response is compromised this will 
result in an accumulation of misfolded proteins in the ER, prompting the Unfolded 
Protein Response (UPR) in an attempt to maintain ER proteostasis (Kim et al. 
2008, Ron et al. 2007). The continued accumulation of misfolded proteins 
eventually culminates in ER stress and the well characterized upregulation of the 
pro-apoptotic protein C/EBP homologous protein (CHOP) (Schröder et al. 2005). 
ER stress has been documented in the adipose tissue of type 2 diabetic patients 
(Boden et al. 2008, Boden et al. 2014a, Sharma et al. 2008), and is reduced 
following weight loss (Gregor et al. 2009). Hyperinsulinemia, hypoxia and 
inflammation have been proposed to initiate the development of ER stress in 
human adipose tissue (Boden et al. 2014b, Hosogai et al. 2007). ER stress has 
also been described in 3T3-L1 adipocytes (particularly through protein kinase 
RNA-like endoplasmic reticulum kinase signaling) and in the adipose tissue of 
type 2 diabetic mice (Han et al. 2013a, Kawasaki et al. 2012, Lefterova et al. 
2009, Özcan et al. 2004). The treatment of adipocytes from obese subjects with 
lipopolysaccharides, high glucose concentrations or free fatty acids has been 
shown to promote ER stress in vitro (Alhusaini et al. 2010, Jiao et al. 2011). 
While all of these may be physiologically relevant contributors to ER stress, there 
remains limited insight on the mechanistic processes that directly cause 
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disturbed protein folding in the adipocyte (Sha et al. 2011, Sun et al. 2012). In 
this study we identify a novel biochemical mechanism responsible for reduced 
protein folding and increased ER stress in the adipocyte during diabetes. 
Protein disulfide isomerase (PDI) is the most abundant ER oxidoreductase 
that facilitates the formation of correctly configured substrate disulfide bonds 
(Hatahet et al. 2009, Rutkevich et al. 2010). PDI contains two active sites with 
the sequence motif -CGHC- in the a and a’ domains, and both of these play 
crucial roles in the reduction and oxidation of substrate disulfide bonds in the ER 
(Appenzeller-Herzog et al. 2008, Hawkins et al. 1991, Karala et al. 2010, Lappi et 
al. 2004). ER oxidoreductin 1α (Ero1) functions in re-oxidizing PDI using similar 
CXXC active sites, to sustain oxidative protein folding (Tu et al. 2002). S-
glutathionylation of PDI active-site cysteines in both HL60 leukemia cells and 
SKOV3 ovarian cancer cells alters PDI protein structure and inhibits PDI 
isomerase activity in vitro, leading to stimulation of the UPR and the production of 
CHOP (Townsend et al. 2009, Xiong et al. 2012). In addition, nitrosative stress 
induced S-nitrosylation of PDI promotes UPR activation, ER stress and eventual 
cell death in cerebrocortical neurons (Uehara et al. 2006). These models 
demonstrate that the post-translational modification of PDI active-site cysteines 
precedes the development of ER stress. Oxidized low density lipoprotein (oxLDL) 
treatment of HMEC-1 cells augments CHOP mRNA levels and ER stress 
specifically due to decreased PDI reductase activity (Muller et al. 2013). 
However, HMEC-1 cells that over-express native PDI are immune to the 
induction of ER stress with oxLDL treatment (Muller et al. 2013). Importantly, the 
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restoration of functional ER chaperone levels is sufficient to decrease CHOP 
protein expression and ameliorate ER stress in the adipocyte (Liu et al. 2015, 
Zhou et al. 2010), therefore it is critical to mechanistically understand how 
chaperone function is altered under diabetic conditions.  
 We have previously confirmed that the ER residents PDI and glucose-
regulated protein 78 (GRP78) are succinated by endogenously produced 
fumarate in the adipocyte under high glucose conditions (Nagai et al. 2007). 
Protein succination occurs when fumarate reacts non-enzymatically with cysteine 
thiols to produce the irreversible modification S-2-succino-cysteine (2SC) 
(Alderson et al. 2006, Frizzell et al. 2009, Nagai et al. 2007). The analysis of 
proteomic targets identified to date suggests that low pKa thiols that may also be 
susceptible to oxidation as well as those with increased solvent accessibility may 
be most likely to react with endogenously produced fumarate (Merkley et al. 
2014, Miglio et al. 2016) Protein succination is increased in the adipose tissue of 
db/db mice and in 3T3-L1 adipocytes matured in high glucose (10-30 mM) 
(Frizzell et al. 2009, Nagai et al. 2007). We previously demonstrated that the 
ATP:ADP ratio, NADH:NAD+ ratio and the mitochondrial membrane potential are 
significantly increased in 3T3-L1 adipocytes matured in high (30 mM) glucose 
versus normal (5 mM) glucose concentrations (Frizzell et al. 2012, Tanis et al. 
2015). In the metabolically challenged adipocyte the intracellular fumarate levels 
are elevated due to glucotoxicity driven mitochondrial stress and this results in 
the accumulation of succinated proteins (Figure 1.3)(Frizzell et al. 2012). 
Considering that protein succination occurs as a direct result of mitochondrial 
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stress in the adipocyte, and that functional PDI is critical to maintain ER 
proteostasis, we propose that the succination of PDI active-site thiols would 
inhibit its oxidoreductase activity, contributing to ER stress. 
 Mitochondrial uncouplers lower the inner mitochondrial membrane potential, 
created during glucose oxidation, by shuttling protons back into the mitochondrial 
matrix without generating additional ATP. Mitochondrial uncouplers are 
increasingly being investigated as therapeutic strategies to protect against 
coronary heart disease, ischemia-reperfusion injury, nonalchoholic 
steatohepatitis, obesity and diabetes (Kenwood et al. 2013, Long et al. 2016, 
Perry et al. 2015, Zhang et al. 2016). We have previously shown that the 
treatment of adipocytes matured in high glucose with mitochondrial uncouplers, 
2,4-dinitrophenol (DNP) and carbonyl cyanide m-chlorophenyl hydrazone 
(CCCP), reduces both the intracellular fumarate concentration and the degree of 
protein succination (Frizzell et al. 2012). While DNP and CCCP are effective in 
vitro, both drugs are considered toxic and are unsuitable therapeutics. 
Niclosamide is a mild mitochondrial uncoupler (Satoh et al. 2016, Tao et al. 
2014), approved by the US Food and Drug Administration as an anthelmintic 
drug for treating intestinal infections of tapeworms. Importantly, Tao et al. have 
demonstrated the beneficial outcomes of niclosamide in db/db mice after two 
months of oral administration, where niclosamide lowered both blood glucose 
and glycated hemoglobin levels and normalized plasma insulin levels (Tao et al. 
2014). We investigated if targeting mitochondrial stress using niclosamide or a 
model of simple caloric restriction would subsequently reduce protein succination 
 
45 
and eliminate ER stress in the adipocyte matured in high glucose. The results of 
this study provide a novel mechanistic link between mitochondrial stress and the 
development of sustained ER stress, as evidenced by increased CHOP 
production, in the adipocyte during diabetes. 
2.2 Results 
 The development of mitochondrial stress as a direct result of increased 
glucose oxidation (Figure 1.4) is expected to increase the basal oxygen 
consumption rate (OCR) of the adipocyte under diabetic conditions. We matured 
3T3-L1 adipocytes in glucose and insulin concentrations that we have previously 
shown are physiologically representative of normal versus 
hyperglycemic/hyperinsulinemic conditions (5 mM glucose/0.3 nM insulin versus 
30 mM glucose/3 nM insulin) (Tanis et al. 2015). We observed a ~90% increase 
in the basal oxygen consumption rate (OCR) of adipocytes matured in 30 mM 
glucose compared to 5 mM glucose after 2 days of maturation (Figure 2.2B). Our 
previous analyses of uncoupled respiration in adipocytes cultured in high glucose 
demonstrated that the cells are operating close to their maximal respiratory 
capacity, a manifestation of mitochondrial stress (Tanis et al. 2015). Metabolomic 
analyses confirmed that Krebs cycle intermediates, including fumarate, were 
increased in concert in high glucose conditions as a consequence of respiratory 
control and the inhibition of NAD+-dependent dehydrogenases (Figure 
2.1A)(Figure 2.2B, 2.2E). The increase in malate as well as fumarate confirms 
that the adipocyte is overwhelmed due to excessive ATP production (Frizzell et 
al. 2012), and immunoblotting using the anti-2SC antibody verifies that protein 
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succination is significantly increased in adipocytes matured in high versus normal 
glucose concentrations (Figure 2.2C)(Nagai et al. 2007). Adipocytes were 
matured in 5 mM glucose and treated with 0, 2 or 4 mM dimethyl succinate 
(DMS), an esterified form of the Krebs cycle intermediate succinate, to confirm 
that the anaplerotic supply of an alternative intermediate could augment 
endogenous fumarate production and protein succination. An anti-2SC 
immunoblot confirms increased succination of target proteins in the succinate 
supplemented adipocytes (Figure 2.2A). These results emphasize that 
adipocytes matured in high glucose exhibit features of mitochondrial stress early 
in maturation, with a subsequent increase in protein succination after 8 days of 
maturation (Figure 1.3). In contrast, adipocytes that mature and accumulate lipid 
normally in 5 mM glucose show no evidence of mitochondrial stress and have 
limited protein succination. 
Protein succination occurs as a direct result of mitochondrial respiratory 
control in the metabolically challenged adipocyte (Figure 1.3)(Frizzell et al. 2012) 
therefore, we hypothesized that uncoupling the inner mitochondrial membrane 
using niclosamide would lower fumarate and 2SC levels. 3T3-L1 adipocytes were 
matured in 5 mM or 30 mM glucose or 30 mM glucose and treated with 2 µM 
niclosamide for 8 days. Metabolomic analyses substantiated the data that 
uncoupling the inner mitochondrial membrane, demonstrated by the acute 
increase in the basal oxygen consumption rate (Figure 2.2D)(Tao et al. 2014), 
prevents the accumulation of Krebs cycle intermediates in adipocytes matured in 
high glucose concentrations (Figure 2.1A)(Figure 2.2E). Immunoblotting with the 
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anti-2SC antibody demonstrates that niclosamide treatment reduces the degree 
of protein succination in adipocytes matured 30 mM glucose concentrations 
(Figure 2.1B). The lower panels depict shorter exposure times of the same anti-
2SC immunoblot and highlight the decreased succination of several higher 
molecular weight proteins (50-150 kDa) (Figure 2.1B). Examining the relationship 
between protein folding, ER stress and glucose concentration we assessed the 
levels of CHOP, Ero1 and PDI in adipocytes matured in 5 mM or 30 mM glucose. 
The levels of CHOP were pronouncedly increased in adipocytes matured in high 
glucose compared to normal glucose (Figure 2.2C), confirming that persistent ER 
stress is selectively present in adipocytes matured under hyperglycemic 
conditions (Tanis et al. 2015). It is important to note that we did not detect 
differences in the protein levels of GRP78 or any components of the PERK, IRE1 
or ATF6 branches of the UPR in adipocytes in normal/high glucose as the UPR is 
induced as a normal function of adipocyte maturation in the presence of insulin 
(Han et al. 2013a, Minard et al. 2016, Tanis et al. 2015). In order to establish a 
novel link between mitochondrial stress and the sustained ER stress, we 
examined CHOP protein expression levels in adipocytes matured in 5 mM, 30 
mM or 30 mM glucose treated with 2 µM niclosamide for 8 days (Figure 2.1C). 
The data confirms that alleviating mitochondrial stress prevents the presence of 
prolonged ER stress generated by high glucose conditions. Although the 
transcription of ER chaperones may be up-regulated in parallel with ER stress, 
we did not detect any changes in the total protein levels of Ero1 or PDI between 
groups (Figure 2.1C)(Figure 2.2C). Importantly, alleviation of both mitochondrial 
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and ER stress with niclosamide corresponds to improved adiponectin secretion 
(Figure 2.1D), confirming that mitochondrial stress and succination impair 
adiponectin processing in the ER (Frizzell et al. 2009). These data confirm that 
mitochondrial stress and protein succination influence the development of ER 
stress and reduce adiponectin secretion from the adipocyte. 
Lentiviral delivery of fumarase shRNA to adipocytes matured in normal 
glucose was used to increase fumarate levels in the adipocyte independent of 
glucotoxicity, since this prevents the hydration to malate and permits fumarate 
accumulation. The successful transduction of both the scrambled control and 
fumarase knockdown (FHKD) lentivirus was evaluated by monitoring green 
fluorescent protein (GFP) positive adipocytes 6 days post transduction (Figure 
2.4A). Adipogenesis proceeded normally in FHKD cells and was confirmed by 
the elevated expression of adiponectin and peroxisome proliferator-activated 
receptor gamma (PPARγ) isoforms (Figure 2.3A). Reduced serum adiponectin 
species are a hallmark of type 2 diabetes. We observed a decrease in secreted 
adiponectin profiles from the FHKD adipocytes versus the scrambled controls 
(Figure 2.4D), similar to Yang et al. that reported lower circulating adiponectin 
levels in the plasma of adipose tissue specific fumarase knockout mice 
compared to control mice (Yang et al. 2016). These data again verify that 
elevated fumarate and succination lead to reduced serum adiponectin levels 
(Frizzell et al. 2009, Yang et al. 2016). The quantification of the triglyceride 
content in control and FHKD adipocytes matured in 5 mM or 30 mM glucose 
(Figure 2.3B), as well as the documented lipid accumulation by Oil Red O 
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staining (Figure 2.4B) verified that knocking down the expression of fumarase 
does not interfere with adipogenesis. The ~50% knockdown of fumarase levels 
observed was sufficient to increase protein succination in the adipocytes (Figure 
2.3A). The pronounced escalation in protein succination in the FHKD adipocytes 
is directly proportional to the dramatic increase in the intracellular fumarate 
production. Analysis of mitochondrial metabolites from control and FHKD 
adipocytes matured in 5 mM glucose reveals a ~30 fold increase in fumarate 
compared to controls (Figure 2.3C)(Figure 2.4C). FHKD adipocytes displayed 
significant increases in the secretion of the pro-inflammatory cytokines TNFα, IL-
1α and IL-1β, as well as VEGF, versus control adipocytes (Figure 2.3D) (Figure 
2.4E). This similar to the significant increases in TNFα, MCP-1 and VEGF that 
we observed previously in adipocytes matured in 30 mM versus 5 mM glucose 
(Tanis et al. 2015). These data suggest that elevated fumarate and protein 
succination may play a role in the chronic low grade inflammatory state of 
adipose tissue observed during diabetes. Elevated CHOP levels were observed 
in both 30 mM glucose and FHKD adipocytes matured in 5 mM glucose (Figure 
2.3E), confirming that protein succination alone functionally contributes to both 
the development of ER stress and the pro-inflammatory state of adipocytes, 
independent of other glucose derived metabolic stressors. In order to 
mechanistically understand how succination might contribute to ER stress, we 
examined the succination of PDI in adipocytes during glucotoxicity. PDI was 
immunoprecipitated from adipocytes matured in 5 mM or 30 mM glucose and 
examined by 2D-immunoblotting to detect succination, (Figure 2.3F, top panels) 
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followed by re-probing with anti-PDI (Figure 2.3F, lower panels). Compared to 
the total levels of immunoprecipitated PDI, there was significantly more 
succinated PDI in adipocytes matured in high glucose. We also confirmed 
increased PDI succination in fumarase knockout (Fh-/-) mouse embryonic 
fibroblasts (MEFs), whose endogenous fumarate concentrations are ~5 mM 
(Ternette et al. 2013) (Figure 2.5). Overall, the results confirm that PDI is 
succinated in the presence of excess fumarate, potentially interfering with protein 
folding. 
We were also interested in determining if Ero1, the thiol-dependent protein 
responsible for re-oxidizing PDI active-site cysteines, is also susceptible to 
succination by fumarate. Since mammalian Ero1 also contains redox-sensitive 
cysteine thiols (Inaba et al. 2010), we hypothesized that Ero1 might be a novel 
target of succination in the adipocyte. We incubated recombinant Ero1α (Araki et 
al. 2011) with increasing concentrations of fumarate in vitro to investigate if Ero1 
is susceptible to succination. 1D-immunoblotting with anti-2SC and anti-Ero1 
antibodies confirmed that Ero1 is succinated when incubated with 5 mM or 25 
mM fumarate (Figure 2.6A). We next immunoprecipitated Ero1 from adipocytes 
matured in 5 mM or 30 mM glucose and immunoblotted with the anti-2SC 
antibody. However, Ero1 succination was not detected in the adipocytes (Figure 
2.6B). The blot was re-probed with an anti-Ero1 antibody to confirm the presence 
of Ero1 in the immunoprecipitates (Figure 2.6B). Therefore, while recombinant 
Ero1 could be succinated in vitro, there were no detectable increases in the 
endogenous succination of Ero1 in adipocytes. 
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 The succination of catalytically important thiols in the metabolic enzymes 
GAPDH and aconitase have been shown to reduce their enzymatic activity 
(Blatnik et al. 2008, Ternette et al. 2013). We hypothesized that succination at 
the active-site cysteines of PDI might also reduce enzymatic activity. Incubation 
of recombinant wild-type PDI (PDI-WT) with either 5 or 25 mM fumarate 
increased succination of PDI compared to the unmodified control (Figure 2.7A). 
Succination of PDI in vitro functionally decreased PDI reductase activity by 15% 
and 21% for 5 and 25 mM fumarate respectively (n=5, **p< 0.01) (Figure 2.7A, 
B). In addition, we used a mutant form of PDI (PDIFLFL) to determine if 
succination of PDI active-site cysteines is essential for inhibition of PDI reductase 
activity. The residues His and Lys, adjacent to either side of the C-terminal 
active-site cysteines, are mutated to Phe and Leu (H55ΔF:K57ΔL and 
H399ΔF:K401ΔL), respectively in both the a and a’ domains of the mutant form 
of PDI (Xiong et al. 2012). While remaining enzymatically functional, these 
simultaneous mutations are predicted to alter the active-site thiol pKa, and 
prevent S-gluthionylation of PDI (Xiong et al. 2012). In contrast to the data 
obtained with PDI-WT, the mutant PDI could not be succinated in the presence of 
increasing fumarate concentrations in vitro, and its reductase activity was 
unaffected (Figure 2.7C, D), indicating that active-site cysteine modification by 
fumarate is necessary for inhibition of PDI reductase activity. 
 We confirmed that direct succination of active-site cysteines was 
mechanistically responsible for the inhibition of PDI reductase activity by LC-
MS/MS mass spectrometry. Recombinant PDI that had been incubated in the 
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presence or absence of fumarate (Figure 2.8A) was alkylated with 4-vinylpyridine 
to produce a control pyridylethyl modification (CPE, +105.058 Da) on the 
remaining free thiols. The tryptic precursor ion masses for control (CPE, CPE) and 
succinated (CPE, C2SC, +116.011 Da) peptides were analyzed by LC-MS/MS in 
order to determine the specific site of succination. We identified the MS/MS 
spectrum corresponding to the succinated peptide 
45YLLVEFYAPWCPEGHC2SCK59 ([M+3H]3+: 683.9882 m/z) and 
388KNVFVEFYAPWCPEGHC2SCK403 ([M+3H]3+: 717.0033 m/z) in the recombinant 
PDI sample modified by fumarate (Figure 2.8B, D), as well as each analogous 
control peptide (Cys55PE, Cys58PE) (Cys399PE, Cys402PE) in the unmodified 
recombinant PDI sample (Figure 2.8C, 2.8E). In the case of both active-site 
peptides the succination site was confirmed to be the second (C-terminal) 
cysteine, and was only detected in the PDI samples incubated with fumarate in 
vitro. 
 While succination of PDI active-site cysteines inhibits reduction of insulin 
disulfide bonds in vitro (Figure 2.8) the assay is not specific for PDI activity in cell 
lysates due to the presence of other oxidoreductases. Di-Eosin-GSSG is a 
fluorescent self-quenching synthetic PDI specific substrate (Klett et al. 2010, 
Raturi, 2007) frequently utilized to evaluate PDI reductase activity in protein 
lysates (Muller et al. 2013, Xiao et al. 2011). PDI reductase activity was 
decreased by ~36% (Figure 2.9A, 2.9D n=3, *p<0.05) in adipocytes matured in 
high glucose versus normal glucose, and increased succination was detected at 
the molecular weight of PDI (~57 kDa, arrow, Figure 2.9B) where the total levels 
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of PDI remained similar between all samples (Figure 2.9B). 1D-immunoblotting of 
PDI immunoprecipitates with anti-2SC verified that succination of PDI increased 
in FHKD versus control adipocytes (Figure 2.9C). The evaluation of PDI 
reductase activity in FHKD adipocytes demonstrated specifically that succination 
of PDI accounted for a 15% decrease in PDI reductase activity versus controls 
(Figure 2.9D, n=3, *p<0.05). 
PDI was enriched from adipocytes matured in 5 mM or 30 mM glucose 
and analyzed by LC-MS/MS to confirm the endogenous sites of succination. A 
fragment ion (y13) representative of both control precursor ions containing 
active-site cysteines was detected in both adipocytes matured in 5 mM 
([M+3H]3+: 680.3434 m/z) ([M+3H]3+: 670.6406 m/z) or 30 mM ([M+3H]3+: 
680.3387 m/z) ([M+3H]3+: 670.6228 m/z)  glucose (Figure 2.9E, 2.9F; panels 1 
and 3). In contrast, the mass of the representative y13 fragment ion from each 
succinated precursor ion containing active-site cysteines ([M+3H]3+: 683.3942 
m/z) ([M+3H]3+: 674.3534 m/z) was only detected in adipocytes matured in 30 
mM glucose (Figure 2.9E, 2.9F; panel 2 versus 4). While the fragment ion profile 
was unique to these succinated peptides, the N-terminal or C-terminal location of 
the succinated cysteine could not be assigned, however, modification of either 
cysteine is sufficient to impair PDI function as both thiols participate in the 
oxidoreductase mechanism of PDI. Importantly, these measurements confirm 
that the endogenous succination of active-site cysteines in PDI selectively occurs 
in adipocytes matured in high glucose. 
Control and db/db mice at 15 weeks of age were used for the analysis of 
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protein succination. The total epididymal fat pad weight, fasting blood glucose 
and plasma triglyceride levels of the db/db mice were all elevated compared to 
age matched control mice (Figure 2.10A). In order to establish if succination 
impacts PDI functionality in vivo we examined PDI enzymatic activity in the 
epididymal adipose tissue of db/db diabetic mice. Succinated PDI is found only in 
the epididymal adipose tissue of db/db mice and is absent in the epididymal 
adipose tissue of the control mice (Figure 2.10B, upper panels). Total PDI is 
detectable in both the control and db/db adipose tissue samples ~57 kDa (Figure 
2.10B, lower panels). Assessment of PDI reductase activity using Di-Eosin-
GSSG in control and db/db adipose tissue demonstrated that activity was 
reduced by 52.6% in the diabetic mice (n=4, *p<0.05, Figure 2.10C), while 
immunoblotting demonstrated equal amounts of PDI (Figure 2.10C). 
Immunoblotting with anti-GRP78 antibody verified our in vitro results that 
emphasize no alteration in the protein levels of GRP78 in the adipose tissue 
during diabetes however, probing with anti-CHOP confirmed the existence of ER 
stress in the epididymal adipose tissue from db/db mice versus controls, (Figure 
2.10C) (Zhou et al. 2010). The succination of PDI occurs in parallel with reduced 
PDI reductase activity and the development of ER stress in the epididymal 
adipose tissue of db/db mice.   
 We have reported that decreasing glucotoxicity prevents the 
accumulation of succinated proteins in adipocytes (Frizzell et al. 2012), 
alleviating mitochondrial stress and permitting the turnover of succinated 
proteins. In the current study, we examined if limiting chronic glucose exposure 
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would be beneficial for recovery from ER stress in adipocytes. The accumulation 
of succinated proteins after 4 days of maturation (Tanis et al. 2015) was 
prevented when the high glucose medium was removed and replaced with 
normal glucose concentrations (30→5, Figure 2.11A). Notably, CHOP levels 
were also restored to those observed in normal glucose concentrations (Figure 
2.11A), suggesting that limiting chronic high glucose exposure is sufficient to 
ameliorate ER stress in the adipocyte. To determine the mechanism of ER stress 
reduction, PDI was immunoprecipitated from adipocytes matured in 5 mM, 30 
mM or 30→5 mM glucose. Immunoblotting verified that succination of PDI was 
greatest in adipocytes matured in 30 mM glucose for all 8 days of maturation, 
whereas 4 days of recovery under normal glucose concentrations rescued the 
amount of succinated PDI (Figure 2.11B). PDI reductase activity was 60% lower 
in adipocytes matured in 30 mM glucose versus 5 mM glucose, whereas the 
adipocytes matured in 30→5 mM glucose displayed a 46% decrease in PDI 
reductase activity (Figure 2.11C), indicating that a significant fraction of PDI 
functionality had been restored. The rescue of PDI reductase activity due to 
reduced succination of PDI contributes to an improved protein folding capacity, 





Figure 2.1: Mitochondrial stress drives ER stress in adipocytes matured in 
high glucose. (A) Krebs cycle metabolites were extracted from adipocytes 
matured in 5 mM or 30 mM glucose or 30 mM glucose and 2 µM niclosamide for 
3 days prior to quantification by GC-MS. High glucose concentrations result in 
significantly increased levels of both fumarate and malate relative to the levels 
quantified in 5 mM glucose (n=3/group, mean +/- SEM, *p< 0.05). (B) Adipocytes 
were matured in 5 mM or 30 mM glucose for 8 days. A western blot was 
performed with 30 µg of protein from duplicate representative samples using anti-
2SC antibody to detect succinated proteins. Molecular weight markers are shown 
on the far left. (C) Adipocytes were matured in 5 mM or 30 mM glucose 30 mM 
glucose with 2 µM nicolsamide for 8 days. Western blots were performed with 30 
µg of protein to detect ER stress markers with anti -CHOP, -GRP78, -Ero1, and -
PDI antibodies. Coomassie blue stain of the blot confirms equal loading of all 
samples. (D) An immunoblot probed with anti-adiponectin antibody shows the 
levels of secreted adiponectin assessed in the conditioned medium collected 
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after 4 hours from adipocytes matured in 5 mM or 30 mM glucose treated with 2 
µM niclosamide. This is a merged image (merged between lanes 3 & 4). 




Figure 2.2: Quantification of additional Krebs cycle metabolites and 
confirmation of increased adipocyte metabolism, the uncoupling 
mechanism of niclosamide and ER stress in adipocytes matured in high 
glucose. (A) 3T3-L1 adipocytes were matured in 5 or 30 mM glucose and 
treated with 0, 2 or 4 mM dimethylsuccinate for 8 days. A 1D-immunoblot probed 
with anti-2SC antibody displays increased protein succination, specifically 
~57kDa (black arrow). Re-probing with anti-actin antibody represents equal 
protein loading and molecular weight markers are shown of the left. (B and E) 
Krebs cycle metabolites were extracted from adipocytes matured in 5 mM or 30 
mM glucose treated with or without 2 µM niclosamide for 3 days and derivatized 
prior to quantification by GC-MS. High glucose concentrations result in 
significantly increased the levels of all metabolites. The increases are expressed 
relative to the levels quantified in 5 mM glucose (n=3/group, mean +/- SEM, *p< 
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0.05). (C) Adipocytes were matured in 5 mM or 30 mM glucose for 8 days. 
Western blots were performed with 30 µg of protein to detect ER stress markers 
with anti -CHOP, -Ero1, and -PDI antibodies. Anti-actin immunoblot confirms 
equal loading of all samples. Immunoblots are representative of n=6 
experiments. (D) The acute change in the oxygen consumption rate of 
adipocytes matured in 30 mM glucose for 2 days when niclosamide is added. 
0.25 µM niclosamide was used in the acute 2 hour period to confirm uncoupling 
activity. The rate of oxygen consumption in adipocytes was measured by XF Flux 
Analyzer (Seahorse Biosciences) and the data was normalized to the total DNA 





Figure 2.3: Protein succination induces ER stress independent of glucose 
levels. (A) Fibroblasts were transduced with scrambled (control) or fumarase 
(Fh) knockdown (FHKD) shRNA and grown to confluence. FHKD or control 
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adipocytes were matured in 5 mM or 30 mM glucose for 8 days. A merged image 
of the same 1D-immunoblot probed with anti-2SC and -Fh antibodies display 
increased protein succination in both fibroblasts and adipocytes when Fh 
expression is knocked down. The blot was stripped and reprobed with anti-
PPARγ antibody to confirm that FHKD 3T3-L1 fibroblasts differentiate normally to 
adipocytes. The blot was reprobed with anti-α tubulin antibody as a protein 
loading control. (B) Control or FHKD adipocytes were matured in 5 mM or 30 mM 
glucose for 8 days. The triglyceride content was measured as described in 
Materials and Methods (n=3/group, mean +/- SEM, *p<0.05). (C) Krebs cycle 
metabolites were extracted from adipocytes transduced with scrambled control or 
FHKD lentivirus and matured in 5 mM glucose for 3 days and derivatized prior to 
quantification by GC-MS. Limited Fh expression result in significantly increased 
the levels of all metabolites. The increases are expressed relative to the levels 
quantified in control adipocytes that have normal levels of Fh present (n=3/group, 
mean +/- SEM, *p< 0.05). (D) Secreted levels of pro-inflammatory cytokines were 
measured by a mouse obesity ELISA as described in the Materials and Methods 
(n=4/group, mean +/- SEM, *p<0.05). (E) Adipocytes transduced with FHKD or 
scrambled control lentivirus were matured in 5 mM or 30 mM glucose for 8 days. 
1D-immunoblots of duplicate samples probed with anti-2SC and -Fh antibodies 
show that knocking down Fh levels increases protein succination in adipocytes to 
the greatest degree versus both 5 mM and 30 mM glucose treatments when Fh 
is present. Western blotting with anti-CHOP antibody confirms that ER stress is 
present in both adipocytes matured in 30 mM glucose and FHKD adipocytes 
matured in 5 mM glucose. (F) Protein (500 µg) from adipocytes matured in 5 mM 
or 30 mM glucose was immunoprecipitated with anti-PDI antibody. The antibody-
antigen complex was captured with Protein G beads. The eluted complex was 
isoelectrically focused on strips with a pI range 3.9-5.1. After 2D electrophoresis 
and protein transfer a western blot was performed to detect succination using 
anti-2SC (upper panel), followed by re-probing with anti-PDI to verify PDI 








Figure 2.4: Verification of lentivirus transduction and adipocyte 
differentiation and quantification of Krebs cycle metabolites and secreted 
adipokines in control and FHKD adipocytes. (A) 3T3-L1 adipocytes were 
transduced with a scrambled (control) vector or FHKD shRNA coupled to green 
fluorescent protein expression. Positive green fluorescent protein (GFP) 
expression within adipocytes matured in 30 mM glucose for 8 days confirms 
scramble (left) or FHKD (right) viral expression. (B) 3T3-L1 fibroblasts and FHKD 
adipocytes matured in 5 mM or 30 mM glucose were stained with Oil Red O and 
representative images (n=3) of lipid droplet accumulation are documented by 
brightfield microscopy. (C) Krebs cycle metabolites were extracted from 
adipocytes transduced with scrambled control or FHKD lentivirus and matured in 
5 mM glucose for 3 days and derivatized prior to quantification by GC-MS. 
Limited fumarase expression result in significantly increased the levels of all 
metabolites. The increases are expressed relative to the levels quantified in 
control adipocytes that have normal levels of fumarase present (n=3/group, mean 
+/- SEM, *p< 0.05). (D) An immunoblot probed with anti-adiponectin antibody 
shows the levels of secreted adiponectin analyzed in the conditioned medium 
collected from control and FHKD adipocytes. (E) Secreted levels of pro-
inflammatory cytokines were measured by a mouse obesity ELISA as described 






Figure 2.5: Succination of endogenous PDI in Fh1-/- MEFs. 200 µg of cell 
lysate protein from (A) wild-type (WT) and (B) Fh1-/- MEFs (1,2) was 
isoelectrically focused on strips with a pI range 3.9-5.1. After 2D electrophoresis 
& protein transfer a western blot was performed to detect succination using anti-
2SC (left panels). Enlarged 2D-immunoblot images in the pI 4.7-5.0 region of the 
WT (A) and Fh1-/- (B) MEFs depict the presence of PDI at 57 kDa (pI ~4.8) in 
each sample. Fh-/- MEFs contain a significant amount of succinated PDI (note 3 
distinct spots in the oval region corresponding to the 3 spots labeled with anti-
PDI below), while there is no detectable succinated PDI in WT MEFs. Molecular 
weight markers are shown on the far left. (C) Fh1-/- MEFs were matured in 25 mM 
glucose for 4 days. The active site peptide of PDI containing Cys55 and Cys58 
were analyzed by LC-ESI-MS/MS. The detection of the y13 fragment ion at 
retention time ~32.73 minutes represents the presence of the control (CysPE, 
CysPE) active site peptide in PDI (panel 1). The detection of the analogous y13 
fragment ion at the retention time ~34.58 minutes represents the presence of the 
succinated (CysPE, Cys2SC) active site peptide (panel 2). WT, wild type; Fh-/-, 





Figure 2.6: Succination of Ero1α in vitro. (A) 2.77 µg of recombinant Ero1α (3) 
was incubated in the presence or absence of the indicated fumarate 
concentrations for 24 hrs. A western blot with 2.77 µg of protein was probed with 
anti-2SC antibody confirmed a concentration-dependent increase in Ero1 
succination when incubated with 5 mM or 25 mM fumarate. The blot was 
reprobed with anti-Ero1α antibody to verify equal protein loading. (B) Protein 
(500 µg) from adipocytes matured in 5 mM or 30 mM glucose was 
immunoprecipitated with anti-Ero1α antibody. The antibody-antigen complex was 
captured with Protein A beads. The eluted complex was subjected to 1D-
immunoblotting with anti-2SC antibody to detect succination of Ero1. However, 
Ero1 succination was not detected in the adipocytes, independent of glucose 
concentration. The blot was reprobed with anti-Ero1α antibody to confirm the 
presence of Ero1 in the immunoprecipitated samples. Therefore, although 
recombinant Ero1 could be succinated in vitro, we were not able to detect any 
endogenous succination of Ero1 in the adipocytes. Immunoblots are 














Figure 2.7: Succination inhibits PDI reductase activity in vitro. (A and B) 
Both the wild type and mutant recombinant PDI were incubated with indicated 
fumarate concentrations for 24 hrs. A western blot with 2.77 µg of protein was 
probed with anti-2SC and anti-PDI antibodies. Immunoblots are representative of 
n=5. (C and D) 2.77 µg of wild type or mutant recombinant PDI were incubated in 
the presence or absence of the indicated fumarate concentrations for 24 hrs. PDI 
reductase activity of control and succinated PDI was assayed as described in 
Materials and Methods using a fluorescent insulin turbidity assay. Fluorescence 









Figure 2.8: Identification of succination sites in PDI. (A) 2.77 µg of 
recombinant human PDI (PDI-WT) was incubated with 0 or 100 mM fumarate at 
37°C for 24 hrs. A 1D-immunoblot probed with anti-2SC antibody followed by 
reprobing with anti-PDI antibody shows enhanced succination of PDI when 
incubated with 100 mM fumarate. (B-E) 3 µg of recombinant PDI was incubated 
in the presence (B and D) or absence (C and E) of 100 mM fumarate to 
maximize succinated peptides for LC-MS detection, resolved by SDS-PAGE and 
stained with Coomassie Brilliant Blue. The protein corresponding to 57 kDa was 
excised from the gel, digested with trypsin and the active site peptides were 
analyzed by LC-ESI-MS/MS mass spectrometry. (B and D) MS/MS spectra 
showing that the C-terminal cysteines in both active site peptides 
45YLLVEFYAPWCPEGHC2SCK59 and 389KNVFVEFYAPWCPEGHC2SCK403 are the 
target of succination in vitro. (C and E) MS/MS spectra showing the unmodified 
peptides 45YLLVEFYAPWCPEGHCPEK59 and 389KNVFVEFYAPWCPEGHCPEK403 






Figure 2.9: Succination of PDI active-site cysteines inhibits PDI reductase 
activity in 3T3-L1 adipocytes. (A) Adipocytes were matured in 5 mM or 30 mM 
glucose for 7 days. 6 µg of adipocyte cell lysate protein was incubated with 1.08 
µM Di-Eosin-GSSG for 1 hr. Fluorescence was measured at λex= 510 nm and 
λem= 550 nm and the initial rate of reaction calculated (n=4/group, mean +/- SEM, 
*p< 0.05). (B) Western blots with anti-2SC and -PDI antibodies show succination 
of PDI in the adipocytes matured in 30 mM glucose (black arrow) and 
representative equal amounts of PDI in each sample. An immunoblot with anti-
actin antibody displays equal protein loading. (C) Protein (400 µg) from control or 
FHKD adipocytes matured in 5 mM glucose was immunoprecipitated with anti-
PDI antibody and the antibody-antigen complex was captured with Protein G 
beads. The eluted complex was subjected to 1D-immunoblotting and probed with 
anti-2SC (upper panel) and anti-PDI (lower panel) antibodies. (D) 6 µg of 
adipocyte cell lysate protein was incubated with 1.08 µM Di-Eosin-GSSG for 1 hr. 
Fluorescence was measured at λex= 510 nm and λem= 550 nm (n=3/group, mean 
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+/- SEM, *p< 0.05). (E) The active-site peptides of PDI from adipocytes matured 
in 5 mM or 30 mM glucose for 8 days were analyzed by LC-ESI-MS/MS. The 
detection of the y13 fragment ion at retention time ~36.4 minutes represents the 
presence of the control (C55PE, C58PE) PDI active-site peptide from adipocytes 
matured in both 5 mM (panel 1) and 30 mM (panel 3) glucose. The detection of 
the y13 fragment ion at the retention time ~36.6 minutes represents the presence 
of the succinated (C55PE, C582SC) active-site peptide in adipocytes matured in 30 
mM glucose (panel 4) and the absence of the succinated peptide in adipocytes 
matured in 5 mM glucose (panel 2). (F) The detection of the y13 fragment ion at 
retention time ~33.4 minutes shows the presence of the control (C399PE, C402PE) 
active-site peptide in PDI from adipocytes matured in both 5 mM (panel 1) and 30 
mM (panel 3) glucose. The detection of the y13 fragment ion at the retention time 
~35.5 minutes indicates the presence of the succinated (C399PE, C4022SC) 
active-site peptide in adipocytes matured in 30 mM glucose (panel 4) and the 















Figure 2.10: Succination inhibits PDI reductase activity in adipose tissue of 
db/db mice. (A) Epididymal fat pads were removed and weighed at the time of 
sacrifice. Fasting blood glucose was measured from the tail vein and serum 
triglyceride levels were measured (n=5-6 mice/group, mean +/- SEM, **p<0.01, 
***p<0.001). All in vivo analysis were performed at 15 weeks of age. (B) 200 µg 
of protein from control (top) and db/db (lower) mouse epididymal adipose tissue 
was isoelectrically focused on a pI range 4-7. After 2D electrophoresis & protein 
transfer a western blot was performed to detect succination using anti-2SC 
antibody, followed by reprobing to verify PDI. Enlarged 2D-immunoblot images in 
the pI 4.7-4.9 region of the control and db/db adipose tissue depict the presence 
of PDI at 57 kDa (pI ~4.85) in each sample. Molecular weight markers are shown 
on the far left and right. (C) 6 µg of protein from control and db/db mouse 
epididymal adipose tissue was incubated with 1.08 µM Di-Eosin-GSSG for 1 hr. 
Fluorescence was measured at λex = 510 nm and λem = 550 nm (n=3/group, 
mean +/- SEM, *p< 0.05). A western blot with anti-PDI antibody shows 
representative equal amounts of PDI in each sample. Immunoblotting 30 µg of 
total protein lysate from control and db/db mouse epididymal adipose tissue with 
anti-CHOP and -GRP78 antibodies of demonstrates increased levels of CHOP 
and no change in the levels of GRP78 in the adipose tissue from db/db versus 








Figure 2.11: Reducing glucose concentrations rescues PDI reductase 
activity and ameliorates ER stress in adipocytes. (A) Adipocytes were 
matured in 5 mM or 30 mM glucose for 8 days or 30 mM glucose for 4 days, 
followed by a switch to 5 mM glucose for the remaining 4 days of maturation 
(30→5 mM). Western blotting was performed with 30 µg of protein using anti-
2SC antibody to detect succinated proteins. A merged image of the same blot 
displays duplicate representative samples. Molecular weight markers are shown 
on the far left. An immunoblot with the identical samples was probed with anti-
CHOP, -PDI and -actin antibodies to detect changes in protein expression. (B) 
Protein (300 µg) from adipocytes matured in 5 mM, 30 mM or 30→5 mM glucose 
was immunoprecipitated with anti-PDI antibody. After 1D electrophoresis and 
protein transfer a western blot was performed to detect succination using anti-
2SC (upper panel), followed by reprobing with anti-PDI to verify PDI (lower 
panel). (C) Adipocytes were matured in 5 mM, 30 mM or 30→5 mM glucose. 6 
µg of adipocyte cell lysate protein was incubated with 1.08 µM Di-Eosin-GSSG 
for 1 hr after which fluorescence was measured at λex = 510 nm and λem =550 nm 





In this study we mechanistically demonstrate that succination of PDI, as a 
direct result of glucotoxicity driven mitochondrial stress, contributes to the 
presence of ER stress in the adipocyte. Consistent with other reports (Boden et 
al. 2014b, Han et al. 2013b) we document a significant increase in the protein 
levels of CHOP in adipocytes matured in high glucose medium, and notably this 
occurs in parallel with an increase in protein succination, suggesting a link 
between mitochondrial stress and ER stress. Niclosamide is a mild mitochondrial 
uncoupler that reduces mitochondrial stress by lowering the mitochondrial 
membrane potential and increasing the ADP:ATP ratio in vitro, and significantly 
improves glucose homeostasis in diabetic mice (Tao et al. 2014). In Figure 2.1 
we demonstrate two novel roles for niclosamide; succination of proteins, 
including PDI, is decreased by directly reducing mitochondrial stress, and it 
prevents increased protein levels of CHOP, indicative of protection against ER 
stress in adipocytes matured under diabetic conditions. In addition, we detected 
a significant improvement in high molecular weight adiponectin secretion from 
adipocytes in the presence of niclosamide.  Zhou et al. have described the 
requirement for normal levels of the ER chaperone disulfide-bond-A 
oxidoreductase-like protein to successfully combat ER stress in the adipocyte 
(Zhou et al. 2010). Our initial assessment of ER stress markers demonstrated 
that increased CHOP was present, however we did not observe altered PDI or 
Ero1 protein levels in the adipocytes matured in high glucose. Instead our 
findings suggest that succination-mediated inhibition of the enzyme determines 
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the ability of PDI to facilitate protein folding in a metabolically challenging 
environment. 
The mitochondrial associated ER membrane (MAM) facilitates the 
passage of lipids and several ions through several defined channels (Arruda et al. 
2014, Rutter et al. 2014). MAM enrichment, facilitating calcium transport, has 
been reported in hepatocytes of ob/ob- and high fat diet fed mice (Arruda et al. 
2014). Excess fumarate produced in the mitochondria is transported to the 
cytosol and out of the cell (Lai and Gold, 1992), or it may enter the ER lumen 
through the MAM, facilitating the succination of ER proteins (Merkley et al. 2014). 
In this study, we have confirmed that endogenously produced fumarate 
increased succination of PDI in adipocytes matured in high glucose 
concentrations, and that succination inhibits PDI reductase activity in these 
adipocytes and in the adipose tissue of diabetic db/db mice. Similar to the 
inhibitory effect of S-glutathionylation and S-nitrosylation on PDI enzymatic 
activity (Townsend et al. 2009, Uehara et al. 2006), increasing succination of PDI 
is also indirectly correlated with its reductase activity. Alongside this, we 
specifically confirmed that the cysteine containing active-site peptides of PDI are 
endogenously succinated in adipocytes matured in high glucose medium. The 
significant reduction in PDI reductase activity contributes to disturbed protein 
folding by decreasing the capabilities of the major ER oxidoreductase, ultimately 
resulting in the pronounce CHOP levels sustained in adipocytes in vitro and in 
vivo. 
PDI-A1 is the most abundant isoform of the PDI oxidoreductase family in 
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the adipocyte. Despite the fact all PDI family member (A1-A6) active-site 
peptides were analyzed by MS/MS mass spectrometry, the active-site peptides 
of PDI-A1 remained the most abundantly detected, suggesting that PDI-A1 has a 
major role in adipocyte ER protein folding. In addition, Muller et al. have 
demonstrated that increased expression of functional PDI-A1 alone is sufficient 
to preclude ER stress in HMEC-1 cells (Muller et al. 2013). We originally 
hypothesized that the N-terminal low pKa active-site Cys55 and Cys399 of PDI 
would be more reactive with fumarate than the higher pKa C-terminal active-site 
Cys58 and Cys402 (Lappi et al. 2004). However, MS/MS analysis of recombinant 
PDI that had been succinated in vitro confirmed that the C-terminal Cys58 and 
Cys402 are the targets of succination. The recombinant PDI mutant used was 
refractory to modification by fumarate, suggesting that the pKa of at least one of 
the thiols is an important determinant of reactivity to succination. Importantly, 
mutation of the N-terminal, C-terminal or both active-site Cys of PDI to Ser 
decreases PDI oxidoreductase activity and increases the accumulation of PDI-
substrate intermediates (Walker et al. 1996), suggesting that modification of the 
active site will promote the accumulation of misfolded proteins in the ER.  
Although the ER resident protein Ero1 is susceptible to succination in vitro 
(Figure 2.6A), immunoprecipitation of Ero1 confirms that endogenous succination 
of Ero1 is not altered between adipocytes matured in normal or high glucose 
concentrations (Figure 2.6B). The reduced form of Ero1 mediates the flavin-
dependent transfer of electrons to oxygen producing hydrogen peroxide and the 
oxidized form of Ero1. Peroxiredoxin-4 (Prx-4) is responsible for regulating 
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excess reactive peroxides produced in the ER via Ero1 oxidation (Tavender et al. 
2008, Tavender et al. 2010). Proper functioning PDI will reduce the oxidized form 
of Prx-4 to allow for recycling of Prx-4 active site cysteines and continued 
moderation of reactive peroxide levels in the ER (Tavender et al. 2010, Zito et al. 
2010). Overall, the inhibition of PDI reductase activity by 2SC may promote the 
accumulation of oxidized Ero1, oxidized Prx-4 and elevated hydrogen peroxide 
levels in the adipocyte ER and additionally contribute to oxidative stress. In other 
studies we have observed that oxidized thiols (sulfenic acid form) do not react 
with fumarate as readily as the thiolate (unpublished observations), providing an 
explanation for the absence of succinated, but possibly oxidized, Ero1 in our 
immunoprecipitations, even when the recombinant protein could be succinated in 
vitro. 
High glucose conditions facilitate increased metabolic stress derived in 
part from fumarate, but also increased oxidative and lipotoxic stress. To 
determine the contribution of fumarate and protein succination to reduced PDI 
functionality, we knocked down fumarase expression and generated mature 
adipocytes with elevated levels of protein succination. Strikingly, the elevation in 
CHOP protein levels in FHKD adipocytes demonstrates that ER stress is a direct 
negative consequence of mitochondrial stress in adipocytes. In addition, Figure 
2.9 suggests that half of the total decrease in PDI reductase activity in adipocytes 
matured in high glucose may be specifically attributed to increased succination of 
PDI. 
 Chemical chaperones, such as PBA have been employed to combat ER 
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stress in several rodent models of obesity and diabetes (Basseri et al. 2009, 
Özcan et al. 2006), as continuous ER stress ultimately culminates in cell death 
(Han et al. 2013b). The accumulation of adipose tissue macrophages as a result 
of hypertrophied adipocyte death is central to the chronic low-grade inflammatory 
response observed in obese adipose tissue (Giordano et al. 2013, Weisberg et 
al. 2003). We have reported that greater amounts of inflammatory cytokines are 
released from adipocytes matured in high glucose compared to normal glucose 
levels in parallel with increased protein succination (Tanis et al. 2015). In Figure 
2.3 we show that increased inflammatory cytokine secretion occurs as a result of 
increased fumarate content and protein succination in the FHKD adipocyte. This 
data suggests that intra-organelle stress derived from elevated mitochondrial 
intermediary metabolism may be an early contributor to adipose tissue 
inflammation in diabetes. 
 The accumulation of the mitochondrial metabolite fumarate and resultant 
succination and inhibition of PDI activity uniquely links mitochondrial stress, a 
decreased protein folding capacity and ER stress. The reduction of ER stress in 
obese humans using chemical chaperones has had some success (Kars et al. 
2010), however, we have mechanistically demonstrated that targeting 
mitochondrial stress is a necessary component of successfully preventing ER 
stress-associated increases in CHOP. Since mitochondrial stress is a product of 
nutritional overload, we reduced the glucose concentration to normal levels in 
maturing adipocytes for several days, similar to a calorie restriction intervention, 
and demonstrated a significant reduction in PDI succination and an improvement 
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in PDI reductase activity. Stanford et al. have described the importance of 
healthy adipose tissue for systemic glucose homeostasis by transplanting the 
subcutaneous white adipose tissue from exercised lean animals into sedentary 
animals fed a high fat diet, improving insulin sensitivity and blood glucose levels 
in the sedentary animals (Stanford et al. 2015). We demonstrate that a reduction 
in exposure to glucotoxicity limits CHOP production as a result of reduced 
mitochondrial stress and improved PDI reductase activity. While specific agents 
that prevent protein succination in adipose tissue, such as niclosamide, may 
have therapeutic utility, our data clearly demonstrates that simple nutritional 
interventions will restore ER oxidative protein folding capacity. 
In summary, we find that the active-site cysteines of PDI are succinated 
during glucotoxicity induced mitochondrial stress, reducing PDI oxidoreductase 
activity and contributing to disturbed protein folding and adipocyte ER stress. The 
improvement in PDI enzymatic function and the reduction in ER stress as a direct 
result of reduced glucose concentration fortify the importance of emphasizing the 
link between healthy dietary consumption and proper adipocyte function in the 
management of Type 2 diabetes.
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The production of C/EBP homologous protein (CHOP) as a consequence 
of prolonged endoplasmic reticulum stress has been documented extensively in 
the adipose tissue of diabetic mouse models and type 2 diabetic patients (Boden 
et al. 2008, Kawasaki et al. 2012, Özcan et al. 2004, Schröder et al. 2005, 
Sharma et al. 2008). Consistent with these observations, in chapter 2 we 
described a prominent role for increased fumarate to elevate CHOP production 
during sustained ER stress. CHOP signaling is regulated by casein kinase 2 
phosphorylation at Ser30, inhibiting transcriptional activation in 3T3-L1 fibroblasts 
and HeLa cells (Ubeda et al. 2003), and promoting the ubiquitination and 
proteasomal degradation of CHOP in macrophages (Dai et al. 2016). However, 
little is known about the mechanism regulating CHOP stability in the adipocyte 
during normal versus diabetic conditions. CHOP levels are increased as a result 
of adipogenesis and remain elevated in adipocytes matured in high glucose 
(Basseri et al. 2009, Han et al. 2013a, Tanis et al. 2015). In an extension of this 
observation, Tanis et al. highlighted the difference in CHOP levels between 
adipocytes matured in normal (5 mM) glucose versus high (30 mM) glucose after 
monitoring CHOP for up to 8 days of maturation. Interestingly, CHOP levels are 
transiently elevated and then decreased in adipocytes matured in 5 mM glucose 
in a time-dependent manner, in contrast they remain elevated in high glucose 
(Tanis et al. 2015). The sustained increase in CHOP that is unique to high 
glucose occurs in parallel with increased protein succination, and in the absence 
of continued activation of the unfolded protein response (Tanis et al. 2015). 
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Kelch-like ECH-associated protein 1 (Keap1) has recently been described 
as a negative regulator of CHOP stability in the LiSa-2 adipocyte cell line (Huang 
et al. 2012). In adipocytes, Keap1 and cullin3 E3 ubiquitin ligase form a 
supercomplex with the COP9 signalosome (CSN) (Huang et al. 2012), a protein 
complex containing metalloprotease that removes the ubiquitin (Ub)-like protein 
Nedd8 from cullins (Hannss et al. 2011). Additionally, CSN associated kinases, 
including casein kinase 2, phosphorylate proteasome substrates to regulate 
protein stability (Hannss et al. 2011). Huang et al. showed that CHOP binds the 
CSN/cullin3 E3 ubiquitin ligase/Keap1 supercomplex, and that this stimulates its 
degradation by the proteasome in adipocytes (Figure 1.2) (Huang et al. 2012). 
Using siRNA targeting the CSN1 component of the CSN reduces the formation of 
the supercomplex, leading to a 2-fold increase in CHOP protein levels and 
subsequent inhibition of adipogenesis in LiSa-2 adipocytes (Huang et al. 2012). 
Importantly, this study also confirmed that silencing the expression of Keap1 
directly impairs CHOP turnover (Huang et al. 2012). This suggests that the 
modification of stress-responsive Keap1 cysteines, and subsequent Keap1 
degradation, may be a significant contributor to the sustained presence of 
cytoplasmic and nuclear CHOP during cellular stress.  
Keap1 contains 25 cysteine residues, 3 of these (Cys151, Cys273, 
Cys288) have been confirmed to be sensors of oxidative stress that result in the 
stabilization of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) (McMahon et al. 
2010, Levonen et al. 2004). The post-translational protein modification 2-(S-
succino)cysteine (2SC) (Alderson et al. 2006)(Figure 1.3) has previously been 
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detected on the regulatory Cys151 and Cys288 of Keap1 in fumarase knockout 
mouse embryonic fibroblasts, and in neurons treated with fumaric acid esters 
(Adam et al. 2011, Linker et al. 2011). The nuclear accumulation of Nrf2 and 
transcriptional upregulation of Nrf2 target antioxidant genes, under control of the 
antioxidant response element (ARE), directly correlates with the succination of 
Keap1 (Adam et al. 2011, Linker et al. 2011). Therefore, fumarate is recognized 
as a physiologically relevant electrophilic activator of Nrf2 transcription. Our 
laboratory has established that fumarate levels and protein succination increase 
in adipocytes cultured in high (30 mM) versus normal (5 mM) glucose 
concentrations (Nagai et al. 2007), and in the white adipose tissue of type 2 
diabetic db/db mice compared to lean controls (Frizzell et al. 2009, Thomas et al. 
2012). In this study, I investigate if Keap1 is a target of succination in the 
adipocyte, similar to published studies in the fumarase deficient model (Adam et 
al. 2011), and I hypothesize that succination of Keap1 will prevent CHOP 
degradation, thereby stabilizing CHOP protein levels during diabetes.  
CHOP is classically known to drive a pro-apoptotic response in damaged 
cells as a result of prolonged ER stress (Han et al. 2013b, Kim et al. 2008). 
However, our observations thus far do not support a role for CHOP-mediated 
apoptosis in adipocytes. Cell viability is not reduced in adipocytes matured in 
high glucose, even when CHOP levels are elevated (Frizzell et al. 2012, Tanis et 
al. 2015). In addition, the accumulation of CHOP in the absence of apoptosis has 
been described in the adipose tissue of obese insulin resistant patients (Diaz et 
al. 2015), and insulin resistant mice fed a high fat diet (Suzuki et al. 2017). As 
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discussed in section 1.6 above, several recent reports confirm that CHOP has 
alternative physiological roles distinct from apoptosis. CHOP can directly bind the 
promoter/enhancer region of Ppara, Srebf1 and Cebpa in hepatocytes 
culminating in the suppression of metabolic gene expression during stress, 
without inducing cell death (Chikka et al. 2013). In addition, Prasad et al. have 
described a novel role for CHOP as an important mediator of phosphate 
movement into the mitochondria in adrenal cells. This results in increased steroid 
synthesis by stabilizing 3β-hydroxysteroid dehydrogenase type-2 protein 
conformation and its association with translocase outer membrane-22 during 
periods of stress (Prasad et al. 2016). While CHOP is a recognized terminus for 
UPR signaling, our published data coupled with the data in chapter 2 suggests 
that CHOP is increased even in the absence of concomitant UPR activation in 
high glucose. In this study, I investigated the mechanisms contributing to CHOP 
stability in the adipocyte, with an emphasis on the role of fumarate as a novel 
physiological regulator of CHOP stability. I extended these studies to examine 
the impact of persistent nuclear CHOP in suppressing an important anti-
inflammatory response in metabolically stressed adipocytes. 
3.2 Results 
C/EBP homologous protein (CHOP) is upregulated in response to 
hyperglycemic/hyperinsulinemic driven ER stress in adipose tissue during type 2 
diabetes (Boden et al. 2008, Özcan et al. 2004)(Figure 2.12C). Our earlier 
investigation documented prominent increases in CHOP protein levels in both 
adipocytes matured in normal (5 mM) and high glucose (25-30 mM) in the first 2 
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days of maturation (Tanis et al. 2015), presumably due to activation of the 
unfolded protein response during adipogenesis (Basseri et al. 2009, Han et al. 
2013a). Remarkably, this transient increase in CHOP disappears by day 3 of 
maturation in normal glucose, while CHOP levels continue to increase for the 
duration of maturation in high glucose (Figure 3.1A)(Tanis et al. 2015). To 
determine if glucotoxicity impairs CHOP turnover versus the continuous 
production of more CHOP, a cycloheximide (CHX) chase experiment was 
performed using adipocytes matured in 5 mM or 25 mM glucose for 8 days. 
CHOP stability was monitored over 4 hours and both CHOP and actin total 
protein levels were detected by immunoblotting. Prolonged CHOP stability was 
observed in the absence of protein translation solely in adipocytes matured in 
high glucose (Figure 3.1B), and the proteasomal inhibitor MG132 was utilized as 
a positive control for CHOP accumulation (Diaz et al. 2015). Densitometric 
analysis of immunoblots from each time point revealed an 29.5% increase in 
CHOP stability in adipocytes matured in high glucose versus normal glucose 
after 4 hours (n=3, p<0.01)(Figure 3.1B). Previous results in chapter 2 confirmed 
that lentiviral knockdown of fumarase expression results in a pronounced 
increase in both intracellular fumarate levels and protein succination in 3T3-L1 
adipocytes matured in a normal glucose concentration (Figure 2.5A, 2.5B, 2.5C, 
2.6A). The CHX chase experiment was repeated using adipocytes transduced 
with a scrambled control or fumarase knockdown (FHKD) lentivirus, and cultured 
in 5 mM glucose to ascertain if protein succination directly inhibits CHOP 
degradation. Similar to adipocytes matured in high glucose, after 4 hours FHKD 
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adipocytes displayed a 28.5% increase in CHOP stability compared to the control 
(n=3, **p<0.01)(Figure 3.1C), confirming a role for succination in the regulation of 
CHOP turnover. 
Complete silencing of Keap1 expression increases the steady state level 
of CHOP in LiSa-2 adipocytes (Huang et al. 2012), emphasizing the importance 
of Keap1 as a critical regulatory protein during CHOP turnover. We therefore 
sought to determine whether the modification of Keap1 regulatory cysteines 
would stabilize CHOP levels. Since Keap1 is a low abundance cytosolic protein, 
both control and FHKD adipocytes were transduced with a Keap1-V5 or a 
scrambled control lentivirus to obtain a sufficient amount of protein for molecular 
analyses. A significant increase in protein succination in the FHKD adipocytes 
was first confirmed by a western blot probed with the anti-2SC antibody (Figure 
3.2A). The successful transduction using each lentivirus was verified visually 
following the observation of green fluorescent protein (GFP) immunofluorescence 
(unpublished observation), and by immunoblotting to detect both the V5 tag and 
Keap1 (Figure 3.2A). To determine if fumarate modifies Keap1 cysteines in the 
adipocyte Keap1 was immunoprecipitated from the Keap1-V5 over-expressed 
control and FHKD adipocytes. The immunoprecipitates were subjected to 
immunoblotting to detect 2SC levels, and the results demonstrated that Keap1 is 
succinated in the presence of excess fumarate in these adipocytes (Figure 3.2B). 
 Replicate Keap1-V5 immunoprecipitates from FHKD adipocytes were 
subjected to in gel trypsin digestion for MS/MS mass spectrometry analysis to 
identify the precise cysteine residue modified by fumarate. The top panel of 
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Figure 3.2C displays the identified MS spectrum corresponding to the succinated 
tryptic peptide 288C2SCE I L Q A D A R296 ([M+2H]2+: 567.7625), containing the 
Keap1 regulatory Cys288 at the retention time 25.47 minutes. This result 
confirmed the previous observation in Fh1-/- MEFs that Cys288 is a target of 
succination (Adam et al. 2011). The mass of the analogous control precursor 
peptide containing the pyridylethyl (PE) cysteine modification ([M+2H]2+: 
562.2803) was detected at 16.57 minutes (lower panel, Figure 3.2C).  
The antioxidant sulforaphane and the fumarate ester dimethyl fumarate 
(DMF) are both recognized modifiers of the redox sensitive cysteines of Keap1, 
resulting in activation of the Nrf2 signaling pathway (Hong et al. 2005, Hu et al. 
2011, Linker et al. 2011). Adipocytes were treated for 3 hours with 40 µM 
sulforaphane or 300 µM DMF and immunoblotting demonstrated that modifying 
Keap1 redox sensitive cysteines preserves CHOP protein levels (Figure 3.2D 
and 3.2E). Heme oxygenase 1 (HOX1) is an antioxidant protein upregulated 
following Nrf2 transcriptional activity. Assessment of increased HOX1 protein 
levels confirmed activation of the Nrf2 antioxidant pathway following the 
modification of Keap1 by each compound (Figure 3.2D and 3.2E). Overall, this 
data established that the modification of Keap1 cysteines by fumarate promotes 
CHOP accumulation in the adipocyte. 
Assessment of HOX1 levels revealed increased protein levels in both 
adipocytes matured in 25 mM glucose and in the adipose tissue of db/db mice 
compared to their respective controls (Figure 3.3A), concomitant with increased 
Keap1 modification/Nrf2 activity. Importantly, we also observed elevated HOX1 
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protein levels in the FHKD adipocytes (Figure 3.3A), reinforcing that succination 
of Keap1 promotes Nrf2 downstream signaling in the adipocyte (Adam et al. 
2011, Linker et al. 2011). Given that Keap1 is succinated in the presence of 
excess fumarate (Adam et al. 2011)(Figure 3.2B, 3.2C), and that fumarate levels 
significantly increase in adipocytes matured in high glucose (Frizzell et al. 2012, 
Nagai et al. 2007), we next investigated if Keap1 is succinated in adipocytes 
cultured under diabetic conditions. An immunoblot confirmed the successful 
transduction and overexpression of the Keap1-V5 lentivirus in adipocytes 
matured in 5 mM or 25 mM glucose (Figure 3.3B). Surprisingly, 
immunoprecipitation of Keap1 (black arrow at 73 kDa) and western blotting to 
detect 2SC revealed that Keap1 is not succinated in adipocytes matured in high 
glucose (Figure 3.3C), despite confirming enrichment of Keap1-V5 in the 
immunoprecipitates (Figure 3.3C).  
The regulatory cysteines of Keap1 are known targets of oxidation 
(Kobayashi et al. 2006) and, since Keap1 did not appear to be directly modified 
by fumarate in the high glucose environment; we next investigated if fumarate 
indirectly regulates CHOP stability by inducing oxidative stress and the oxidation 
of Keap1. Analysis of reactive oxygen species (ROS) utilizing the Amplex Red 
(hydrogen peroxide) and dichlorofluorescein (DCF) assays revealed a significant 
increase in ROS production in adipocytes matured in high glucose versus normal 
glucose (n=3, *p<0.05) (Figure 3.3D). Importantly, a pronounced increase in 
ROS levels was also observed in the FHKD adipocytes, and in adipocytes 
following direct DMF treatment (n=3, *p<0.05, **p<0.01) (Figure 3.3D, 3.3E). This 
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indicates that elevated fumarate is capable of inducing oxidative stress in the 
adipocyte. We have previously shown that reducing the mitochondrial membrane 
potential with the potent mitochondrial uncoupler carbonyl cyanide m-
chlorophenyl hydrazone (CCCP) reduces fumarate levels and protein succination 
in adipocytes matured in 30 mM glucose (Frizzell et al. 2012). In addition, CCCP 
stimulates superoxide generation in 3T3-F442A adipocytes in vitro (Carriére et al. 
2004). To confirm that oxidative stress predominantly stabilizes CHOP 
expression in the absence of succination we treated adipocytes matured in high 
glucose with 10 µM CCCP for 6 days. An immunoblot depicts reduced levels of 
2SC with CCCP treatment in high glucose, while CHOP levels remained stable 
due to the presence of oxidative stress (Figure 3.3F). Importantly, the difference 
in the endogenously produced fumarate levels between FHKD and high glucose 
models appears to dictate which one is the more potent Keap1 modifier between 
fumarate and ROS. Together these results indicate that high glucose derived 
protein succination indirectly promotes CHOP stability through induction of 
oxidative stress and oxidation of Keap1 cysteines. 
Our laboratory has shown that the antioxidant N-acetylcysteine (NAC) 
reacts slowly with fumarate to form 2SC in vitro (Alderson et al. 2006). In 
addition, other laboratories have shown that glutathione (GSH) has some 
reactivity with fumarate in fumarase deficient cells (Sciacovelli et al. 2016, Zheng 
et al. 2015). Both GSH and NAC have a similar pKa ~9.5 and NAC is known to be 
a precursor for GSH synthesis (Medved et al. 2004, Phelps et al. 1992). 
Therefore, we investigated if NAC would reduce fumarate levels and protein 
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succination in adipocytes cultured in hyperglycemic/hyperinsulinemic conditions 
over 6-8 days. The quantification of intracellular fumarate levels following 
treatment of adipocytes with 0-5 mM NAC revealed that intracellular fumarate 
concentrations were decreased 2 and 2.65 fold with 2.5 and 5 mM NAC, 
respectively (n=3, *p<0.05, ***p<0.001). In parallel with this Figure 3.4B 
demonstrates a significant decrease in total protein succination in adipocytes 
matured in high glucose in the presence of 2.5 or 5 mM NAC. This suggested 
that the available thiol of NAC may react with endogenous fumarate to lower 
protein succination.  
Considering that the exogenous supply of NAC may also promote the 
synthesis of GSH, we also measured ROS levels to examine if there was a 
concomitant decrease in oxidative stress. Figure 3.4C demonstrated that ROS 
production in 30 mM glucose was reduced in the presence of 1 mM NAC. Since 
ROS levels were decreased with NAC treatment, we next quantified total 
intracellular GSH in adipocytes matured in normal or high glucose in the 
presence of 5 mM NAC for 8 days, or 100 µM DMF for 24 hours (as a positive 
control to reduce GSH, Manuel and Frizzell, 2013). Total GSH levels were 
reduced by 36% in high glucose versus normal glucose (n=3, *p<0.05)(Figure 
3.4D). Notably, NAC protected against glucotoxicity induced oxidative stress by 
improving GSH levels and reducing ROS in adipocytes cultured in high glucose 
(Figure 3.4C, 3.4D). An immunoblot representative of adipocytes matured in 5 
mM or 25 mM glucose in the presence or absence of NAC demonstrated a 
significant decrease in both CHOP and HOX1 levels in the presence of NAC 
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(Figure 3.4E). Considering that there was no evidence for direct succination of 
Keap1 in high glucose conditions (Figure 3.3C), and that NAC reduces ROS 
levels, it appears that oxidative stress may be the direct regulator of CHOP 
stability in adipocytes.  
In order to specifically delineate the contribution of fumarate towards the 
induced oxidative stress and CHOP stability, we treated FHKD adipocytes 
cultured in normal glucose concentrations with 5 mM or 10 mM NAC for 8 days. 
Interestingly, NAC administration increased protein succination and 
simultaneously decreased CHOP and HOX1 protein levels in FHKD adipocytes 
(Figure 3.5A). In contrast to NAC treatment of glucotoxic adipocytes, the 
treatment of FHKD adipocytes with 2.5, 5 or 10 mM NAC was not sufficient to 
reduce fumarate levels (Figure 3.5B). The levels of intracellular fumarate are ~5-
10 mM in fumarase deficient cancer cells (Ternette et al. 2013), and fumarate 
increases 20-fold in FHKD adipocytes compared to adipocytes matured in 25 mM 
glucose (Figure 3.5C). Therefore, our data demonstrates that NAC does not 
react directly with the endogenously produced fumarate to reduce succination in 
FHKD adipocytes, and is instead acting to reduce the oxidative stress induced by 
fumarate excess. Further, the surprising increase in succination in the FHKD 
adipocytes suggested that depletion of oxidative stress might allow for increased 
thiol reactivity with fumarate (Figure 3.5A). To confirm if NAC was limiting thiol 
oxidation, and thereby promoting the availability of thiols to react with fumarate, 
we examined the levels of cysteine sulfenic acids. Mature FHKD adipocytes were 
treated with 2 mM dimedone, which covalently modifies cysteine sulfenic acids, 
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(Martínez-Acedo et al. 2014, Seo and Carroll, 2011) prior to cell lysis to assess 
the oxidized thiol content in the presence or absence of NAC. Immunoblotting 
with an antibody that detects the dimedone adduct demonstrated a significant 
reduction in protein oxidation upon NAC treatment (Figure 3.5D). This confirms 
that competition exists between fumarate and ROS for thiol reactivity within the 
fumarase depleted cells; a decrease in thiol oxidation due to NAC addition allows 
the excess fumarate to irreversibly modify more cysteines by succination (Figure 
3.5A, 3.5D).  
We have previously observed that oxidation and succination can compete 
for the same cysteine thiol target in vitro (unpublished data). Importantly, this 
increase in protein succination occurred in parallel with a decrease in both CHOP 
and HOX1 levels (Figure 3.5A), further suggesting that fumarate does not directly 
regulate CHOP stability and Nrf2 activation, but rather indirectly triggered these 
pathways through increased oxidative stress (Figure 3.3D, 3.3E). The combined 
data suggests that oxidative stress in the adipocyte, generated as a result of 
glucotoxicity or specific fumarate excess, contributes to the stabilization of CHOP 
protein levels since reduction of ROS promoted CHOP turnover. Interestingly, the 
correction of oxidative stress in the glucotoxicity model reduced fumarate 
mediated succination. In contrast, the correction of oxidative stress facilitated 
enhanced protein succination in FHKD adipocytes where fumarate levels are 
significantly higher. 
Figure 3.6 confirms the increased presence of CHOP in parallel with 2SC 
in adipocytes cultured in 25 mM glucose (Figure 3.6A), and the adipose tissue 
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from db/db mice (Figure 3.6B), as well as in FHKD adipocytes (Figure 3.6C). 
Contrary to the established role of CHOP to promote cleaved caspase 3 
mediated apoptosis (Li et al. 2014), cleaved caspase 3 levels were unchanged in 
all models (Figure 3.6A, 3.6B and 3.6C). In addition, there were no morphological 
changes or loss of cells observed by light microscopy, no change in nuclear 
content/structure (assessed by DAPI imaging of adipocytes) (Figure 3.6D), levels 
of cleaved caspase 3 in adipocytes matured in high glucose or FHKD adipocytes 
after 12 days of maturation (Figure 3.6E), or total protein content (Figure 3.6F). 
Therefore, we next investigated an alternative role for CHOP as it was not 
promoting apoptotic cell death, even in the mature hypertrophic adipocyte.  
The cytosolic, mitochondrial and nuclear fractions were isolated by 
centrifugation and immunoblotting confirmed increased succination and organelle 
enrichment in each fraction (Figure 3.7A). In addition to the cytosolic 
accumulation, CHOP accumulates in the nuclear fraction of adipocytes matured 
in 25 mM glucose (Figure 3.7B), suggesting that CHOP continues to have a 
critical role in transcription during diabetes. Interestingly, Suzuki et al. elegantly 
demonstrated that silencing CHOP expression improves transcription of IL-13 
mRNA and secretion in 3T3-L1 adipocytes, and in the adipose tissue of CHOP 
knockout mice fed a high fat diet (Suzuki et al. 2017). The improvement in IL-13, 
IL-4 and eotaxin secretion from the adipose tissue of CHOP knockout mice 
modulates an anti-inflammatory M2 macrophage phenotype leading to decreased 
extracellular inflammation and heightened insulin sensitivity (Suzuki et al. 2017). 
Therefore, we investigated if CHOP mediated IL-13 regulation is governed by 
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glucotoxicity induced oxidative stress. Conditioned medium was collected from 
adipocytes cultured in 5 mM or 25 mM glucose +/- 5 mM NAC for 8 days, and 
secreted IL-13 was quantified by ELISA (Figure 3.7C). While the levels of 
secreted IL-13 were reduced in adipocytes matured in high glucose by 70%, 
supplementation with NAC completely restored IL-13 secretion. Importantly, this 
data shows that oxidative stress underlies the nuclear CHOP mediated 






Figure 3.1: Succination regulates CHOP stability in the adipocyte. (A) 
Western blot probed with anti-CHOP antibody shows consistent increased CHOP 
levels in adipocytes matured in high glucose versus normal glucose throughout 
maturation. (B) 3T3-L1 adipocytes were matured in 5 mM or 25 mM glucose or 
(C) transduced with the scrambled control or fumarase knockdown lentivirus and 
matured in 5 mM glucose for 8 days. Each group was subjected to protein 
synthesis inhibition with 3.5 µg/mL cycloheximide (CHX) and the adipocytes were 
harvested at the indicated times after addition of CHX. CHOP protein levels over 
time are shown by immunoblotting with anti-CHOP antibody and Coomassie blue 
staining represents equal protein loading. The graphs display the natural 
logarithm of the relative levels of CHOP as a function of CHX chase time. 





Figure 3.2: The modification of Keap1 cysteines enhances CHOP stability. 
(A) Control and fumarase knockdown (FHKD) adipocytes were transduced with 
the Keap1-V5 tagged or empty control lentivirus. Immunoblotting using the anti-
2SC antibody confirms increased protein succination in adipocytes transduced 
with the FHKD versus the scrambled control lentivirus. The over expression of 
Keap1 protein was confirmed via western blotting utilizing anti-Keap1 and -V5 
antibodies. (B) Keap1 was immunoprecipitated with anti-V5 agarose beads from 
800 μg or 400 μg of protein from control or FHKD adipocytes, respectively. A 
western blot probed with anti-2SC antibody shows a significant increase in the 
amount of succinated Keap1 in the FHKD adipocytes versus the control. The blot 
was re-probed with anti-Keap1 and -V5 antibodies to confirm the presence of 
Keap1 in each immunoprecipitate sample. (C) MS spectra showing that the 
regulatory Cys288 of Keap1 is a target of succination in the FHKD adipocytes 
(top panel). (D-E) Western blots with 30 μg of protein from adipocytes matured in 
normal glucose and treated with 40 μM sulforaphane, 300 μM dimethylfumarate 
(DMF) or 10 μM MG132 for 3 hours were probed with anti-CHOP and re-probed 
with anti-heme oxygenase 1 antibody. Coomassie blue staining shows equal 





Figure 3.3: Protein succination induces oxidative stress to activate the 
Keap1/Nrf2 pathway and stabilize CHOP. (A) Protein from mature 3T3-L1 
adipocytes, control or db/db epididymal adipose tissue and control or FHKD 
adipocytes was subjected to immunoblotting with anti-heme oxygenase 1 (HOX1) 
antibody. Coomassie blue staining verifies equal protein loading. (B) Western 
blotting with anti-Keap1 and -V5 antibodies validates the successful transduction 
of the scrambled control or Keap1-V5 tagged lentivirus into adipocytes matured 
in 5 mM or 25 mM glucose. (C) Protein (600 µg) from adipocytes matured in 5 
mM or 25 mM glucose was immunoprecipitated with anti-V5 agarose beads. The 
eluted protein was subjected to western blotting to detect succination of the total 
homogenate (TH) and immunoprecipitate (IP) utilizing anti-2SC, followed by re-
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probing with anti-Keap1 and -V5 antibodies. Measurement of reactive oxygen 
species was monitored using the Amplex Red and DCF assays according to the 
manufacturer’s instructions outlined in the Materials and Methods section. (D) 
Control or FHKD adipocytes were cultured in 5 or 30 mM glucose or (E) 5 mM 
glucose and treated with 200 µM DMF. (n=3/group, mean +/- SEM, *p< 0.05, 
**p<0.001) (F) Adipocytes matured in high glucose were treated with 10 µM 
CCCP for 8 days. Immunoblotting with anti-2SC antibody shows decreased 
protein succination and anti-CHOP antibody displays increased CHOP levels in 





Figure 3.4: N-acetylcysteine reduces protein succination, fumarate levels 
and ROS production in high glucose, and reduces CHOP levels. (A) 
Metabolites were extracted from adipocytes matured in 5 or 25 mM glucose or 25 
mM glucose treated with 5 mM NAC for 3 days as described in Materials and 
Methods. Fumarate levels are significantly increased with glucotoxicity and 
fumarate levels are returned back to normal with NAC. Data is normalized to total 
protein content (µg) (n=3/group, mean +/- SEM, *p< 0.05, ***p<0.001 vs. 5 mM 
glucose). (B) 30 µg of protein from adipocytes cultured in 5 or 25 mM glucose 
and treated with 0, 0.5, 1, 2.5 or 5 mM N-acetylcysteine (NAC) for 8 days was 
subjected to immunoblotting using anti-2SC antibody.  (C) Reactive oxygen 
species were quantified by the DCF assay in adipocytes matured in 30 mM 
glucose with or without 1 mM NAC for 8 hours (n=4/group, mean +/- SEM, 
**p<0.01). (D) Adipocytes were treated with 100 µM dimethyl fumarate (DMF) for 
24 hours or 5 mM NAC for 8 days. Total glutathione levels were quantified 
according to the manufacturer’s instructions as described in Materials and 
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Methods (n=3/group, mean +/- SEM, *p< 0.05 vs. 5 mM glucose). (E) A western 
blot was performed with anti-CHOP and re-probed with -HOX1 antibodies to 
show reduced CHOP and HOX1 levels in adipocytes treated with NAC for 8 




Figure 3.5: Protein oxidation regulates CHOP stability. (A) An immunoblot 
probed with anti-2SC, -CHOP and -HOX1 antibodies show that 5 and 10 mM N-
acetylcysteine (NAC) treatment simultaneously increase protein succination and 
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decreases CHOP and HOX1 levels in FHKD adipocytes. (B, C) Metabolites were 
extracted from control adipocytes matured in 30 mM glucose or FHKD 
adipocytes cultured in 5 mM glucose and treated with 0, 2.5, 5 or 10 mM NAC for 
3 days. Fumarate levels are normalized to total protein content (µg). (D) 
Dimedone labeled protein cysteine sulfenic acids are displayed with a western 
blot probed with anti-cysteine sulfenic acid antibody from FHKD adipocytes 







Figure 3.6: 2SC and CHOP accumulate in the absence of apoptosis. 
Western blots probed with anti-2SC, -CHOP and -cleaved caspase 3 antibodies 
with protein from (A) 3T3-L1 adipocytes, (B) control or db/db epididymal adipose 
tissue or (C) control or FHKD adipocytes. Immunoblots probed with anti-actin 
antibody and Coomassie staining displays equal protein loading. (D) DAPI 
imaging with the InvitrogenTM EVOSTM FL Auto Imaging System of duplicate 
adipocyte samples treated with 5 mM or 30 mM glucose 8 days. (E) Control or 
FHKD adipocytes were matured in 5 mM or 30 mM glucose for 12 days. An 
immunoblot probed with anti-cleaved caspase 3 antibody shows no evidence of 
increased apoptosis in adipocytes matured in high glucose concentrations or in 
FHKD adipocytes versus control adipocytes matured in normal glucose 
concentration. (F) The total protein content (µg) of control or FHKD adipocytes 







Figure 3.7: Accumulation of nuclear CHOP is associated with impaired IL-
13 secretion in high glucose. (A) Protein succination increases in the total 
homogenate (T), nuclear (N), mitochondrial (M) and cytosolic (C) enriched 
fractions in adipocytes matured in 25 mM versus 5 mM glucose. Organelle 
enriched fractions are confirmed by immunoblotting with anti-actin (cytosolic), -
citrate synthase (mitochondrial) and -histone H3 (nuclear) antibodies. (B) The 
nuclear fraction from adipocytes cultured in 5 or 25 mM glucose was isolated by 
centrifugation and a western blot probed with anti-CHOP antibody depicts a 
higher amount of CHOP in the nucleus during glucotoxicity. (C) Serum free 
medium was collected after 4 hours in adipocytes treated with normal or high 
glucose +/- 5 mM NAC. IL-13 levels were quantified using an IL-13 specific 






Figure 3.8: Beneficial effect of N-acetylcysteine during glucotoxicity. (A) 
Glucotoxicity increases fumarate levels that results in increased protein 
succination and reduced glutathione (GSH) concentrations. Augmented 
succination and lower GSH levels results in the accumulation of reactive oxygen 
species (ROS) that are able to react with redox sensitive cysteines on Keap1. 
Oxidized Keap1 is unable to sequester Nrf2 and may be unable to form the CSN 
supercomplex resulting in the accumulation of C/EBP homologous protein 
(CHOP) and increased production of heme-oxygenase 1 (HOX1). (B) N-
acetylcysteine (NAC) decreases fumarate concentrations and protein succination 
and rescues the concentration of GSH in the adipocyte resulting in decreased 
ROS levels. In the absence of oxidative stress Keap1 is able to bind the CSN 
complex to promote CHOP degradation and down regulate HOX1 production by 




In this study, we demonstrate that protein succination contributes to the 
development of oxidative stress in the adipocyte, and that oxidative stress can 
promote the accumulation of CHOP and the suppression of anti-inflammatory IL-
13. We also show that the anti-oxidant N-acetylcysteine (NAC) resolves oxidative 
stress, reduces CHOP protein stabilization and improves IL-13 secretion. CHOP 
is known to increase during the late stages of adipogenesis to restrict prolonged 
adipogenic signaling after the mature adipocyte phenotype is attained (Han et al. 
2013a). We confirmed this increase in CHOP protein levels following adipocyte 
maturation in high glucose, however, unlike earlier studies we compared the high 
glucose matured adipocytes to adipocytes matured in normal glucose (Tanis et 
al. 2015). Importantly, we noted that while CHOP protein levels did increase 
during early adipogenesis (1-3 days) in normal glucose, there was a decline 
during the later stages (3-8 days), whereas CHOP levels were increasingly 
elevated in high glucose (Figure 3.1A)(Tanis et al. 2015).  
Since 3T3-L1 adipocytes matured in normal glucose differentiate normally, 
evidenced by the synthesis and storage of triglycerides, it suggested that CHOP 
accumulation in high glucose may have a role beyond the suppression of 
adipogenesis. Notably, sustained CHOP protein levels occur in parallel with 
increased protein succination (Tanis et al. 2015), suggesting a potential 
association between protein succination and impaired CHOP turnover. In Figure 
3.1 we demonstrate that glucotoxicity, and more specifically protein succination, 
lead to decelerated CHOP turnover, implying that there is a defect in the CHOP 
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degradation pathway. CHOP ubiquitination and subsequent degradation is 
regulated by the formation of a COP9 signalosome/Cullin-3 E3 ligase/Keap1 
supercomplex in adipocytes (Huang et al. 2012). We hypothesized that 
succination of Keap1 in the presence of excess fumarate (Adam et al. 2011, 
Linker et al. 2011) may disturb the interaction of CHOP with the degradation 
supercomplex, leading to the accumulation of CHOP. Immunoprecipitation of 
overexpressed V5 tagged Keap1 from fumarase knockdown (FHKD) adipocytes 
confirmed that Keap1 is succinated (Figure 3.2B). Further mass spectrometry 
analysis confirmed that the redox sensitive Cys288 in the intervening region 
(IVR) of Keap1 is susceptible to modification by fumarate in FHKD adipocytes 
(Figure 3.2C). The modification of cysteines within the IVR domain is predicted to 
distort the tertiary structure of Keap1, impairing substrate ubiquitination and 
preventing protein:protein interactions in the Cullin-E3 ligase complex (Canning 
et al. 2015). Importantly, eliminating mRNA expression and protein utilizing 
Keap1 siRNA stabilizes CHOP in the adipocyte (Huang et al. 2012), confirming 
that Keap1 is a vital regulatory component of CHOP turnover. In support of this, 
we determined that acute treatment with sulforaphane or dimethyl fumarate 
(DMF), both of which act to modify Keap1 regulatory thiols, confirmed the 
involvement of Keap1 cysteines as a regulator of CHOP protein longevity in the 
adipocyte (Figure 3.2D, 3.2E).  
In response to oxidative stress and the oxidation of Keap1 cysteines, Nrf2 
translocates into the nucleus and binds to the anti-oxidant response element 
(ARE) in the promotor region of the heme-oxygenase 1 gene (Alam et al. 1999). 
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We verified that this pathway is active in the metabolically stressed adipocyte in 
vitro, as well as in the adipose tissue of db/db diabetic mice (Figure 3.3A). In 
contrast to the FHKD adipocytes, Keap1 was not directly confirmed as a target of 
succination in the adipocyte matured in high glucose (Figure 3.3C), despite 
prominent activation of the Keap1/Nrf2/HOX1 signaling pathway in the db/db 
adipose tissue and in adipocytes cultured in 25 mM glucose (Figure 3.3A). 
Considering that we could not detect Keap1 succination in the high glucose 
model where fumarate is elevated in parallel with other sources of oxidant stress, 
we hypothesized that Keap1 thiol oxidation was more prominent than Keap1 
succination under diabetic conditions. Unpublished studies from our laboratory 
have demonstrated that both oxidation and succination may compete to modify 
the same cysteine thiols; therefore the modification generated would depend on 
the concentration and reactivity of the oxidant or electrophile. We have also 
shown that the sulfenic acid (-SOH) generated by oxidation cannot be further 
succinated by fumarate in vitro, therefore fumarate does not appear to react with 
already oxidized thiols.  
We and others have confirmed increased ROS production in adipocytes 
matured in high glucose versus normal glucose (Han et al. 2017, Houstis et al. 
2006, Lin et al. 2005)(Figure 3.3D), suggesting that oxidation, rather than 
succination, is indeed the principal Keap1 modification regulating CHOP stability 
in the adipocyte during diabetes. Importantly we also documented that ROS 
production is pronouncedly increased in FHKD adipocytes and adipocytes 
treated with dimethyl fumarate (DMF) (Figure 3.3D, 3.3E), similar to the observed 
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accumulation of ROS in fumarase deficient mouse kidney epithelial cells (Zheng 
et al. 2015). This striking data demonstrates that the remarkable increase in 
fumarate alone is sufficient to drive oxidative stress; and that mitochondrial 
derived metabolite stress and oxidant stress are inextricably linked. Furthermore, 
we also showed that chronic treatment with the mitochondrial uncoupler CCCP 
reduces protein succination, yet also increases CHOP levels (Figure 3.3F), which 
is likely due to CCCP stimulated superoxide production (Carriére et al. 2004). 
Therefore, although fumarate and oxidative stress occur concurrently in the 
adipocyte in high glucose, our data suggests that it is the increase in oxidative 
stress that directly contributes to impaired CHOP turnover. Moreover, protein 
succination indirectly contributes to CHOP stabilization through the continued 
induction of oxidative stress. 
 Considering the known increase in ROS production in adipocytes 
cultured in high glucose medium (Han et al. 2017, Houstis et al. 2006, Lin et al. 
2005), we next investigated if the antioxidant N-acetylcysteine (NAC) might have 
a beneficial action that would also impact the levels of protein succination. NAC 
has been shown to attenuate the hyperglycemic pro-inflammatory response, 
evidenced by lower plasminogen activator inhibitor-1 (PAI-1) mRNA and protein, 
in the epididymal adipose tissue of diabetic mice (Lin et al. 2005). NAC treatment 
(2.5 and 5 mM) reduced the excess fumarate by 2-2.5 fold in the adipocyte 
matured in high glucose (Figure 3.4A). We also observed lower protein 
succination following NAC treatment (Figure 3.4B), consistent with the decrease 
in intracellular fumarate (Figure 2.1A, 2.1B) (Frizzell et al. 2012). Both DMF and 
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endogenously produced excess fumarate directly modify glutathione (GSH) in 
control or fumarase knockout mouse kidney epithelial cells, respectively (Zheng 
et al. 2015). The decrease in reduced GSH concentration due to succination in 
these models leads to a decrease in the GSH:GSSG ratio, elevated ROS levels 
and activation of several anti-oxidant response genes including HOX1 (Zheng et 
al. 2015). Figure 3.4D confirmed that DMF also lowers GSH levels in the 
adipocyte (Manuel and Frizzell, 2013), suggesting that increased endogenous 
fumarate may partially contribute to reduced total GSH levels in adipocytes 
matured in high glucose (Figure 3.4D). NAC, a known precursor of GSH 
synthesis, improved the concentration of GSH in adipocytes matured in high 
glucose (Figure 3.4D). In parallel, the decrease in oxidative stress also 
corresponded to reduced fumarate levels, although it is unclear if NAC reacts 
directly with fumarate, or decreases other factors related to mitochondrial stress 
in the adipocyte. 
Hypoxia induced oxidative stress in 3T3-F442A preadipocytes is linked to 
the initiation of CHOP transcription (Carriére et al. 2004), and Diaz et al. have 
inferred that oxidative stress is associated with proteasomal dysfunction in 
subcutaneous adipose tissue from obese insulin resistance patients contributing 
to CHOP stability (Diaz et al. 2015). Lowering ROS levels with NAC (Figure 
3.4C) diminished both HOX1 and CHOP protein levels in adipocytes matured in 
high glucose (Figure 3.4E), representative of a potentially renewed interaction 
between CHOP and the degradation supercomplex. Taken together, this 
demonstrates that succination contributes to reduced GSH levels and the 
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development of oxidative stress in adipocytes matured in hyperglycemic 
conditions. Limiting GSH contributes to the accumulation of ROS in the 
adipocyte, prompting oxidation of Keap1 and CHOP stabilization (Figure 3.8A). 
NAC decreases fumarate and protein succination while simultaneously 
increasing available GSH to scavenge ROS and prevent oxidation of Keap1. In 
the absence of oxidative stress, Keap1 is able to sequester target substrates 
such as Nrf2 (Kobayashi et al. 2006) and CHOP (Huang et al. 2012) in the 
cytosol, allowing them to be tagged for proteasomal degradation (Figure 3.8B). 
In contrast to adipocytes matured in 25 mM glucose, NAC actually 
augmented protein succination in FHKD adipocytes (Figure 3.5A). Surprisingly 
NAC treatment also had no effect on the concentrations of endogenously 
produced fumarate generated in this model (Figure 3.5B). This may be related to 
the excessive concentration of fumarate produced in these cells, 20 fold greater 
than that in adipocytes matured in 25 mM glucose (Figure 3.5C). Interestingly, 
we still observed a significant decrease in both CHOP and HOX1 expression with 
NAC treatment (Figure 3.5A), despite continued increased protein succination 
and high fumarate levels. Assessment of protein cysteine sulfenic acid content in 
FHKD adipocytes (Figure 3.5D) revealed that reducing oxidative protein damage 
with NAC decreased thiol oxidation, which in turn down-regulates CHOP levels 
and Nrf2 signaling, likely by attenuating Keap1 oxidation. Remarkably, prolonged 
adipose tissue Nrf2 activity has been associated with decreased lipid 
accumulation, lipogenic gene expression and glucose tolerance while 
simultaneously increasing insulin resistance in the adipose tissue of ob/ob type 2 
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diabetic mice (Xu et al. 2012). While sustained Nrf2 activity was suspected to 
underlie the unhealthy phenotype in these mice, our data suggests that sustained 
CHOP, also regulated by Keap1 modification, may be a more significant 
contributor. Collectively, these results emphasize the importance of cysteine 
oxidation as a primary regulatory factor governing Keap1:protein interactions and 
CHOP stability in the adipocyte. Protein thiol oxidation indirectly correlates with 
succination in FHKD adipocytes (Figure 3.5A, 3.5D) confirming that oxidation and 
succination compete for thiol targets when fumarate levels are elevated. While 
fumarate levels are augmented in both of the models used (high glucose and 
FHKD), and it is evident that increased fumarate can further exacerbate oxidative 
stress, it is also clear that both models differed dramatically in response to NAC 
treatment. This is significant considering that knockdown models are frequently 
employed to model metabolite stress (Nishida et al. 2015, Park et al. 2013, 
Wagner et al. 2017), but these may not always exhibit the same concentrations 
observed in the disease state, producing different, perhaps more pronounced, 
signaling effects. 
CHOP is classically known to induce apoptotic signaling via suppression 
of the Bcl-2 family gene transcription in the nucleus. However, the accumulation 
of CHOP in adipocytes due to proteasomal inhibition by MG132 has no effect on 
the protein levels of anti-apoptotic proteins Bcl-2 or Bax (Diaz et al. 2015). In 
addition, wild type and CHOP knockout mice fed a high fat diet display similar 
expression of apoptosis-related proteins Bcl-2 and CD95 and show no change in 
the ratio of TUNEL-positive cells to total nuclei (Suzuki et al. 2017). These 
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studies emphasize the absence of immediate CHOP-mediated apoptosis in 
obese adipocytes. Figure 3.6 supports these studies as we find that CHOP levels 
are indirectly proportional to cleaved caspase 3 protein levels in adipocytes 
matured in high glucose, adipose tissue from db/db mice and FHKD adipocytes 
at 8 or 12 days of adipocyte maturation. Giordano et al. have described 
increases in caspase-1 mRNA and over activation of the nucleotide-binding 
oligomerization domain-like receptor-3 (NLRP3) inflammasome in obese adipose 
tissue (Giordano et al. 2013). This leads to hypertrophic adipocyte death by 
pyroptosis, rather than CHOP induced apoptosis, in the visceral adipose tissue of 
ob/ob and db/db mice and subcutaneous adipose tissue of mice fed a high fat 
diet (Giordano et al. 2013). 
Investigation into the functional role of CHOP in obese adipocytes led 
Suzuki et al. to determine that stabile CHOP signaling suppresses IL-13 and IL-4 
mRNA transcription, promoting M1 macrophage polarization in mice after 6 
weeks of high fat diet feeding (Suzuki et al. 2017). Eosinophils are the major 
source of IL-4 in the adipose tissue microenvironment while healthy adipose 
tissue secrets modest levels of IL-4. CHOP knockout mice display upregulated 
transcription of eotaxins and increased eosinophil recruitment resulting in 
increased IL-4 levels and attenuated inflammation in the adipose tissue 
microenvironment (Suzuki et al. 2017). In addition, CHOP knockout mice have 
improved insulin sensitivity after consumption of a high fat diet (Suzuki et al. 
2017). This study emphasizes an important role for CHOP to promote adipose 
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tissue inflammation linked to insulin resistance during high fat diet feeding 
(Suzuki et al. 2017).  
Notably, adipose tissue IL-13 secretion increases in mice fed a high fat 
diet for 13 weeks in response to exogenous TNFα and IL-1β inflammatory 
signaling (Kwon et al. 2014). Elevated IL-13 production observed in obese versus 
lean omental human adipose tissue is predicted to attenuate the inflammatory 
immune cell response to implement the ‘low-grade’ inflammation hallmark of 
obesity (Kwon et al. 2014). We confirmed that accumulation of CHOP specifically 
in the nuclear fraction of adipocytes matured in high glucose (Figure 3.7B) 
correlates with impaired IL-13 secretion during the onset of adipocyte 
hypertrophy (Figure 3.7C). This data suggests that CHOP may regulate IL-13 
mRNA transcription at an early stage of obesity to initiate a pro-inflammatory 
immune cell response in the adipose tissue microenvironment. Notably, we 
demonstrated that NAC mediated suppression of oxidative stress (Figure 3.4C) 
reduced CHOP expression (Figure 3.4E) and rescued IL-13 secretion (Figure 
3.7C), possibly reducing the pro-inflammatory environment. Chromatin 
immunoprecipitation sequencing identified GATA3, a zinc finger transcription 
factor, and STAT5a bound to the promotor region of IL-13 resulting in the 
upregulation of IL-13 mRNA transcription (Wei et al. 2011). Interestingly, GATA3 
is expressed in white adipose tissue (Tong et al. 2000) and forms transcription 
factor complexes with C/EBPα and C/EBPβ to inhibit adipogenesis (Tong et al. 
2005). Future studies will investigate if CHOP directly binds anti-inflammatory 
transcription factor complexes such as GATA3 or STAT5a (Zhu, 2015) or the 
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DNA promotor region to suppress IL-13 mRNA production and secretion (Figure 
3.7C) (Suzuki et al. 2017). 
In summary, we find that increased fumarate levels and protein 
succination are coupled to elevated oxidative stress; and that this leads to 
oxidative protein damage and impaired CHOP turnover in the adipocyte. 
Sustained CHOP protein levels in the nucleus correlates with decreased 
secretion of the anti-inflammatory cytokine IL-13. The improvement in IL-13 
secretion following NAC treatment is a direct result of limiting oxidant-mediated 
CHOP stabilization, emphasizing the importance of the intracellular oxidative 








 Adipose tissue is an important endocrine organ responsible for energy 
storage, insulation, protection and the secretion of adipokines that help regulate 
systemic nutrient homeostasis. The accumulation of excess adipose tissue is 
associated with the secretion of pro-inflammatory cytokines and insulin 
resistance. Type 2 diabetes is frequently associated with obesity and ~29 million 
Americans are either diabetic or have pre-diabetes. Due to the growing number 
of individuals affected by obesity and type 2 diabetes, it is critical to understand 
the complex origins of disease pathology. The mechanistic studies investigated 
here increase our knowledge regarding the biochemical contribution of excessive 
caloric intake to the metabolic dysfunction known to occur in adipose tissue. 
Overall, I explored the contribution of nutrient excess to alterations in the post-
translational regulation of protein stability and function, and how this impacts 
adipocyte dysfunction.  
Protein succination occurs when a thioether bond is formed between the 
Krebs cycle intermediate fumarate and the thiol groups of cysteine residues to 
form S-(2-succino)cysteine (2SC) (Figure 1.3). The accumulation of fumarate and 
2SC increases in adipocytes matured in high glucose and in adipose tissue from 
type 2 diabetic (db/db) mice, due to glucotoxicity driven mitochondrial stress 
(Frizzell et al. 2012) (Figure 1.4). Protein disulfide isomerase (PDI) is an 
abundant endoplasmic reticulum (ER) oxidoreductase that is responsible for the 
successful formation of disulfide bonds in the majority of proteins in the ER. In 
chapter 2 I identified the active site cysteines of PDI as the targets of succination 
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in adipocytes matured in high glucose.  
The use of a fumarase knockdown model (FHKD) to directly increase 
endogenous fumarate production facilitated determination of the impact of 
metabolite stress on PDI activity. Direct succination of PDI active site cysteines 
inhibits PDI reductase activity interfering with normal protein folding and 
contributing to the documented increase in the unfolded protein response (UPR) 
and ER stress (Figure 4.1) in the adipose tissue of diabetic patients (Boden et al. 
2014b, Hosogai et al. 2007). Notably, adipose tissue secretory function is not 
decreased for all secreted proteins. During diabetes there is increased secretion 
of leptin, retinol binding protein 4 (RBP4) and inflammatory proteins in parallel 
with adipose tissue expansion. However there are paradoxical decreases in the 
secretion of adipsin, omentin, vascular endothelial growth factor (VEGF) as well 
as the thiol dependent hormone adiponectin (Deng and Scherer, 2010). We have 
previously shown that the critical cysteine for adiponectin oligomerization is 
succinated in diabetic adipose tissue and adipocytes (Frizzell et al. 2009). Taken 
together, our data suggests that protein succination is a relevant negative 
regulator of protein folding and oligomerization during diabetes.  
During our studies on adipocyte protein folding capacity, we noted that 
the protein levels of the ER stress marker C/EBP homologous protein (CHOP) 
were elevated, yet we found limited evidence for a pronounced up-regulation of 
the unfolded protein response (UPR) in diabetic conditions (versus normal 
glucose). This is in agreement with more recent publications documenting the 
presence of UPR activation in the presence of insulin, since the normal response 
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to insulin both in vivo and in vitro would include increased proteostasis (Boden et 
al. 2014b, Minard et al. 2016). Therefore, we continued to examine the persistent 
up-regulation of CHOP in diabetic conditions (Figure 3.1A). CHOP is a negative 
regulator of transcription and we confirmed that it was accumulating in the 
nucleus of adipocytes matured in high glucose. While increased levels of CHOP 
are normally associated with prolonged ER stress and the induction of apoptosis, 
we found no evidence for an association between CHOP and increased 
apoptosis (Figure 3.6).  
Kelch-like ECH-associated protein 1 (Keap1) is a negative regulator of 
CHOP stability and Figure 3.1 demonstrates that CHOP turnover is impaired in 
adipocytes cultured in high glucose. The modification of Keap1 regulatory 
cysteines promotes the accumulation of CHOP protein levels. We identified 
Cys288 as the target residue for Keap1 succination in FHKD adipocytes, but 
surprisingly Keap1 was not directly succinated in high glucose conditions where 
fumarate is also increased, although to a lower extent than the FHKD model. We 
further demonstrated that it is oxidative stress and the accumulation of reactive 
oxygen species that leads to oxidation of Keap1 and the accumulation of CHOP 
protein levels in high glucose conditions. Interestingly, we also documented that 
increased fumarate promotes oxidative stress; therefore elevated fumarate can 
regulate Keap1/CHOP indirectly through the production of ROS. Boden et al. 
recently demonstrated the significance of adipose tissue oxidative stress in the 
acute development of insulin resistance in humans, independent of ER stress 
and inflammation (Boden et al. 2015). Our data elegantly demonstrates that both 
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oxidative stress and metabolite stress occur simultaneously, and further explains 
how increased fumarate levels as diabetes develops may exacerbate the existing 
oxidative stress. In further considering the implications of sustained CHOP levels 
in the nucleus, we demonstrate that CHOP may contribute to the inhibition of IL-
13 production and secretion during adipocyte dysfunction (Figure 3.7C, 4.1).  
In summary, the data obtained here demonstrates that elevated fumarate 
contributes to impaired protein folding and altered functionality in parallel with 
oxidative modification and inflammatory stress. Fumarate levels and protein 
succination are lowered following the reduction of high glucose levels, 
demonstrating that metabolite stress, like obesity and inflammation, can be 
resolved following caloric restriction. 
4.2 Future Directions 
 It will be important to extend these studies on the role of succination in 
adipocyte pathophysiology to human adipose tissue. In particular, we are 
interested in investigating if other isomers of the PDI family, such as ERp57, are 
targets of succination and whether this affects protein glycosylation in the 
adipocyte. Continuous with our results regarding caloric restriction, it will also be 
beneficial to confirm that caloric restriction and/or exercise decreases protein 
succination and CHOP levels in the adipose tissue of type 2 diabetic mice and 
patients.  
 Our results on the increased production of ROS as a result of protein 
succination are insightful and exciting; suggesting that fumarate indirectly 
regulates the oxidative modification of proteins. Figures 3.3 and 3.4 suggest that 
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protein succination alone is sufficient to induce oxidative stress and activate the 
Keap1/Nrf2 antioxidant response pathway in the adipocyte. Interestingly, 
reducing protein succination with the antioxidant and glutathione precursor N-
acetylcysteine (NAC) ameliorates ROS production and lessens the Keap1/Nrf2 
oxidative stress response in adipocytes matured in high glucose. The precise 
mechanism by which NAC simultaneously reduces protein succination in the 
adipocyte has not been described, but it may involve the production of 
succinated NAC or succinated glutathione and we plan to develop methods to 
detect this.  
We have noted in unpublished observations that oxidized thiols (sulfenic 
acid) will not react with fumarate in vitro. Figure 3.5 shows that NAC reduces 
protein oxidation in FHKD adipocytes (where fumarate levels are 20-fold greater 
than in high glucose), but simultaneously increases protein succination. Our data 
demonstrates that pronouncedly elevated fumarate levels, such as those 
observed in fumarase deficient renal cell carcinoma or fumaric aciduria, both 
contribute to and compete with the oxidative modification of proteins. While the 
use of antioxidants in these conditions might actually reduce oxidative stress, 
they are also likely to propagate the irreversible succination of other proteins. We 
would predict that treating adipocytes matured in high glucose with the 
antioxidants superoxide dismutase (SOD) or MitoQ might also decrease the 
amount of oxidized protein thiols and this may be more beneficial in situations 
where fumarate levels are not elevated to the extent that they are in models of 
fumarase deficiency. The combined assessment of protein oxidation, succination 
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and fumarate levels in adipocytes treated with SOD and MitoQ during maturation 
in high glucose or the fumarase knockdown model will further confirm whether 
endogenous fumarate and ROS compete to react with the same thiol targets.  
 Our laboratory is currently working to produce a tamoxifen inducible 
adipose tissue specific fumarase knockout mouse to delineate the whole-body 
ramifications of augmented adipose tissue fumarate production in vivo. 
Preliminary data generated from our laboratory demonstrates that CHOP levels 
increase in the white adipose tissue from another fumarase knockout model 
(Yang et al. 2016). We will continue to investigate several additional roles for 
CHOP in the regulation of metabolism and inflammation in this model and in 
human adipose tissue from diabetic patients. We are currently planning 
chromatin immunoprecipitation (ChIP) studies to detect genes directly regulated 
by CHOP-DNA interactions in adipocytes matured in high glucose. 
 Lastly, our laboratory has confirmed that succination increases on ~40 
different proteins in the adipocyte during diabetes. We will continue to investigate 
the significance of other identified sites, and specifically pursue the stoichiometry 
of protein succination by multiple reaction monitoring mass spectrometry. We are 
committed to further understanding the quantitative significance of protein 
succination in the complex network of metabolic stressors occurring present 






Figure 4.1. Mitochondrial stress drives adipocyte dysfunction during 
diabetes. The resultant accumulation of fumarate due to mitochondrial stress 
leads to increased protein succination. Succination of the important endoplasmic 
reticulum oxidoreductase protein disulfide isomerase (PDI) results in the 
accumulation of misfolded proteins and the ER stress markerf C/EBP 
homologous protein (CHOP). Additionally, succination promotes oxidative stress 
and the build-up of reactive oxygen species (ROS). The modification of Kelch-like 
ECH-associated protein 1 (Keap1) by ROS coincides with impaired CHOP 
turnover and the accumulation of CHOP in the nucleus. Nuclear CHOP 








Materials. Unless otherwise noted, all chemicals were purchased from Sigma 
Aldrich (St. Louis, MO). Anti-2SC antibody was prepared by Eurogentec 
(Fremont, CA). Insulin was purchased from Bio Ab Chem (Ladson, SC) for in 
vitro studies. Tween-20 and Criterion™ TGX™ Precast Gels were from Bio-Rad 
(Hercules, CA). Polyvinylidene fluoride (PVDF) was purchased from GE 
Healthcare (Fairfield, CT). L-glycine and sodium dodecyl sulfate (SDS) were 
purchased from Fisher Scientific (Waltham, MA). All materials for the Seahorse 
XF24 were purchased from Seahorse Bioscience (Agilent, Santa Clara, CA) 
except insulin, glucose and pyruvate. The CyQuant® assay was from Invitrogen 
(Grand Island, NY). The PROTEOSTAT® PDI assay kit was purchased from 
Enzo Life Sciences Inc. (Farmingdale, NY) and the Di-Eosin-GSSG was 
generously provided by Dr. Bulent Mutus, University of Windsor, Ontario, 
Canada. 
Animal Models. Male db/db mice (BKS.Cg-Dock7m +/+ Leprdb/J, JAX 000642) 
and heterozygote control mice were purchased from Jackson Laboratories (Bar 
Harbor, ME). The mice were obtained at 5-6 weeks of age and allowed to 
acclimate 1-2 weeks with unrestricted access to food and water before initiation 
of experimental monitoring. Blood glucose levels were measured at 15 weeks of 
age after an overnight fast by collecting tail vain blood using a Bayer Contour® 
(Whippanny, NJ) blood glucose meter for all groups. A glucose oxidase assay 
was also performed to obtain values for db/db mice as some of these surpassed 
the range of the glucometer. The animals were sacrificed at 15 weeks of age 
using CO2 asphyxiation and epididymal adipose tissue was removed and frozen 
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on dry ice. 
Protein Extraction from Adipose Tissue. Adipose tissue was added to 0.5 – 5 
mL radio immunoprecipitation assay (RIPA) buffer and sonicated 4 times for 30 
seconds each. The tissue was incubated on ice for 10 minutes and centrifuged at 
5000 rpm for 10 minutes at 4°C. A supernatant, infranatant and pellet were then 
visible. The infranatant volume was extracted using a needle and syringe. 
Acetone (9x volume) was then added to each infranatant sample. The samples 
were vortexed, allowed to sit on ice for 10 minutes and then centrifuged at 2000 
rpm for 10 minutes at 4°C. The acetone was removed completely and the protein 
pellets were re-suspended in 0.5 mL of RIPA buffer and sonicated two times for 
30 seconds each. The protein concentration was determined using the Lowry 
method. 
Cell Culture. 3T3-L1 murine fibroblasts were purchased from American Type 
Culture Collection (Manassas, VA) and maintained up to 7 passages in 
Dulbecco's Modified Eagle Medium (DMEM) containing 5 mM glucose, 1% 
penicillin/streptomycin (CellGro, Corning Life Sciences, Tewksbury, MA) and 
10% Fetal Calf Serum (FCS) (Thermo Scientific, Waltham, MA) at 37°C with 95% 
humidity and 5% CO2. The medium was changed every 48 hours, with glucose 
supplementation at 20-24 hour intervals. At 70-80% confluence the fibroblasts 
were trypsinized (Thermo Scientific, Waltham, MA), neutralized with excess 
DMEM and collected by centrifugation at 1000 rpm for 5 minutes at 25°C. The 
fibroblasts were then re-suspended in DMEM for each new passage. 
 3T3-L1 fibroblasts were seeded at densities of 20,000, 50,000, 90,000 
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and 300,000 cells/ well for 24-well, 12-well, 6-well plates and 10 cm2 petri dishes 
respectively. 3T3-L1 fibroblasts were induced to differentiate to adipocytes 24 
hours post-confluence (~4-5 days) in DMEM with 1% penicillin/streptomycin 
(CellGro), 10% Fetal Bovine Serum (FBS) (Atlanta Biologicals, Flowery Branch, 
GA), 3-isobutyl-1 methylxanthine (0.5 mM), dexamethasome (IBMX) (0.3 µM), 
insulin (10 µg/mL) and glucose (30 mM) for 72 hours at 37°C with 95% humidity 
and 5% CO2. The differentiation medium was removed at maturation day 0, the 
cells were washed with PBS and maturation DMEM containing DMEM with 1% 
penicillin/streptomycin (CellGro), 10% Fetal Bovine Serum (FBS) (Atlanta 
Biologicals, Flowery Branch, GA), 5 mM glucose/0.3 nM insulin or 30 mM 
glucose/3 nM insulin was applied. These conditions were selected as we have 
observed that adipocytes cultured in normal glucose/insulin are a more 
appropriate control for the high glucose/insulin (diabetic) conditions (Tanis et al. 
2015). The medium was changed every 48 hours and the adipocytes were 
matured for 5, 8 or 12 days. Adipocytes were treated with 2 µM niclosamide upon 
standard medium change. 10 µM MG132 or 40 µM sulforaphane was added to 
the maturation medium 3 hours prior to harvest. Adipocytes matured in normal 
glucose and insulin concentrations were treated with 2, 4 or 6 mM dimethyl 
succinate for 8 days or 100 µM dimethyl fumarate for 3, 6 or 24 hours. Cells 
cultured in 5 mM glucose were supplemented with 5-6 mM glucose daily and 5 
hours prior to protein harvest in maintain glucose levels. 
Lentiviral Vector Production. The lentiviral vectors were prepared by the 
University of South Carolina Viral Vector Facility. Lentiviral vectors were 
 
127 
generated using a transient transfection protocol, as described in Kantor et al., 
2011. TRC2 Fh1 shRNA, clone- TRCN0000246831 or SHC202 MISSION TRC2 
pLKO.5-puro non-mammalian shRNA control plasmids (Sigma/Aldrich, St. Louis, 
MO) were used to generate the lentiviral vectors. The vectors also contained a 
puromycin resistance gene. 15 μg vector plasmid, 10 μg psPAX2 packaging 
plasmid (Addgene #12260, Cambridge, MA), 5 μg pMD2.G envelope plasmid 
(Addgene #12259, Cambridge, MA) and 2.5 μg pRSV-Rev plasmid (Addgene 
#12253, Cambridge, MA) were transfected into 293T cells. The filtered 
conditioned medium was collected and stored at -80°C until use. The Keap1-V5 
overexpression plasmid was kindly provided by Anil Jaiswal, University of 
Maryland. The plasmid sequence was validated by PCR and cloned into a 
lentiviral vector containing green fluorescent protein (GFP) (pLenti-CMV-KEAP1-
IRES-GFP). A vector containing the Keap1-V5 sequence in the opposite 
orientation was used as a control. The vector was produced as described above 
and the filtered conditioned medium was stored following titer determination. 
Lentiviral Vector Transduction. 3T3-L1 fibroblasts were incubated overnight 
with 150 µL of filtered conditioned medium containing Fh1 shRNA or control 
lentivirus. Successfully transduced fibroblasts were selected using 1 µg/mL 
puromycin. The selected fibroblasts were propagated until confluent, then 
differentiated to adipocytes and matured for 8 days in 5 or 30 mM glucose as 
described above. 3T3-L1 fibroblasts or FHKD fibroblasts were differentiated as 
described above and transduced with the Keap1-V5 plasmid on maturation day 
1. Over-expression of the Keap1 protein was monitored in adipocytes via green 
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fluorescent protein through 5 or 8 days of maturation. Successful maturation in 
both glucose concentrations was confirmed by the accumulation of lipid droplets 
in the adipocyte by light microscopy (Nagai et al. 2007, Tanis et al. 2015). 
Seahorse Extracellular Flux Analyzer 24. 3T3-L1 fibroblasts were plated in V7-
microassay plates on 0.2% gelatin at 10,000 cells per well. 150 µL of medium 
was added after 24 hours. Fibroblasts were differentiated as described above 
and matured for 2 days in 5 mM or 30 mM glucose.  
An XF calibrant cartridge was hydrated 24 hours prior to analysis in XF 
calibrant solution pH 7.4 at 37°C with 0% CO2. The cells were washed with 750 
µL of XF assay buffer pH 7.4 and 600 µL of XF Assay Medium pH 7.4 (Agilent 
Technologies, Santa Clara, CA), supplemented with 5 mM or 30 mM glucose, 0.3 
or 3 nM insulin, and 1 mM sodium pyruvate, was added to replace the culture 
media 1 hour before the analysis (Tanis 2015). 0.25 µM niclosamide was added 
to adipocytes by XF analyzer injection after 4 measurements of the basal oxygen 
consumption rate (OCR). All measurements involved a mixing (3 minutes), a wait 
(2 minutes) and a measure (3 minutes) period after the addition of the normal 
medium or the 0.25 µM niclosamide. The OCR data was normalized to the total 
DNA or protein content of the wells using the CyQuant® Assay (Invitrogen, 
Grand Island, NY) or Lowry assay, and the data was expressed in 
pmoles/minute/ng DNA or µg protein (Tanis et al. 2015). 
Oil Red O Staining. 0.5 grams of Oil Red O was thoroughly mixed in 100 mL 
isopropanol and diluted 6:4 in nano-pure distilled water. The dye was allowed to 
stand for 10 minutes and filtered through Whatman No.1 filter paper. 100% 
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confluent 3T3-L1 fibroblasts and differentiated FHKD adipocytes were fixed for 1 
hour in 4% formaldehyde. The cells were washed with PBS, stained with the Oil 
Red O dye for 1 hour and washed with water. The lipid droplets were visualized 
by brightfield microscopy and the images were obtained with an InvitrogenTM 
EVOSTM FL Auto Cell Imaging System (Thermo Fisher Scientific, Waltham, MA). 
Amplex Red Assay. FHKD or scrambled control adipocytes were matured in 5 
mM or 30 mM glucose in serum free and phenol red free medium for 2.5 hours 
on day 0 of maturation. The fluorescent Amplex® UltraRed Reagent was 
resuspended in 1 mL of sterile DMSO and diluted to a 333 µM stock in DMSO. 
0.5 U/mL horseradish peroxidase and 10 µM Amplex UltraRed Reagent was 
added directly to the maturation medium/well. The fluorescence was recorded at 
490ex nm and 585em nm every hour for 4 hours. Relative fluorescent units were 
normalized to total protein content per well following determination by the Lowry 
assay. 
Dichlorofluorescein (DCF) Assay. FHKD or scrambled control adipocytes were 
matured for 2 days in 5 mM or 30 mM glucose medium. The cells were rinsed 
with sterile PBS and incubated for 45 minutes at 37°C with 500 µL serum free 
phenol red free medium and 0.0065 µg/µL DCF. The DCF containing medium 
was removed and the cells were returned to maturation medium with serum free, 
phenol red free DMEM. Relative fluorescent units were measured at 485ex nm 
and 535em nm every 30 minutes for 4 hours. 
Cycloheximide Pulse Chase. 3T3-L1 control or FHKD adipocytes were matured 
in 5 mM or 30 mM glucose for 8 days. Adipocytes (triplicate samples/group) were 
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harvested at time point 0 hours and 3.5 µg/mL cycloheximide was added to four 
additional groups, harvested every hour for 4 hours. 10 µM MG132 was added to 
a separate group of adipocytes for 4 hours.  
Glutathione Quantification. Adipocytes were matured for 8 days in the 
presence of 5 mM or 30 mM glucose with 0, 2.5 or 5 mM NAC, or 100 µM 
dimethyl fumarate (DMF) for 24 hours. Cells were harvested in 5% salicyclic acid 
sonicated, allowed to sit on ice for 10 minutes and centrifuged at 14,000 rpm, 
+4*C for 10 minutes. The supernatant was removed and diluted 1:5 with assay 
buffer and then diluted 1:6 with sample diluent buffer supplied by the 
commercially available kit (Arbor Assay Glutathione Fluorescent Detection Kit, 
Ann Arbor, MI). Total glutathione levels were quantified according to the 
manufacturer’s instructions. 
Metabolite Quantification. The quantification of fumarate was performed by 
GC-MS at the David H. Murdock Research Institute (DHMRI, Kannapolis, NC). 
Metabolite extraction was performed in an adaptation of previous methods (Piroli 
2016). Adipocyte lysates harvested in methanol from confluent 10 cm2 petri 
dishes were washed three times with ice-cold PBS followed by the immediate 
addition of 20 volumes ice-cold chloroform:methanol (2:1). The samples were 
vortexed and allowed to stand on ice for 10 min with intermittent vortexing prior to 
addition of 0.2 volumes H2O. The samples were sonicated and allowed to stand 
on ice for an additional 2 min, followed by centrifugation at 3,220 x g for 20 min. 
The aqueous supernatant was transferred into a clean tube and dried under air. 
The extraction was repeated an additional time by adding equal parts of 
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methanol and deionized water, centrifuging, and transferring the aqueous layer 
into the respective tube to dry. The protein interface for each sample was 
removed for quantification of protein by the Lowry assay.  
Prior to derivatization the extracts were resuspended in ethyl acetate and 
transferred to GC-MS vials. The samples were dried with N2, and an internal 
standard (100 μM succinate-13C4, Cambridge Isotope laboratories, Inc.) was 
added to each of the samples and fumarate standards. The samples and 
standards were derivatized with 200 μl of methylamine (20 mg/ml in pyridine, 
M.P. Biomedicals, Solon, OH) at 30°C for 90 min, followed by drying under N2. 
This was followed by the addition of 120 μl of N-methyl-N-(trimethylsilyl) 
trifluoroacetamide (MSTFA, Sigma, St. Louis, MO) with 1% trimethylchlorosilane 
(TMCS, Sigma, St. Louis, MO); the mixture was incubated at 70°C for 60 min. 
The derivatized product was stored in a -20°C freezer for one hour. A 100 μl 
aliquot of the prepared product was transferred to a deactivated glass insert in a 
2 ml glass vial (Agilent Technologies, Santa Clara, CA) for GC/MS analysis. An 
Agilent 7890A GC system, coupled to an Agilent 5975C electron ionization (EI) 
mass selective detector (MSD) was used to analyze the TMS-derivatized 
samples. A column with dimensions 30 m × 0.25 mm I.D., 0.25 μm film thickness 
(Restek, Bellefonte, PA) was used, and the column operation conditions were as 
follows: helium carrier gas at 1.0 ml/min; GC oven temperature program of 70°C 
(2 min), 70-100°C (30°C/min, 1 min), 100-140°C (10°C/min, 4 min), 140-188°C (4 
°C/min, 12 min), 188-280°C (5 min), with a transfer line temperature of 270°C. 
The GC-MS was operated under a splitless mode (inlet at 250°C). The mass 
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spectrometry was performed at an electron energy of -70 eV and the ion source 
temperature was 230°C. Selected ion monitoring (SIM) was performed for 
fumarate and the peak areas obtained were normalized to the added internal 
standard. Absolute quantitation was performed based on standard curves 
obtained from the normalized reference standards, and the final metabolite 
concentrations were normalized to the protein content of the cells. 
Protein Extraction from Cells. All samples and reagents were kept on ice 
during protein harvest. The cells were washed 3 times with phosphate buffered 
saline (PBS) solution, collected in RIPA buffer and sonicated 3 times (10 
seconds) at 30 second intervals. Acetone (9 volumes) was added to each sample 
and the samples were vortexed and incubated on ice for 10 minutes. A protein 
pellet was generated after centrifugation at 2000 rpm for 10 minutes at 4°C. The 
supernatant was removed and the protein was re-suspended in RIPA buffer and 
sonicated 2 times for 30 seconds. Protein concentration was determined by the 
Lowry method and the samples were stored at -70°C. 
Intracellular Organelle Fractionation. 3T3-L1 adipocytes were matured for 8 
days as described above. On ice, the cells were washed 3 times with ice cold 
PBS and once with homogenization buffer (detailed in Appendix A). The cells 
were scraped into 500 µL of homogenization buffer+ (detailed in Appendix A) and 
lysed using a glass homogenizer 20 times before passing each lysate through a 
25 gauge needle 6 times on ice. The samples were centrifuged at 500 x g for 10 
minutes at +4ºC to generate the nuclear pellet, and the supernatant was 
removed and re-centrifuged at 10,000 x g for 20 minutes at +4ºC to produce the 
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mitochondrial rich pellet and cytosolic supernatant. 
Measurement of Triglycerides and Inflammatory Markers in 3T3-L1 
Adipocytes. Control and FHKD adipocytes were matured in 5 mM or 30 mM 
glucose concentrations for 8 days and harvested in PBS. The triglyceride 
concentration was measured in 10 μL aliquots of cell lysates utilizing the 
InfinityTM Triglycerides assay kit (Thermo Fisher Scientific, Waltham, MA), 
according to the manufacturer’s instructions. The media on scrambled control or 
FHKD 3T3-L1 adipocytes matured for 6 days was replaced with serum-free 
DMEM for 6 hrs prior to collection of conditioned media. Pro-inflammatory 
cytokines in serum-free conditioned media were analyzed by ELISA according to 
the manufacturer's instructions (Mouse Obesity ELISA, Signosis, Santa Clara, 
CA). Secreted IL-13 levels were determined by the abcam® Mouse ELISA kit 
according to the manufacturer’s instructions (Interleukin-13 Mouse ELISA, 
abcam®, Cambridge, UK). 
Western Blotting. 15-30 μg cell lysate protein and 30-100 μg mouse epididymal 
fat protein was diluted to 20 μL total volume with nano-pure deionized water and 
incubated with 5-7 μL 4X Laemmli loading buffer at 95°C for 15 minutes. The 
samples were centrifuged at 5000 rpm for 10 seconds and then loaded on 7.5%, 
12% or 18% gels and electrophoresed at 200 volts for 60 minutes. The protein 
was transferred to a PVDF membrane in transfer buffer (0.1% Tris Base, 20% 
methanol, 79.9% nano-pure deionized water) at 250 mA for 100 minutes or 40 
mM overnight at 4°C. The membrane protein loading was visualized with 
Ponceau Red, followed by blocking in 5% bovine serum albumin (BSA) or 5% 
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non-fat milk for 1 hour at room temperature, or overnight at 4°C according to the 
antibody manufacturer’s recommendations. Primary polyclonal antibodies to actin 
(sc-1616), Ero1α (sc-365526), GRP78 (sc-1051) and PDI (sc-30932) were from 
Santa Cruz Biotechnology Inc. (Dallas, TX). Polyclonal antibodies to cleaved 
caspase 3 (#9664), fumarase (#4567), PPARγ (#2435) and Keap1 (#4617) were 
from Cell Signaling (Danvers, MA). The anti-adiponectin antibody was from R&D 
Systems (AF1119) and the anti-hemeoxygenase1 antibody was from Enzo Life 
Sciences (ADI-SPA-896D) (Farmingdale, NY). The histone-H3 antibody (05928) 
was from Merck Millipore (Billerica, MA). Monoclonal antibodies to PDI (MA3-
019) and CHOP (MA1-250) and the anti-V5-HRP linked (MA5-15253) antibody 
were from Pierce (Rockford, IL). The monoclonal C/EBPα (#8178) and citrate 
synthase (#14309) antibodies were from Cell Signaling (Danvers, MA). The 
polyclonal anti-2SC antibody was prepared as described previously (Nagai et al. 
2007). Chemiluminescent substrate (Thermo Pierce, Rockford, IL) was utilized 
followed by detection on photographic film (Denville Scientific, Metuchen, NJ). 
Immunoblots were stripped (62.5 mM Tris, pH 6.8, 2% SDS and 0.7% (v/v) beta 
mercaptoethanol) for 20 minutes at 67°C prior to re-probing with new primary 
antibodies. Image J software (National Institute of Health) was used to quantify 
band intensity by densitometry. 
2-Dimensional Polyacrylamide Gel Electrophoresis. 150-200 μg of protein 
was acetone precipitated from wild-type or Fh1-/- MEFs, control and db/db 
adipose tissue, or total PDI immunoprecipitate were re-suspended and incubated 
for 10 minutes in rehydration buffer (7 M urea, 2M thiourea, 2% CHAPS, 1% IPG 
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buffer, and 50 mM dithiothreitol (DTT), 3.0% DeStreak, 0.5% ampholytes) at 
room temperature followed by centrifugation at 10,000 rpm for 5 minutes. Each 
sample was pipetted into an 11 inch strip and absorbed overnight into IPG strips 
with a pI range of 3.9-5.1, 4-7 or 3-10 (BioRad, Richmond, CA) in mineral oil. 
Each IPG strip was placed gel side up on the Ettan™ IGPphor II with a thick 
paper salt bridge soaked in 150 µL nano-pure deionized water at each end. The 
electrode was placed on top of the paper salt bridge that overlapped with the IGP 
strip and the strips were focused to 12,000-14,000 total volt hrs and frozen at -
70°C. The next day, 50 mg of DTT and 125 mg of iodoacetamide were each 
dissolved in 5 mL of equilibration buffer. The IPG strips were allowed to thaw for 
5 minutes at room temperature and incubated with 2 mL of DTT equilibration 
buffer for 15 minutes followed by 15 minutes incubation with 2 mL of 
iodoacetamide equilibration buffer. During this time the agarose sealing solution 
was melted in the microwave, a 4-20% 11 cm IPG+1 Criterion™ TGX™ gel was 
placed into the electrophoresis tank and all excess water at the top of the gel was 
absorbed by filter paper. Extra equilibration buffer was rinsed off the strips in 1x 
SDS running buffer and the strips were placed onto the gel with 300 µL agarose 
sealing solution pipetted around each strip. The tank was filled with 1x SDS 
running buffer and western blotting was performed as described above. 
Protein Immunoprecipitation. 500-1000 µg adipocyte cell lysates was diluted to 
500 µL total volume with immunoprecipitation buffer or PBS with 2 µL protease 
inhibitor, sonicated for 30 seconds and incubated (rotating) with 10 µL of washed 
Protein G or A agarose beads for 30 minutes. The samples were centrifuged at 
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5000 rpm for 5 minutes at 4°C and the supernatant transferred to a new clean 
tube while the beads were discarded. 4-5 µg of anti-PDI, -Ero1α or -CHOP 
antibodies were added to the supernatant and allowed to rotate overnight at 4°C. 
15 µL of Protein G or A agarose beads were washed with 800 µL of PBS, 
centrifuged at 5000 rpm for 5 mins, re-suspended in 30 µL of PBS and added to 
each sample with 1 µL protease inhibitor. The samples incubated on the rotating 
wheel for 3.5 hours at room temperature, centrifuged at 5000 rpm at 4°C for 5 
minutes and the supernatant was collected and frozen at -70°C. The beads were 
washed 4 times with PBS or PBS with 0.1% Tween-20, re-suspended in 2-4x 
loading buffer and boiled at 95˚C for 8 minutes to remove the bound antibody-
antigen complex prior to immunoblotting. Keap1 was immunoprecipitated from 
control and FHKD adipocytes matured for 6 days that overexpressed the V5-
Keap1 plasmid. 400-800 µg of protein was diluted in 350 µL PBS and sonicated 
for 30 seconds. 15 µL of V5-antigen linked agarose beads were washed 4x with 
PBS, the protein samples were added to the beads and incubated on the rotating 
wheel for 1.5 hours. The beads were washed 5 times with PBS and incubated 
with 2x loading buffer at 100°C for 5 minutes to remove the antibody-antigen 
complex. 
Detection of Ero1 Succination. Ero1α immunoprecipitated from 3T3-L1 
adipocytes was resolved by electrophoresis and immunoblotted with anti-2SC 
and anti-Ero1α antibodies. Recombinant Ero1α isolated from Escherichia coli 
strain BL21(DE3) was generously provided by Dr. Kazutaka Araki (Kyoto Sangyo 
University, Japan)(Araki et al. 2011). 2.77 µg protein was incubated in 0.1 M 
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potassium phosphate buffer with 2 mM ethylenediaminetetra acetic acid (EDTA), 
100 µM diethylenetriaminepentaacetic acid (DTPA) and either 0, 1, 5 or 25 mM 
fumarate at 37°C for 24 hours prior to SDS-PAGE and immunoblotting with anti-
2SC and anti-Ero1 antibodies.  
Protein Succination Identification by Mass Spectrometry. For the 
identification of succination sites in PDI, 2.0 µg of recombinant PDI was 
incubated with 100 mM fumarate for 24 hrs at 37°C. The sites of endogenous 
succination of PDI were investigated following immunoprecipitation of PDI from 
adipocytes matured in 5 mM or 30 mM glucose for 8 days. Endogenous 
succination of Keap1 was identified following immunoprecipitation of the V5 
tagged Keap1 protein over-expressed in FHKD adipocytes for 6 days. In all 
cases, samples were resolved by SDS-PAGE, and the gels were stained with 
Coomassie Brilliant blue. After de-staining overnight, the protein was excised 
from the gel and washed in 20% methanol and 7% acetic acid solution to entirely 
remove the Coomassie blue stain. The samples were washed with 200 µL of 100 
mM ammonium bicarbonate (pH 7.4) and dehydrated via acetonitrile and vacuum 
centrifugation for 3 minutes. The gel pieces were allowed to rehydrate in 10 mM 
DTT for 30 minutes at room temperature, followed by alkylation by 170 mM 4-
vinylpyridine in methanol for 30 minutes. Next, the protein samples were washed 
twice with 100mM ammonium bicarbonate (10 minutes) and acetonitrile (5 
minutes) and completely dehydrated in the speed vacuum centrifuge for 3 
minutes. The gel pieces were rehydrated on ice in 50 mM ammonium 
bicarbonate buffer with 2 pmol of Promega sequencing grade modified trypsin 
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(Promega, Madison, WI) and the protein was digested overnight at 37°C. 
Peptides were then extracted from the gel using 4% formic acid and 20% 
acetonitrile solution and were concentrated to a total volume less than 15 µL in 
the speed vacuum centrifuge prior to MS/MS analysis. Selected ion monitoring 
was performed to identify select pyridylethylated and succinated cysteine 
containing tryptic peptides. 1 µL of the digested samples were analyzed on a 
Dionex Ultimate 3000-LC system (Thermo Scientific, Rockford, IL) coupled to a 
Velos Pro Orbitrap mass spectrometer (Thermo Scientific, Rockford, IL). A 75-µm 
C18 stationary-phase LC column was used with a 60-min gradient from 2% 
acetonitrile in 0.1% formic acid solution (solvent A) to 70% solvent A and 30% 
solvent B (40% water in acetonitrile containing 0.1% formic acid). The Orbitrap 
was operated in data-dependent MS/MS analysis mode and excluded all ions 
below 200 counts. An inclusion list of up to 6 abundant isotopic masses +/- 3 
amu was used to select the specific peptides for selected resonance monitoring 
and determination of the site of modification. To further identify specific 
succinated sites MRM was used to monitor select pyridylethylated and 
succinated tryptic peptide masses of interest (generated using Protein Calculator 
software) for CID (collision-induced dissociation)-MS/MS analysis. The data-
dependent and CID-MS/MS data were analyzed using Proteome Discover 1.4 
software with SEQUEST search engine against the uniprot_database October 
2014 (Mus musculus 52,474 proteins). The CID-MS/MS data was sequenced 
manually using Thermo Xcalibur 2.2 software to confirm the modified peptides. 
The variable modifications of methionine oxidation, proline hydroxylation, 
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cysteine pyridylethylation (CPE, 105.058 Da) or cysteine succination by fumarate 
(C2SC, 116.011 Da) were considered in each data search. 
PDI Reductase Activity Assays. Recombinant PDI-wild type (WT) and a mutant 
form of PDI (PDIFLFL) were generously provided by Dr. Danyelle Townsend 
(Medical University of South Carolina, Charleston, SC). 13.85 µg of recombinant 
PDI-WT or PDIFLFL was incubated in 0.1 M potassium phosphate buffer (pH 7) 
with 2 mM EDTA and 0, 1, 5 or 25 mM fumarate for 24 hours at 37°C. PDI 
reductase activity was monitored according to the PROTEOSTAT® PDI assay kit 
instructions (Enzo Life Sciences, Inc. Farmingdale, NY). Di-Eosin-GSSG was 
generously provided by Dr. Bulent Mutus, University of Windsor, Ontario, 
Canada. 6 µg of protein lysate from 3T3-L1 adipocytes or control and db/db 
adipose tissue was incubated with 1.06 µM Di-Eosin-GSSG, 5 µM DTT and 100 
µM DTPA in 0.1 M potassium phosphate buffer, pH 7. Fluorescence was 
measured kinetically (30 sec intervals) on a TECAN Safire2 microplate reader at 
λex= 510 nm and λem= 550 nm.  
Data Analysis. All statistical analysis were preformed using the Sigmaplot 11 
software, using the student t-test (n=3, *p< 0.05, or **p<0.01, ***p<0.001). PDI 
reductase activity in vitro and glutathione measurements were analyzed using a 
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Radio Immunoprecipitation buffer 
50 mM Tris-HCl pH 7.4, 150 mM NaCl, 2mM EDTA, 0.5% sodium deoxycholate, 
0.1% SDS, 1% Triton-X. Dissolve in 200 mL with DI water and store at +4. On 
the day of use, add 2 mM sodium orthovanadate, 2 mM sodium fluoride and 
protease inhibitor cocktail at 1:1000 dilution. 
Sigma Rabbit anti-PDI antibody - IP buffer 
Dissolve 10 mM Tris-Base pH 8, 0.1 mM EDTA, 150 mM NaCl and 0.25% 
Tween-20 in nano-pure water. Add 2 µL protease inhibitor/ sample on the day of 
use. 
10x Wash buffer 
200 mM Tris-HCl pH 7.4 in 1 mL DI water. 0.05% Tween-20 was added to 1x 
wash buffer. 
10x Transfer buffer 
250 mM Tris- HCl and 1920 mM glycine dissolved in 1 mL DI water. 
1x Transfer buffer 
700 mL DI water, 200 mL methanol and 100 mL 10x Transfer buffer 
10X SDS running buffer 




Add 3.785 grams Tris-Base to ~400 mL nano-pure water pH 6.8. Dissolve 10 
grams SDS and bring the final volume to 500 mL with nano-pure water. Before 
stripping add 7 µL beta-mercaptoethanol/1 mL stripping buffer used. 
4x Laemmli loading buffer 
Dissolve 0.969 grams Tris-Base in 10 mL nano-pure water and pH 6.8. Add 
2.468 grams DTT, 3.2 grams SDS, 16 mL glycerol and ~8 milligrams 
bromophenol blue for color. Store at -20ºC. 
Homogenization buffer for intracellular organelle separation 
Dissolve 0.0484 grams Tris-Base in 30 mL nano-pure water and pH 7.4. Add 
0.084 grams MOPS, 0.0156 grams DTPA, 0.0152 grams EGTA and 2.74 grams 
sucrose. Bring the total volume to 40 mL with nano-pure water. Immediately 
before use, add 2 mM sodium orthovanadate, 2 mM sodium fluoride and 
protease inhibitor cocktail at 1:1000 dilution (homogenization buffer+). 
Coomassie Stain 
Stir 400 mL nano-pure water, 100 mL glacial acetic acid and 500 mL methanol 
for 10 mins. Add 2.5 grams Coomassie Brilliant Blue R-250 (*Do not use G-250*) 
and stir for at least 2 hours at room temperature. Filter staining solution using a 
0.45 µm Zap Cap and vacuum aspirator. 
Coomassie Destain 




3T3-L1 Cell Culture Methods 
- Put on gloves and spray your hands with 70% alcohol! 
- All cell culture experiments should be done in the cell culture fume hood. 
- Do NOT open any sterile cell culture plate, container, medium, insulin, 
glucose…. (etc.) outside of the cell culture fume hood. 
- All glass and plastic pipette tips should be autoclaved and dried before using for 
cell culture experiments. 
- NEVER touch the tip of your cell culture pipettes on another surface!!!! (e.g., the 
bottle of medium, the side of the cell culture plate, the surface of the fume 
hood….etc.). If the pipette tip does touch another surface throw out the pipette tip 
and replace it with a new clean tip. 
- Clean the fume hood surface where you will be working with 70% alcohol prior 
to use. 
- Every piece of equipment you will need (pipettes, tubes, medium… etc.) should 
be cleaned with 70% alcohol before placing the item into the cell culture fume 
hood. 
 
Thawing 3T3-L1 fibroblasts 
1) Place the 1L container of 1g/L glucose DMEM +FCS medium in the cell 
culture water bath for ~15 minutes. 
 
2) When the FCS medium is warm take the bottle out of the water bath and 
wipe off any residual water on the outside of the bottle. Then spray the 
outside of the bottle with 70% alcohol and wipe with a paper towel. Place 
the bottle into the fume-hood. 
 
3) Clean one 15 mL tube, one T-75cm2 flask, the 1000 µL pipette and the 
mechanical pipette with 70% alcohol and place in the fume-hood. You will 
also need a few 10 mL sterile pipettes located in the top drawer next to the 
cell culture freezer. 
 
4) Pipette 6 mL of FCS into the 15 mL tube and 10 mL of FCS into the T-
75cm2 flask. Now the work station is set-up and you are ready to get out 




5)  Slowly pull the rack out of the nitrogen tank and remove one vial of (P2 or 
P3) 3T3-L1 fibroblasts from the box. Leave the vial of cells on the 
countertop while you return the rack of boxes to the liquid nitrogen tank. 
 
6) Allow the vial of cells to thaw at room temperature in the cell culture fume 
hood, ~10 minutes. Immediately after the cells have thawed, pipette the 
cells from the vial into the 6 mL of FCS in the 15 mL tube. Centrifuge 
(located in the Frizzell lab) the 15 mL tube containing the cells at 1000 
rpm for 5 minutes at room temperature. A 15 mL balance tube of water is 
located next to the centrifuge in the Frizzell lab. After centrifugation there 
will be a SMALL white pellet on the bottom of the 15 mL tube containing 
the cells. 
 
7) Aspirate all of the medium on top of the pellet using the glass pipettes 
located in the tall metal cylinder in the fume hood. DO NOT DISTURB 
THE CELL PELLET. 
 
8) Re-suspend the cell pellet in 5 mL of FCS medium by pipetting up and 
down ~3 times or just until the pellet is completely dissolved. 
 
9) Pipette all 5 mL of re-suspended cells into the 10 mL of FCS in the T-
75cm flask. Gently swirl the medium in the flask to mix all the cells into the 
medium evenly. Label the flask (P3) 3T3-L1 fibroblasts and today’s date. 
Place the flask into the cell culture incubator. 
 
Cell Culture- Passaging Cells 
 
1L container of 1g/L glucose DMEM +FCS medium and sterile PBS warmed to 
~37°C in the cell culture water bath 
Trypisin- let thaw in the cell culture water bath 
15 mL tube    mechanical pipette 
new flask    200 µL and 1000 µL pipettes 
correct number of plates Sterile 10 mL cell culture pipettes 
 
1) When the PBS and FCS medium is warm take the bottles out of the water 
bath and wipe off any residual water on the outside of the bottle. Then 
spray the outside of the bottle with 70% alcohol and wipe with a paper 
towel. Place the bottle into the cell culture fume hood. 
 





3) Place the flask of cells into the cell culture fume hood. 
 
4) Turn the flask upside down and gather all of the medium into the back 
corner of the flask. Aspirate the FCS medium from the flask and pipette a 
sufficient amount of sterile PBS onto the cells in the flask. Gently swirl the 
PBS around the flask to wash the cells and aspirate the PBS. 
 
5) Pipette trypsin onto the flask and place the flask back into the cell culture 
incubator for ~3 minutes. 
 
a. 25 cm2 flask; 1.5 mL trypsin 
b. 75 cm2 flask; 4 mL trypsin 
c. 150 cm2 flask; 6 mL trypsin 
 
6) Gently tap the bottom of the flask and use the microscope the make sure 
the cells have detached from the flask and are floating in the trypsin 
medium. 
 
7) Pipette enough FCS into the flask to bring the total volume of cells to 12 
mL (use the FCS to wash the cells completely off the bottom of the flask). 
Pipette all of the cells/trypsin/FCS into the 15 mL tube and centrifuge at 
1000 rpm for 5 minutes at room temperature. A 15 mL balance tube of 
water is located next to the centrifuge in the Frizzell lab. After 
centrifugation there will be a small white pellet on the bottom of the 15 mL 
tube containing the cells. 
 
8) Aspirate all of the medium on top of the pellet. DO NOT DISTURB THE 
CELL PELLET! 
 
9) Re-suspend the cell pellet in FCS medium by pipetting up and down ~3 
times or just until the pellet is completely dissolved. 
 
10) Cell Density: pipette 15 µL of cells into the hemocytometer and place on 
the microscope. Count the number of cells in each quadrant of the 
hemocytometer and calculate the average number of cells/ quadrant. 
Example: 
Average 50 cells/0.1 µL = 500 cells/ 1 µL (concentration of cell in 
the 15 mL tube) 
If you want to plate 50,000 cells/ well… 
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50,000/500 cells/µL = 100 µL of cells should be pipetted onto each 
well 
 
11) Pipette FCS medium onto each well and a new flask. Pipette the desired 
density of cells directly into each well and the flask. Gently swirl/mix the 
cells and medium thoroughly. Label each plate and the flask with today’s 
date, the passage number and type of the cell. Place the flask into the cell 
culture incubator. 
 
Cell Culture – Feeding Cells 
*Place the tip of the cell culture pipette close to the wall of each well and slowly 
drip/pipette the cell culture medium down the side of each well. 
24-well plate; 500 µL/well  6-well plate; 3 mL/well 
12-well plate; 1 mL/well  10 cm2 petri dish; 10 mL/dish 
3T3-L1 Fibroblasts 
Medium: 1g/L glucose DMEM + 10% Fetal Calf Serum + 1% (100x) 
Penicillin/streptomycin 
1) Plated fibroblasts are fed every 48 hours until 100% confluent. 
2) Wait 24 hours after wells are 100% confluent before differentiation 
Differentiation 
Medium: 1 g/L glucose DMEM + 10% Fetal Bovine Serum + 1% (100x) 
Penicillin/streptomycin 
1/1000 dilution Dexamethasome 1/100 dilution 1mg/mL insulin   
1/1000 dilution IBMX    25 mM glucose 
1) Slowly aspirate fibroblast medium (FCS) 
2) Add a sufficient amount of sterile PBS to each well, gently swirl plate and 
aspirate PBS off each well 
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3) Add differentiation medium to each well and place the cells back into the cell 
culture incubator for 3 days. 
3T3-L1 Adipocyte Maturation 
Sterile 1 M glucose and 172 nM insulin stocks must be pre-made 
5mM glucose medium: 1 g/L glucose DMEM + 10% Fetal Bovine Serum + 1% 
(100x) Penicillin/streptomycin + 0.3 nM insulin 
25 mM glucose medium: 1 g/L glucose DMEM + 10% Fetal Bovine Serum + 1% 
(100x) Penicillin/streptomycin + 3 nM insulin + 20 mM glucose 
1) Slowly aspirate differentiation medium 
2) Add a sufficient amount of sterile PBS to each well, gently swirl plate and 
aspirate PBS off each well 
3) Add maturation medium to each well and place the cells back into the cell 
culture incubator for 2 days 
4) The maturation medium must be changed every 48 hours throughout the 
duration of the experiment 
Harvesting Cells 
 
1) Label the correct number of 1.5 mL eppendorf tubes (immediately freeze 
samples after harvest) or 15 mL tubes (immediately acetone precipitate 
after harvest). 
 
2) Add 2 mM NaF, 2 mM sodium orthovanadate (SOV) and 1:1000 protease 
inhibitor to RIPA buffer (RIPA+ buffer). 
 
a. Stocks of 500 mM NaF and 500 mM SOV and protease inhibitor 
are all found in the -20 freezer. 
b. Boil the SOV for ~ 7 minutes in the 95°C heating block before you 
add it to the RIPA buffer. Discard the boiled SOV after use in the 
trash can. NaF and protease inhibitor may be re-frozen to use 
again in the -20°C freezer. 
c. You will need 200 µL of RIPA+ buffer/ well on a 6-well plate 
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d. You will need 500 µL of RIPA+ buffer/ 10 cm plate 
 
3) Place PBS on ice 
a. A stock container of PBS should already be made up in the +4 
fridge 
b. You will need total ~100 mL PBS/ 6 well plate 
c. You will need total ~30 mL PBS/ 10 cm plate 
 
4) Wash cell scraper with alcohol pad (wash scraper between each different 
groups of samples) 
 
5) Take your ice bucket to the cell culture room and remove one 6-well plate 
from the cell culture incubator. Place the plate IMMEDIATELY on ice and 
bring the ice bucket back to your lab bench. 
 
6) Discard the cell culture medium into the 1L waste container 
 
7) Wash each well 3x with ICE COLD PBS. Discard PBS into the waste 
container after each wash. 
 
8) Tilt the plate on ice and pipette off the residual PBS 
 
9) Add 200 µL of RIPA+ buffer to each well and rock the plate around so the 
buffer covers the entire well. Open your labeled eppendorf tubes. 
 
10) Tilt the plate downward and scrape the cells toward the bottom of the well 
into the RIPA+ buffer. Keep the plate tilted, do NOT lay the plate flat again 
 
11) Pipette the cells into the open tubes and place immediately on ice. 
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